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1 
Overview 
Part one is a meta-analytic review comparing the efficacy of virtual reality 
treatments (VRTs) and standard psychological therapies for achieving mental health 
symptom reduction. Outcomes from twenty-two randomised-controlled trials were 
quality assessed and meta-analysed. Results indicated that VRTs were equal to, 
and in some cases superior to comparative treatments, depending on the type of 
mental health problem being treated. Methodological and heterogeneity issues 
complicate interpretation. Continued methodologically robust research is required 
before recommendations for practice can be made with confidence. 
Part two presents an empirical study in which virtual reality (VR) was used to 
investigate emotional reactivity and aggression in antisocial personality disorder 
(ASPD). Fifteen individuals diagnosed with ASPD and twenty healthy volunteers 
took part in VR provocation. In response, ASPD participants showed greater 
negative emotional reactivity, less prosocial behaviour, and a trend towards more 
aggression than healthy volunteers. Findings tentatively support the notion that 
ASPD entails difficulties regulating emotions and inhibiting aggression under 
conditions of perceived threat. Modified large-scale replications are required to 
substantiate findings. Improved understanding could inform practices for assessing 
and treating risk of aggression/violence in this population. 
Part three is a critical appraisal of the empirical study. It describes my 
background interest in the research area and critiques a multi-method approach to 
measurement. The potential for VR to be used as a tool to assess and treat 
criminogenic risk in ASPD is discussed in more detail. It concludes with personal 
reflections, highlighting some of the ethical and risk management considerations 
raised by conducting research with this population. 
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ABSTRACT 
Background: Research into virtual reality treatments (VRTs) for a range of mental 
health difficulties has rapidly expanded. There is a need to establish whether the 
theoretical advantages over traditional therapies translate into symptom reduction.  
Objective: To examine the comparative efficacy of VRTs and standard psychological 
interventions.  
Search strategy: Systematic electronic and handsearches from 2001-October 2011.  
Selection criteria: Randomised-controlled trials, comparing VRTs to established 
psychological treatments, designed to reduce mental health symptomatology.  
Analysis: Studies were synthesised according to (1) type of mental health problem 
and (2) time point of outcome measurement. Methodological quality was assessed 
against Cochrane criteria and the Downs and Black checklist (1998). Data was 
analysed in Review Manager (version 5.0).  
Results: Twenty-two RCTs were identified; fourteen treated anxiety disorders, four 
pain and four body-image distortion/obesity. Eighteen studies (n = 741) provided data 
for meta-analysis. There were no differences between interventions for anxiety 
disorder outcomes. Post-treatment, pain symptomatology was significantly reduced 
following VRT compared with established treatment. Trends were observed favouring 
VRT for body image distortion/obesity at both post-treatment and follow-up.  
Conclusions: In light of heterogeneity and methodological issues, it is tentatively 
concluded that VRTs are comparable, and in some instances superior to traditional 
treatments for alleviating mental health symptomatology. Continued efficacy research 
is needed before recommendations for clinical practice can be made with confidence. 
Research into theoretical benefits aside from symptom reduction is also required to 
ascertain the utility and cost-effectiveness of introducing VRT into routine practice. 
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“Any sufficiently advanced technology is indistinguishable from magic”: Arthur C. Clarke  
 
1. INTRODUCTION 
1.1 Virtual reality 
Over the past 15 years advances in computer graphics have revolutionised 
many areas of modern life, ranging from high-tech leisure activities to ground-
breaking medical procedures. One important area of advancement is virtual reality 
(VR), enabling the occupant of a digitalised world to interact with highly realistic 
environments, blurring the boundaries between the artificial and the real.  
VR is “a non-invasive simulation technology that allows a user to interact 
with a computer-generated environment, in the three dimensions of width, height, 
and depth” (Rizzo & Kim, 2005). VR is most commonly presented through a head-
mounted display containing headphones and screens that provide a first-person 
perspective. Motion-tracking devices are embedded in the helmet, which monitor the 
position of the user’s head and adjust the visual imagery, such that the environment 
responds to their body movements in real-time. An alternative is a computer 
automated virtual environment, which projects stereoscopic computer-generated 
images onto three sides of a backlit cubicle. Motion tracking is achieved via an 
electromagnetic tracking system attached to the user’s shutter glasses. The user 
can walk freely and naturally through the installation.  
The success of a VR application hinges in part on the degree to which the 
occupant feels ‘present’, as though physically immersed in the environment (Gregg 
& Tarrier, 2007). This sensation is achieved by shutting out the real world so that 
only computer-generated stimuli are experienced. The use of visual and auditory 
stimuli (and to a lesser extent olfactory and tactile cues) add to this sense of reality. 
Presence can be moderated by individual factors (e.g. the ability to block out 
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distraction) (Witmer & Singer, 1998) as well as the quality of the VR equipment 
(Krijn, Emmelkamp, Olafsson & Biemond, 2004).  
A number of VR systems are available for commercial use. Costs range from 
a few hundred to several thousand pounds (plus the cost of a computer). There is 
scope for purchasers to create and adapt their own environments using 3D software 
packages (Gregg & Tarrier, 2007).  
1.2. VR and psychological research 
In the past 15 years, a range of VR applications have been developed for 
use in psychological and neuropsychological research. VR offers exciting potential 
to observe and measure brain activity and behaviour during dynamic, complex and 
realistic situations, whilst ensuring an exacting degree of control over key variables 
(Bohil, Alicea & Boicca, 2011). Broadly speaking this research has fallen into two 
domains: (i) studies that aim to understand the processes implicated in typical and 
atypical brain functioning and behaviour and (ii) studies that investigate the 
therapeutic application of VR for improving mental health outcomes.  
1.2.1 VR process research  
Given that the focus of the current review is on VR treatments (VRTs), 
process studies are not considered in detail. However, it is worth noting that VR-
assisted research has contributed to the understanding of dementia (e.g. Flynn, 
Schaik, Blackman, Hobbs, & Calderdon, 2003), psychosis (e.g. Ku, Cho, Peled et 
al., 2003) and traumatic brain injury and stroke (e.g. Lee, Ku, Cho et al., 2003). VR 
has also advanced theories of spatial cognition and navigation (e.g. Astur, St. 
Germain, Baker et al., 2005), multisensory integration (e.g. Ehrsson, 2007) and 
social psychology phenomena (e.g. Slater, Antley, Davidson et al., 2006).  
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1.2.2 VR treatments 
In 2002 Norcross, Hedges, and Prochaska conducted a Delphi poll on 
anticipated psychotherapy trends for the coming decade. A panel of psychotherapy 
experts ranked VRT third among 38 therapeutic interventions most expected to 
increase. A plethora of VRTs have since been developed to improve mental health 
outcomes in psychiatric disorders, chronic and acute pain and neurodegenerative 
conditions. Presently, these programs are almost exclusively used in research and 
are yet to filter into routine clinical practice. This is likely to reflect the infancy of 
VRTs, concerns about cost-effectiveness, clinicians’ wariness about heavy reliance 
on technology, and questions about efficacy. However, VRTs offer some theoretical 
advantages over standard therapies, including precise control over the degree of 
exposure to therapeutic scenarios, exposure to scenarios which may otherwise be 
impractical, and the possibility of tailoring VR environments to meet patients’ 
idiosyncratic needs (Gregg & Tarrier, 2007). For these reasons – coupled with 
increasingly sophisticated technology and reductions in equipment costs – research 
into VRTs as a viable treatment option is ever-expanding.  
Most VRTs are based on cognitive and/or behavioural models of treatment. 
However, the therapeutic content varies considerably according to the type of 
mental health difficulty being treated and the corresponding evidence base. The 
extent to which a real-life therapist is involved also varies; a few VRTs deliver both 
cognitive and behavioural elements and may include a ‘virtual therapist’ meaning 
that a real-life therapist has minimal involvement. More commonly, VRTs are 
behavioural and if cognitive components are included in the protocol, they are 
facilitated by a real-life therapist.  
Below the characteristics of three dominant research domains – anxiety 
disorders, body image disturbance/obesity and pain – are considered. As 
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aforementioned, VRTs have been developed to treat other types of mental health 
problems but are beyond the scope of the current review. 
1.3 VRTs for specific mental health conditions 
1.3.1 Anxiety disorders 
VRTs have been most extensively researched in the field of anxiety 
disorders (Powers & Emmelkamp, 2008). These programs are invariably VR 
exposure treatments (VRET’s) in which the user is gradually exposed to computer-
generated internal (e.g. interoceptive arousal) and external (e.g. a phobic object) 
feared stimuli.  Some treatment packages include cognitive components that are 
delivered by a real-life therapist during VRET and/or in concurrent sessions. VRTs 
have been developed for post-traumatic stress disorder (e.g. Difede & Hoffman, 
2002), panic disorder (Choi, Vincelli, Riva, Wiederhold, Lee, & Park, 2005) social 
phobia (e.g. Klinger, Bouchard, Légeron, Roy, Lauer, Chemin, & Nugues, 2005) and 
a range of specific phobias including aviophobia (e.g. Rothbaum, Hodges, Smith, 
Lee, & Price, 2000), acrophobia (e.g. Emmelkamp, Bruynzeel, Drost & van der 
Mast, 2001) and arachnophobia (e.g. Carlin, Hoffman & Weghorst, 1997).  
The therapeutic content reflects the fact that exposure treatment for anxiety 
disorders shows some of the largest effect sizes in the literature (Deacon & 
Abramowitz, 2004) and VRET is seen as a natural extension of this (Emmelkamp et 
al., 2001) with some additional benefits (e.g. Côté & Bouchard, 2008). For some 
anxiety disorders, in vivo exposure is impractical and potentially dangerous (e.g. 
driving phobia) whilst for others the cost is restrictive (e.g. aviophobia). Patients may 
also perceive VRET to be less aversive because they are aware that the technology 
can be switched off (Gregg & Tarrier, 2007). VRET can also recreate situations that 
cannot be re-experienced in vivo such as combat situations (e.g. Rothbaum et al., 
2001). This may be useful for patients with PTSD whose treatment is otherwise 
dependent on their ability to visualise during imaginal exposure. Since avoidance is 
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a core feature of many anxiety disorders, VRET may also prove more effective than 
imaginal exposure as it provides less opportunity for covert avoidance (Tarrier et al., 
1999).  
1.3.2 Pain  
There is a growing body of research into VRTs for pain reduction (Botella et 
al., 2008). These are distraction-based programs, in which the patient enters a 
pleasurable virtual world and is instructed to engage in a cognitive task. For 
example, Hoffman et al. (2006) developed ‘SnowWorld’ in which the user glides 
through an icy canyon and pushes a keyboard button to shoot virtual snowmen. VR 
distraction protocols are predominantly behavioural and do not necessitate a 
therapist’s involvement. They have been developed to reduce experiences of acute 
and chronic pain across a range of contexts, including induced experimental pain 
(e.g. Hoffman et al., 2006), procedural pain (e.g. Nilsson, Finnstrom, Kokinsky, & 
Enskar, 2009) and chronic health conditions (e.g. Leibovici, Magora, Cohen, & 
Ingber, 2009).  
The theoretical rationale is that distraction possesses considerable efficacy 
in pain reduction (Blount, Piira & Cohen, 2003) and it is one of the most commonly 
used psychological methods for analgesia (Botella et al., 2008). Treatment efficacy 
is thought to reflect the fact that because humans have finite attentional resources, a 
distraction task that consumes some portion of those resources leaves less 
cognitive capacity available for processing pain (McCaul & Malott, 1984).  
VR may lend itself to analgesia as it ideally lures attention into the computer-
generated world, leaving less attention available to process incoming nociceptive 
signals (Hoffman et al., 2004). Moreover, VR possesses the characteristics of a 
good distractor, appealing to multiple sensory modalities and provoking emotional 
involvement of the individual (Wismeijer & Vingerhoets, 2005). VR distraction also 
shares the theoretical advantages associated with VRET, including the potential to 
tailor scenarios to meet patients’ idiosyncratic preferences, and to develop scenarios 
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that would otherwise be unaffordable/impractical (e.g. visiting snow canyons). This 
may be particularly important for patients with chronic health conditions, where 
associated disabilities would preclude these activities in reality. 
 
1.3.3 Body-image distortion/obesity   
A less well researched but emerging application of VRT is in the field of 
obesity, with the aim of improving body-image and facilitating weight loss. The focus 
on body-image emerges from the observation that obese populations frequently 
suffer from body-image distortion (Friedman & Brownell, 1995), which has 
repercussions for quality of life and weight gain (Riva, Bacchetta, Baruffi, & Molinari, 
2001). 
The therapeutic content of VRTs in this domain includes: (i) relaxation in 
which the user is immersed in a therapeutic scenario (e.g. a green valley) and, (ii) 
temptation and exposure to triggers of overeating episodes (e.g. a full refrigerator). 
The rationale behind relaxation is that stress and negative emotionality are 
considered critical factors in overeating and preference for calorific foods (Geliebter 
& Aversa, 2003), representing a maladaptive coping strategy (Crowther, Sanftner, 
Bonifazi, & Shepherd, 2001). Traditional obesity treatments therefore include CBT-
based relaxation for managing stress and shifting emotions (Ong, Linden & Young, 
2004). The rationale behind exposure to overeating triggers emerges from CBT 
models of addiction (e.g. Beck, Wright, Newman & Liese, 1993) in which internal 
and external high risk situations trigger cravings, undermine control and provoke 
relapse (Marlatt & Gordon, 1985). Accordingly, CBT packages for obesity (e.g. 
Cooper Fairburn & Hawker, 2003) facilitate relapse prevention by including 
exposure and response prevention.  
Another component of VRT for body-image distortion relates to the VR 
equipment itself, which creates alterations in the occupant’s sensorimotor loops 
(Riva & Melis, 1997). These alterations are unintentionally triggered in almost all VR 
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systems due to distortions, time delays and noise. The somesthetic system contains 
a proprioceptive subsystem that senses the body’s internal state, including the 
position of limbs/joints and muscle tension (Sadowsky & Massof, 1994). Mismatches 
between the signals from the proprioceptive system and the external signals of VR 
lead to greater awareness of the perceptual and sensory processes associated with 
the way the body is experienced. When new information that is incompatible with 
existing body schema is introduced during VR, there may be scope to influence the 
user’s body-image representations.  
When treating body-image distortion/obesity, VR relaxation may be 
preferable to traditional relaxation, as it is not dependent on an individual’s capacity 
to produce relaxing images (Vincelli, 1999). Furthermore, capitalising on the 
inherent psychophysiological effects of VR on body schema may offer an effective 
means of treating body-image distortion, which is conceptualised as a complex 
condition (Thompson, Heinberg, Altabe, & Tantleff-Dunn, 1999). 
 
1.4 Previous reviews of VRT efficacy  
A central question when establishing a new treatment is the degree to which 
it achieves intended outcomes. Outcomes vary from treatment viability, to uptake 
rates, to effects on global functioning. Perhaps most importantly, treatment efficacy 
for achieving symptom reduction requires careful and systematic evaluation. Over 
the past decade, VRT efficacy and effectiveness research for symptomatology 
outcomes has rapidly expanded and been synthesised into a number of narrative 
and meta-analytic reviews (see Table 1).  
1.4.1 Anxiety disorders 
Early qualitative reviews (e.g. Pull, 2005; Krijn, Emmelkamp, Olafsson, 
Biemond, 2004) summarised the results of case studies, open clinical trials and 
uncontrolled designs and concluded that VRET showed promise in treating 
symptomatology in a range of specific phobias (i.e. acrophobia, claustrophobia, 
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aviophobia, and arachnophobia). More recent reviews (e.g. Powers & Emmelkamp, 
2008; Parsons & Rizzo, 2008; Price, Anderson & Rothbaum, 2008; Meyerbroker & 
Emmelkamp, 2010) have synthesised findings from controlled trials. Consistent with 
earlier speculations, VRET out-performed no-treatment conditions in aviophobia, 
acrophobia and arachnophobia, both in primary symptomatology and secondary 
domains (Powers & Emmelkamp, 2008). In terms of comparative treatment 
effectiveness, narrative reviews indicate that VRET is at least as effective as 
traditional exposure for a range of specific phobias (Cote & Bouchard, 2008; 
Meyerbroker & Emmelkamp, 2010). Two meta-analyses have also obtained small 
but significant effects favouring VRET over established treatments for phobias 
(Powers & Emmelkamp, 2008; Parsons & Rizzo, 2008). 
For more complex anxiety disorders, the evidence favouring VRET over no-
treatment conditions is also encouraging. Early narrative reviews (e.g. Pull, 2005) 
summarised findings from several studies of PTSD and social anxiety disorder and 
concluded that there was preliminary evidence for VRET effectiveness. More 
recently, two meta-analyses (Parsons & Rizzo, 2008; Powers & Emmelkamp, 2008) 
found that VRET reduced symptoms of PTSD, social phobia and panic disorder 
compared to no treatment conditions. Research into comparative efficacy for these 
more complex anxiety disorders is less consistent. Although Parsons and Rizzo 
(2008) and Powers and Emmelkamp (2008) found significant effects favouring 
VRET over in vivo exposure for PTSD, panic disorder and social phobia, findings 
were limited by the small combined sample sizes and high proportion of non-
randomised trials included in their meta-analyses.  
Meyerbroker and Emmelkamp (2010) conducted the most recent review of 
the VRET anxiety disorders literature, systematically evaluating the evidence from 
RCTs. Consistent with previous findings, VRET was found to be efficacious for 
specific phobias, comparable – but not necessarily superior – to traditional CBT. The 
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review provided a more sobering look at VRET efficacy for other anxiety disorders, 
noting the lack of comparative treatment trials for PTSD and other complex anxiety 
disorders.  
 
1.4.2 Pain 
Botella et al. (2008) reviewed case-studies, clinical trials and descriptive 
studies for VR distraction in the field of pain management. They concluded that 
immersive VR distraction is a promising technique for treating acute procedural pain 
by way of reducing perceptions of pain, unpleasantness and distress. However, the 
authors cautioned against definitive conclusions, highlighting an absence of 
controlled trials with large samples, and the paucity of research into chronic pain 
management. Shahrbanian, Ma, Korner-Bitensky and Simmonds (2009) narratively 
reviewed 27 RCTs and descriptive studies of VRT. Consistent with Botella et al. 
(2008), they found strong evidence to support immersive VR distraction over no-
treatment conditions for acute pain management, but noted an absence of empirical 
research regarding chronic pain and a paucity of comparative treatment trials.  
Malloy and Milling (2010) described evidence from 11 RCTs and mixed-
model studies that compared VR distraction to control conditions and alternative 
interventions. They concluded that there was solid evidence for the efficacy of VR 
distraction in treating experimental and burn injury pain. However, only three 
comparative psychological treatment trials were reviewed, each with relatively small 
sample sizes. Additionally there was a lack of available evidence for procedural and 
chronic pain, limiting conclusions about efficacy in these domains.  
 
1.4.3 Body-image distortion/obesity  
Riva and Molinari (2009) narratively reviewed case studies, uncontrolled 
trials and RCTs of VRT effectiveness for eating disorders. They concluded that VR 
appeared to be an effective means of reproducing everyday situations that provoke 
negative emotional responses in relation to food. They also concluded that VRT 
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outperformed traditional CBT and psycho-nutrition for reducing body-image 
distortion and improving self-efficacy. However, the review did not critically appraise 
included studies, nor take into account methodological limitations when drawing 
conclusions about effectiveness.  
Gregg and Tarrier (2007) included outcome data from body-image 
distortion/obesity studies in their trans-disorder review of VRT. They tentatively 
concluded that VRT was associated with greater body-image satisfaction and self-
efficacy in the short- and long-term, compared with control conditions and CBT. 
However, no differences were observed between active treatments in the amount of 
weight loss achieved. Gregg and Tarrier (2007) highlighted the need for more 
controlled trials in order to draw conclusions about VRT efficacy in this domain.  
1.5 The current review 
1.5.1 Aims and rationale  
This review provides a systematic overview of existing research into the 
comparative efficacy of VRTs and established psychological treatments for 
achieving symptom reduction across mental health conditions/problems. Primary 
symptom reduction was selected as the outcome of interest as this is a key objective 
in treatment. Other important outcomes (e.g. treatment satisfaction) require 
evaluation, but are beyond the scope of this review.  
Given that several previous reviews have concluded that VRTs out-perform 
no-treatment conditions (e.g. Gregg & Tarrier, 2007; Powers & Emmelkamp, 2008), 
reviewing comparative efficacy is the next logical step. Although Cote and Bouchard 
(2008) point out that VRTs were developed to address the limitations of traditional 
treatments rather than outperform them per se, there is a need to establish whether 
these theoretical benefits translate at a symptom reduction level. This could inform 
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decision-making about the utility and cost-effectiveness of implementing VRTs in 
routine clinical practice.  
Although a number of previous reviews (see Table 1) have synthesised VRT 
efficacy data, there is a need for a fresh look at the existing evidence for a number 
of reasons. First, with the exception of Meyerbroker and Emmelkamp (2010), 
previous reviews have included studies that fail to meet stringent methodological 
criteria, thereby limiting empirical decision-making. Second, most of the earlier 
studies reviewed contained small sample sizes and made inadequate use of null 
hypothesis significance testing (Parsons & Rizzo, 2008). Conversely, studies in the 
present review are limited to RCTs that include samples of 10 or more per condition. 
Third, most of the RCTs have historically been limited to specific phobias; recent 
research regarding the efficacy of VRTs for treating other disorders/conditions 
requires evaluation. Finally, the majority of previous reviews did not quality assess 
studies or meta-analyse outcomes.  
Since there are still relatively few large-scale studies on the effects of VRT 
on mental health symptom reduction, a meta-analytic review may be the most 
appropriate method for synthesising data. Such analyses provide estimates of a 
population effect size across independent studies. They increase statistical power to 
detect true nonzero population effects by lowering the standard error, thereby 
narrowing the confidence intervals associated with the population effect size 
estimate (Cohn & Becker, 2003). Hence, a meta-analysis – as opposed to a 
qualitative review – might facilitate a better understanding of the comparative 
efficacy of VRTs and established psychological treatments.  
The conceptual focus of the present review differs from previous reviews in 
that it includes studies generated from across mental health problem domains that 
applied a range of VRTs. Two previous reviews (Glantz, Rozzo & Graap, 2003; 
Gregg & Tarrier, 2007) synthesised trans-disorder data but the body of efficacy 
research has significantly expanded since their publication.  
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The present review assesses the quality of published RCTs using Cochrane 
criteria and the Downs and Black (1998) checklist. In light of these findings meta-
analytic methods are applied to ask: 
 Are there differences between VRTs and standard psychological treatments on 
symptomatology outcomes across mental health conditions/problems, both at post-
treatment and long-term follow-up?  
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Table 1: Reviews into the effectiveness of VRTs for improving mental health outcomes conducted between 2001 and October 2011 
Author (date) Population/problem Research question  Method  Main Findings  Difference from current review 
ANXIETY 
DISORDERS  
 
Bush (2008) 
 
 
 
 
 
 
 
Coelho et al. 
(2009) 
 
 
 
 
 
 
 
 
 
 
Côté & Bouchard 
(2008) 
 
 
 
 
 
 
Anxiety disorders  
 
 
 
 
 
 
 
Acrophobia (fear of 
heights) 
 
 
 
 
 
 
 
 
 
 
Specific phobias  
 
 
 
 
 
 
 
The viability of VRET for 
treating anxiety disorders.  
 
 
 
 
 
 
The utility of VRET in the 
research and treatment of 
acrophobia.  
 
 
 
 
 
 
 
 
 
Effectiveness and efficacy 
of VRET compared to 
control conditions and 
traditional treatments  
 
 
 
 
Narrative  
 
 
 
 
 
 
 
Narrative  
 
 
 
 
 
 
 
 
 
 
 
Narrative  
 
 
 
 
 
 
 
VRET is effective for treating specific 
phobias compared to control 
conditions. Shows promise in other 
anxiety disorders, but there is limited 
research and absence of RCTs. Need 
to reduce the costs of VRE in order to 
increase uptake.  
 
VRET is well established effective 
treatment. It offers theoretical benefits 
over in vivo exposure, including better 
control over the situation, avoiding 
public embarrassment and 
preservation of confidentiality. VR has 
also contributed to the understanding 
of acrophobia: e.g. it is motion 
combined with height, rather than 
height per se, that triggers phobic 
response.  
 
VRET outperforms control conditions 
and appears to be at least as 
efficacious as traditional exposure. 
However, more studies with stronger 
methodological criteria are needed to 
 
 
 
Limited to anxiety disorders and 
exposure. Included case studies 
and small n designs.  Did not 
evaluate comparative treatment 
efficacy.  
 
 
 
Limited to acrophobia. 
Reviewed process studies as 
well as treatment studies. 
Reviewed case studies in 
addition to controlled trials.  
 
 
 
 
 
 
 
Limited to phobias. Included non 
RCTs and case studies. 
Primarily reviewed VRET in 
comparison to control groups 
rather than active treatment 
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Da Costa et al. 
(2008) 
 
 
 
 
 
 
Da Costa et al. 
(2010) 
 
 
 
 
 
 
 
 
Krijn et al. (2004) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aviophobia (fear of 
flying) 
 
 
 
 
 
 
Driving phobia 
 
 
 
 
 
 
 
 
 
Anxiety disorders  
 
 
 
 
 
 
 
 
 
 
 
 
 
The effectiveness of VRET 
for treating aviophobia. 
 
 
 
 
 
 
The effectiveness of VRET 
for treating driving phobia.  
 
 
 
 
 
 
 
 
Effectiveness of VRET for 
treating anxiety disorders.  
 
 
 
 
 
 
 
 
 
 
 
 
Narrative  
 
 
 
 
 
 
 
Narrative  
 
 
 
 
 
 
 
 
 
Narrative  
 
 
 
 
 
 
 
 
 
fully form conclusions about 
comparative treatment efficacy.  
 
 
VRET appears to be effective in 
aviophobia treatment and out-
performs control conditions. VRET 
effective with or without CBT and/or 
psychoeducation. There is a need for 
more RCTs to assess efficacy.  
 
 
VRET shows promise in reducing 
anxiety associated with driving 
phobia. It is cost-effective and 
reduces some of the risks associated 
with in vivo exposure. However, for 
some patients VRET may not be 
sufficient in isolation. More RCTs are 
required to fully evaluate efficacy. 
 
 
Evidence for the effectiveness of 
VRET for treating aviophobia, 
acrophobia and arachnophobia. 
Requires more RCTs with larger 
samples, comparing VRET to 
standard exposure. Also, need trials 
that assess VRET as standalone 
treatment rather than in conjunction 
with other treatments. 
 
conditions.  
 
 
 
Only focussed on aviophobia. 
Included non-randomised trials 
and no-treatment control 
groups. Was not seeking to 
evaluate comparative treatment 
efficacy.  
 
 
Only focused on driving phobia. 
Included uncontrolled trials 
(case studies) and no-treatment 
conditions. Was not seeking to 
compare VRET to other 
psychological treatments.  
 
 
 
 
Limited to anxiety disorders. 
Included case studies. Did not 
directly set out to assess 
comparative treatment efficacy.  
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Meyerbroker & 
Emmelkamp 
 (2010) 
 
 
 
 
 
 
 
 
 
 
Parsons & Rizzo 
(2008) 
 
 
 
 
 
 
 
 
 
 
 
 
Powers & 
Emmelkamp 
(2008) 
 
 
Anxiety disorders  
 
 
 
 
 
 
 
 
 
 
 
 
Anxiety disorders  
 
 
 
 
 
 
 
 
 
 
 
 
 
Anxiety disorders  
 
 
 
 
The efficacy of VRET for 
treating anxiety disorders 
(controlled studies only). 
Also investigated 
process/mechanisms of 
change underlying VRET.  
 
 
 
 
 
 
 
The effectiveness of VRET 
on affective outcomes for 
treating anxiety disorders 
(PTSD, social phobia, 
acrophobia, aviophobia, 
arachnophobia) 
 
 
 
 
 
 
 
 
The efficacy of VRET 
compared to in vivo 
exposure and control 
conditions (e.g. wait-list) for 
treating primary and 
Systematic 
 
 
 
 
 
 
 
 
 
 
 
 
Meta-
analysis 
 
 
 
 
 
 
 
 
 
 
 
 
Meta-
analysis 
 
 
 
There is only strong evidence for the 
effectiveness of VRET compared to 
established treatments in treating 
specific phobias. Results are also 
promising for more complex anxiety 
disorders, but controlled trials are 
required to inform empirical decisions. 
Many studies used VRT in conjunction 
with other treatment techniques; thus 
more research is required to 
dismantle the effective ingredients.  
 
 
Large decline in affective anxiety 
symptoms across all disorders 
following VRET compared to control 
groups and comparative treatments. 
However, some sample sizes small 
(e.g. PTSD) and there was an 
absence of information available for 
moderator analysis. More research 
needed for uniform and detailed 
understanding of moderators to 
treatment effectiveness (e.g. 
presence, immersion, duration of 
anxiety disorder). 
 
Large effect size for VRET compared 
to control conditions in primary 
symptom reduction and secondary 
domains (e.g. general functioning). 
Also small but significant effect 
Only anxiety disorders and 
VRET. Included no-treatment 
conditions in addition to 
comparative treatments. 
 
 
 
 
 
 
 
 
 
Only anxiety disorders and 
VRET. Only focused on affective 
outcomes, not necessarily 
primary symptom reduction. 
Included case reports in addition 
to RCTs.  
 
 
 
 
 
 
 
 
Limited to anxiety disorders and 
VRET. Included studies that 
compared VRET to no-
treatment/wait-list control in 
addition to traditional 
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Price et al. (2008) 
 
 
 
 
 
 
 
 
 
Pull (2005) 
 
 
 
 
 
 
 
PAIN 
 
Botella et al. 
(2008) 
 
 
 
 
 
 
 
 
 
 
Aviophobia  
 
 
 
 
 
 
 
 
 
Anxiety disorders  
 
 
 
 
 
 
 
 
 
Pain  
 
 
 
 
 
 
secondary outcomes in 
anxiety disorders (specific 
phobias, social phobia, 
panic disorder, PTSD). 
 
The effectiveness of VRET 
for treating aviophobia.  
 
 
 
 
 
 
 
 
The effectiveness of VRET 
for treating anxiety 
disorders.  
 
 
 
 
 
 
 
The effectiveness of VR 
distraction for reducing pain 
during medical procedures. 
 
 
 
 
 
 
 
 
 
Narrative   
 
 
 
 
 
 
 
 
 
Narrative  
 
 
 
 
 
 
 
 
 
Narrative  
 
 
 
 
 
 
favouring VRET over in vivo 
exposure. A dose-response effect was 
found; more VRET sessions were 
associated with larger effects.  
 
VRET effective in treating aviophobia. 
Comparable to established 
treatments, i.e. In vivo and cognitive 
therapy. However, studies that strictly 
used VRET protocol obtained weaker 
effect sizes than those that 
incorporated cognitive elements. 
VRET offers some benefits (e.g. 
privacy) over traditional treatment.  
 
VRET appears to have potential for 
treating a range of anxiety disorders. 
However, there is an absence of 
controlled trials; further research is 
required to confirm VRET efficacy.  
 
 
 
 
 
VR distraction is a promising 
technique for pain control in medical 
procedures. However, there is a need 
for more controlled trials with larger 
samples, using subjective as well as 
objective measures of pain.  
 
treatments.  
 
 
 
 
Only focused on aviophobia and 
VRET. Included case studies in 
addition to controlled trials. 
Included no-treatment 
comparison groups.  
 
 
 
 
 
Only anxiety disorders and 
VRET. Included small n designs, 
uncontrolled trials and case 
studies. Not seeking to directly 
assess comparative treatment 
efficacy. 
 
 
 
 
Focused exclusively on VRTs 
for pain. Included case studies 
and un-controlled studies. Was 
not trying to evaluate efficacy in 
relation to other types of 
psychological treatment.  
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Mahrer & Gold 
(2009) 
 
 
 
 
 
Malloy & Milling 
(2010) 
 
 
 
 
 
 
Shahrbanian et 
al. (2009) 
 
 
 
 
 
Body image/ 
obesity 
 
Riva & Molinari 
(2009) 
 
 
 
 
 
Pain 
 
 
 
 
 
 
Pain 
 
 
 
 
 
 
 
Pain 
 
 
 
 
 
 
 
 
 
Eating disorders/ 
obesity  
 
 
 
 
 
The effectiveness of VRT 
for pain control  
 
 
 
 
 
Effectiveness of VR 
distraction in pain reduction 
in controlled trials only. 
 
 
 
 
 
The effectiveness of VR for 
pain management (RCT 
and descriptive studies 
only).  
 
 
 
 
 
 
The effectiveness of VRET 
for reducing negative 
emotions related to food 
and body-image.  
 
 
 
Narrative  
 
 
 
 
 
 
Narrative  
 
 
 
 
 
 
 
Systematic  
 
 
 
 
 
 
 
 
 
Narrative  
 
 
 
 
 
 
VRT for pain is in infancy but shows 
promise in specific conditions and 
acute procedural pain. More research 
required with sound methodology and 
large samples to draw firm 
conclusions on effectiveness.  
 
VR distraction effective at reducing 
experimental pain and burn injury pain 
compared to non-VR distraction and 
NT. Inconsistent findings for needle-
related pain.  More sophisticated VR 
technology is associated with greater 
pain reduction.  
 
There is strong evidence supporting 
immersive VR for treating acute pain 
but limited evidence for reductions in 
chronic pain. More RCTs and more 
research into non-immersive VR 
approaches are required.  
 
 
 
 
VRET appears to be a valid means of 
simulating everyday situations that 
provoke negative emotional 
responses in patients with eating 
disorders/obesity. It also appears to 
facilitate improvements in body-image 
 
Focus on pain studies only. 
Reviewed case studies and non-
controlled trials in addition to 
RCTs.  
 
 
 
Only pain studies reviewed. 
Included no-treatment control 
groups in addition to non-VR 
distraction and hypnosis.  
 
 
 
 
Pain studies only. Included 
descriptive studies. Review did 
not directly seek to evaluate 
comparative treatment efficacy.   
 
 
 
 
 
 
Eating disorders only. Included 
case studies and uncontrolled 
trials in addition to RCTs. No 
quality assessment or meta-
analysis performed.  
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Trans-disorder 
 
Glantz et al. 
(2003) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gregg & Tarrier 
(2007) 
 
 
 
 
 
 
 
 
 
 
 
Mental health 
problems (various) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mental pealth 
problems (various) 
 
 
 
 
 
The progression of VRT for 
mental health problems.  
 
 
 
 
 
 
 
 
 
 
 
 
 
A review of the current 
status of VRT in the mental 
health arena.  
 
 
 
 
 
Narrative  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Meta-
analysis  
 
and self-efficacy over and above 
traditional treatments.  
 
 
VRTs have been developed for wide 
range of mental health problems. 
There is evidence of effectiveness in 
treating specific phobias. Some 
promising evidence for treating PTSD 
but mostly from case studies. VRT 
offers potential for treating eating 
disorders and pain but research is in 
infancy. The lack of comparative 
treatment trials in pain precludes 
conclusions about cost-effectiveness.   
VRTs for social phobia are only just 
emerging.  
 
 
VRTs are more effective than no-
treatment conditions but the available 
data does not support the 
effectiveness of VRT over traditional 
forms of treatment. There is a need 
for controlled trials involving clinical 
populations in order to assess the 
comparative efficacy of VRTs.   
 
 
 
 
Many uncontrolled trials and 
case studies. Lack of 
comparative treatment studies 
across all mental health 
domains. No meta-analysis 
performed. 
 
 
 
 
 
 
 
 
 
Many studies reviewed were 
case studies. Was seeking to 
assess the efficacy of VRT 
compared to no-treatment 
conditions in addition to other 
treatments.   
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2. METHOD 
2.1 Inclusion and exclusion criteria for studies in this review 
Studies were selected according to the following apriori inclusion criteria:  
 Scope of studies:  
1. Published between 2001 and October 2011  
2. English language  
3. Peer reviewed journal articles  
 
 Design of studies:  
1. Randomised-controlled trials, comparing VRT efficacy with at least one other 
active psychological treatment  
2. A sample size of >10 in each active treatment group  
 
 Types of participants:  
1. Adult, adolescent and child populations; 
2. Suffering from a mental health condition/psychological problem requiring 
intervention  
3. Recruited from clinical (e.g. hospital) and/or non-clinical (e.g. students) 
settings  
 
 Types of interventions:  
1. One or more session(s) of any type of VRT (e.g. VRET, VR distraction,) and; 
2. One or more session(s) of established psychological treatment (e.g. CBT) 
routinely delivered for the presenting problem under investigation 
3. Studies that had a non-active arm (e.g. wait-list) as an adjunct to active 
treatments were also included   
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 Types of primary outcome measures: 
1. At least one validated measure or visual analogue scale of symptom severity 
relevant to the presenting problem(s)  
 Excluded studies:  
1. Reviews/meta-analyses, or other non-primary research 
2. Studies in which the comparative treatments were non-psychological (e.g. 
pharmacological treatment in isolation)  
 
2.2 Search Strategy  
Four procedures were used to identify all relevant studies published 
between 2001 and the cut-off date of October 2011.  
1. The PsychInfo and Medline databases were searched within the specified 
timeframe.  
2. Previous literature reviews in the field of VR and mental health were consulted. 
These reviews were identified during electronic searches and by consulting 
The Cochrane and Campbell Collaboration databases and hand-searching 
Clinical Psychology Review in the last two years.  
3. Within these databases, two key journals (i.e. those that produced the most 
hits relevant to the subject area) were hand-searched over the past two years:  
Annual Review of Cybertherapy & Telemedicine, and Cyberpsychology & 
Behaviour.  
4. The reference lists of identified articles were scanned to detect any studies 
that might have been missed during the electronic search.  
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2.2.1 Electronic search of databases  
A systematic search of the PsychInfo and Medline databases was carried 
out, limiting results to peer reviewed journals (applied post-hoc in Medline) and 
English language articles published between 2001 and October 2011.  
Initial searches included broad search terms to identify studies that 
investigated the application of VR in the mental health arena. Terms such as 
“computer-assisted treatment” were not included in the final search strategy as they 
yielded an over-inclusive group of studies (e.g. computerised CBT) and failed to 
elucidate any relevant studies over-and-above more stringent search terms (e.g. 
virtual reality). Additional problem-specific terms such as 
anger/psychosis/schizophre*/developmental disorders (the asterisk is a wildcard 
convention used to encompass variant terms such as schizophrenia, schizophrenic 
etc.) were initially included but failed to produce any relevant hits and were therefore 
dropped.  
To maximise specificity and relevance of hits, the final search terms (see 
Table 2) delineated (a) clinical condition/problem, (b) intervention type, (c) 
comparison group and (d) outcome of interest (efficacy as opposed to process-
driven studies). Terms were entered as individual ‘Keyword’ searches and thereafter 
in combination. Individual search terms were also exploded and combined (e.g. 
mental health and virtual reality) in the PsychInfo and Medline thesauruses but 
yielded no new relevant studies. This indicated that the chosen search terms 
sufficiently captured all relevant studies in the field. 
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Table 2: Electronic search terms  
Search term category                           Terms applied  
Condition/problem  
 
 
Intervention  
 
Comparison  
 
 
Outcome 
anx*/depress*/phobi*/psychol* disorder/mental health/ 
post traumatic/ pain/eating disorder/obes* 
 
virtual reality/virtual environment 
 
compar*/control group/cognitive behavio?r /in vivo 
exposure/treatment as usual 
 
intervention/treat*/therap*/efficacy/effectiveness/symptom* 
 
 
2.3 Data collection and analysis  
2.3.1 Screening and selection 
All studies were first screened for content relevance by title and were 
included if they referred to any VRT for mental health conditions/problems. 
Thereafter detailed checks were made against selection criteria based on the 
abstracts and full text of articles.  
2.3.2 Data extraction 
Data were extracted from full text copies of studies that met inclusion criteria 
and organised in a data extraction form (see Table 3) according to the 
problem/condition being treated. Information extracted included sample size, age, 
gender mix, length of treatment, number of sessions, VRT treatment components, 
comparative treatment components, diagnostic and outcome measures, length of 
follow-up and the quality rating obtained on the Downs & Black checklist (1998).  
2.3.3 Assessment of risk of bias   
Risk of bias was assessed in two ways. Firstly according to the standard 
approach described in the Cochrane Handbook for Systematic Reviews of 
Interventions (Higgins & Green, 2005), which considers sequence generation, 
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allocation concealment, blinding of assessors and reporting of loss to follow-up. 
Secondly, methodological quality was critically appraised using the Downs and 
Black checklist (1998) (see Appendix 1). This checklist was developed to evaluate 
the quality of randomised and non-randomised studies of healthcare interventions. It 
includes 27 items divided into 5 subscales: reporting (10 items), external validity (3 
items), internal validity bias (7 items), internal validity confounding (6 items), and 
power (1 item). A maximum score of 32 is obtained, with higher scores representing 
better methodology.  
The Downs and Black checklist (1998) possesses good test-retest reliability 
(r = .88) and internal consistency (Kuder-Richardson formula 20 = .89).  The item 
concerning blinding of participants to treatment condition is not relevant to 
psychological intervention research, as it is rarely possible to conceal from 
participants which treatment they are receiving (Roberts, Kitchiner, Kenardy & 
Bisson, 2010). Additionally, due to the inherent characteristics of RCTs, scores on 
the external validity items are typically low.   
2.3.4 Data synthesis   
Studies were classified according to (1) the type of problem/condition being 
treated and (2) time-point of outcome measurement, distinguishing between those 
that utilised a pre-post design and those that included long-term follow-up.  
2.3.5 Measures of treatment effect  
Review Manager 5.0 was used to calculate overall estimates of treatment 
effect with 95% confidence intervals (negative estimates representing results 
favouring VRTs). Owing to the heterogeneity of outcome measures (utilising 
different scales of measurement) continuous data were analysed using standardised 
mean difference (SMD). Separate post-treatment comparisons were run for the 
three categories of mental health problems that emerged from the literature. Where 
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applicable, separate comparisons were also conducted for follow-up data, in order to 
investigate comparative longitudinal treatment effects.  
2.3.6 Unit of analysis issues  
Meta-analytic methods were applied to contribute to the review question; 
namely to establish the comparative efficacy of VRTs versus established 
psychological treatment at achieving primary symptom reduction in the short and 
longer term. Consequently, data from other outcome domains (e.g. treatment 
satisfaction) were not included in the analysis.  
Where studies used multiple outcome measures of symptomatology, the 
meta-analysis included the main measure if this was reported by the authors. Where 
this information was not readily available, the most widely used and/or validated 
measure was selected for analysis. 
In three-armed (or more) trials that included wait-list/no-treatment conditions, 
only active treatments were entered into the meta-analysis. The rationale behind this 
is that previous reviews of the literature (e.g. Powers & Emmelkamp, 2008) have 
provided evidence favouring VR-based treatments over no treatment conditions; 
therefore it was not considered worthwhile repeating this analysis. In three-armed 
trials that included more than two active treatments, the most well-established 
comparative psychological treatment (and best fit to its VRT counterpart) was 
selected for inclusion in the analyses. 
2.3.7 Assessment of heterogeneity  
Forest plots were visually inspected to explore for heterogeneity. 
Heterogeneity between studies was also measured by observing the I squared test 
and the chi-squared test (p < 0.10). An I-squared of less than 30% was considered 
to indicate mild heterogeneity and in these instances a fixed-effects model was 
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applied to synthesise the results. This model makes the assumption that there is 
one single average effect (the comparative efficacy VRT) and that studies which are 
combined come from a population measuring this fixed effect. An I-squared of 30% - 
50% was taken to indicate moderate heterogeneity. An I-squared of above 50% was 
considered to indicate notable heterogeneity and in these instances a random-
effects model was used to synthesise results.  
2.3.8 Assessment of publication bias  
It was decided apriori that if sufficient studies were available, funnel plots (of 
treatment effects estimated against the sample size of the studies) would be 
prepared and examined for signs of asymmetry. Where asymmetry was identified, 
possible reasons for this would be considered.  
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3. RESULTS 
3.1 Results of the search  
The combined electronic searches produced 136 references. Studies were 
immediately excluded if they were not RCTs (e.g. Penate, Pitti, Bethencourt, Fuente, 
& Gracia, 2007), focused exclusively on mediators (e.g. Krijn, Emmelkamp, 
Biemond et al., 2004) and/or moderators (e.g. Gorini, Mosso, Mosso, Pineda et al., 
2009), or concerned outcomes other than symptomatology (e.g. St-Jacques, 
Bouchard & Belanger, 2010). Thereafter the abstracts of 64 articles identified for 
potential inclusion were consulted. This left 39 references, which were read in 
entirety for more detailed checks against inclusion/exclusion criteria. This procedure 
identified 22 eligible studies to be included in the review. Sixteen of these were 
identified from electronic databases and six (Leibovici et al., 2009; Mühlberger et al., 
2003; Patterson et al., 2006; Riva et al., 2001; Riva et al., 2002; Wiederhold et al., 
2002) were sourced elsewhere (e.g. reference lists). The main reasons for excluding 
the 17 trials were insufficient sample sizes and non-randomised allocation to 
treatment conditions. A flow diagram is presented in Figure 1. 
3.2 Description of included studies  
3.2.1 Design of studies  
By virtue of the selection criteria, all 22 studies were RCTs with two or more 
active treatment arms. None of the participants were blinded to their treatment 
group. Sample sizes of the included studies varied between 20 (McLay et al., 2011) 
and 211 participants (Riva et al., 2006), totalling 1192. Full details of included 
studies are described in Table 3.  
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3.2.2 Scope of studies  
Of the 22 studies included in the review, 13 were conducted in European 
countries, five in the United States, two in Canada, one in Asia and one in Australia. 
Fourteen studies recruited participants with anxiety disorders, four with body-image 
distortion/obesity and four with pain. The majority recruited from hospital/clinic 
settings (n = 12) and the remainder from community (n =7) and student populations 
(n = 3). All studies recruited adult samples except for Gershon et al. (2004) and Mott 
et al. (2008) which recruited children and adolescents.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Flow diagram of electronic search strategy  
64 references  
72 excluded references screened for 
content relevance by title 
25 excluded articles screened for 
content relevance by abstract  
39 references   
17 excluded studies based on 
inclusion/exclusion criteria   
22 eligible articles for 
inclusion in the 
review    
Searches 136 
references  
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Table 3: Randomised controlled trials of virtual reality and comparative treatment efficacy  
Author  
(year) 
Condition/problem         Sample/therapist 
characteristics  
 
VR treatment 
characteristics 
Comparative treatment 
characteristics  
   Measurement¹  Post-treatment outcome 
 
Follow-up  Quality 
rating  
 
ANXIETY 
DISORDERS 
 
Banos et al. 
(2011)  
 
 
 
 
 
 
 
Botella et al. 
(2007) 
 
 
 
 
 
 
 
 
Choi et al. 
(2005) 
 
 
 
 
 
 
 
 
 
 
 
 
PTSD, 
Pathological 
grief (PG) & 
Adjustment 
disorders (AD) 
 
 
 
 
Panic Disorder 
& Agoraphobia 
(PDA) 
 
 
 
 
 
 
 
PDA 
 
 
 
 
 
 
 
 
 
 
 
 
 
Volunteers  
Total N = 39  
Female = 69.2% 
Age: M = 30.9 
Therapists: Doctors 
and PhD students 
experienced in CBT 
delivery 
 
Clinic attendees  
Total N = 37 
Female = 70.3% 
Age: M = 34.7 
Therapists:  
Psychologists 
trained in CBT for 
PDA 
 
 
Clinic attendees  
Total N = 40 
Male = 50% 
Age: M = 36.2 
Therapists:  
Unspecified 
characteristics  
 
 
 
 
 
 
 
VR-based emotional 
therapy (education/ 
VR exposure/cognitive 
restructuring/RP) 
Duration: 4-9 x 60-90 min. 
n = 19 
 
 
 
VR exposure  (VRE to 
interoceptive and external 
feared stimuli) with non VR 
education/restructuring/ 
RP 
Duration: 9 x 60 min 
n = 12 
 
 
 
VR-CBT alongside non-VR 
group CBT (both 
components sequentially 
delivered education/ 
restructuring/ 
relaxation/interoceptive 
exposure/VR exposure) 
Duration:4 x 150 min (120 
min of group CBT, 30 min 
VR-CBT), n = 20 
 
 
 
 
Standard CBT (education/ 
imagined exposure/ in 
vivo exposure/ 
restructuring/RP)  
Duration: 4-9 x 60-90 min 
n = 20 
 
 
 
(a) In-vivo exposure (IVE 
to interoceptive and 
external feared stimuli) 
with education/RP  
Duration: 9 x 60 min 
n = 12 
(b) waiting-list (WL)  
n = 13 
 
 
Panic Control Program 
group (education/ 
relaxation/restructuring/ 
interoceptive exposure/ 
in vivo exposure) 
Duration: 12 x 120 min 
n = 20 
 
 
 
 
 
 
 
Diagnosis: Clinical interview 
using DSM-IV criteria 
Symptomatology: FAS, BDI, 
PANAS, MS, 
Interference/Severity Scale:  
adapted from ADIS-IV 
 
 
 
Diagnosis: ADIS-IV 
Symptomatology: FAS, PDSS, 
ASI, idiographic  PA record, 
FQ, BDI; MS 
Treatment expectation/ 
satisfaction: A newly 
designed scale 
 
 
 
Diagnosis: Clinical interview 
using DSM-IV criteria  
Symptomatology: BDI, STAI,  
ASI, ACQ, BSQ, PBQ, amount 
of medication discontinuation  
 
 
 
 
 
 
 
 
 
Both treatment groups 
showed significant 
improvements on all 
outcome measures. VR-
therapy had significantly 
better outcomes than CBT on 
several measures (e.g. BDI).  
 
 
VRE and IVE groups showed 
significant reductions on 
symptomatology outcomes 
compared to WL. No 
significant difference in 
treatment efficacy or 
expectations/satisfaction 
between VRE and IVE.  
 
 
Both groups showed 
significant symptom 
reduction. No between-group 
differences on standardized 
measures or medication 
discontinuation.  
 
 
 
 
 
 
 
 
None  
 
 
 
 
 
 
 
 
12 months: Both 
groups continued 
improving and/or 
maintained treatment 
benefits. No 
significant differences 
in symptomatology or 
satisfaction between 
VR and IVE groups.  
 
6 months: Both 
groups maintained 
treatment benefits. 
Significantly more 
PCP patients had 
discontinued 
medication than VR-
CBT patients; VR less 
efficacious that PCP 
long-term. 
 
 
 
 
21 
 
 
 
 
 
 
 
 
27 
 
 
 
 
 
 
 
 
 
16  
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Emmelkamp 
et al. (2002) 
 
 
 
 
 
 
 
 
 
 
Krijn et al. 
(2007) 
 
 
 
 
 
 
 
 
 
 
 
 
McLay et al. 
(2011) 
 
 
 
 
 
 
 
 
 
Acrophobia  
 
 
 
 
 
 
 
 
 
 
 
Aviophobia 
(FOF) 
 
 
 
 
 
 
 
 
 
 
 
 
PTSD 
 
 
 
 
 
 
 
 
 
 
Volunteers  
Total N = 33 
Male = 54.5 
Age: M = 43.97 
Therapists: Clinical 
psychology 
students/clinical 
psychologist with 
advanced training 
in behavioural 
therapy 
 
Volunteers  
Total N = 59 
Female = 66% 
Age M = 38.58 
Therapists:  
Unspecified 
characteristics 
 
 
 
 
 
 
 
Clinic attendees 
(active military 
servicemen) 
Total N = 20 
Male: 95% 
Age M = 28.4 
Therapists: 
Licensed 
Psychologists 
 
 
VRE (to 3 feared scenarios) 
Duration: 3 x 60 min 
n = 17 
 
 
 
 
 
 
 
 
 
VRE followed by non-VR 
group-based CT (GBCT: 
education/cognitive 
techniques) 
Duration: 9 sessions (4 x 60 
min VRE, 5 x 60 min GBCT)  
n = 30 
 
 
 
 
 
 
 
VR gradual exposure 
therapy (VRGET) with non-
VR education/ attentional 
control/ relaxation 
training/hotspot 
identification  
Duration: 10-20 x 60 min 
n = 10 
 
 
 
IVE (to 3 scenarios) 
Duration: 3 x 60 min 
n = 16 
 
 
 
 
 
 
 
 
 
(a) CBT (education/ 
relaxation/IVE) followed 
by GBCT (education/ 
cognitive techniques) 
Duration: 4-9 sessions (2-
4 x 60 min CBT, 5 x 60 
min GBCT)  
n = 23 
(b) Biblotherapy (BIB: 
educational booklet) 
Duration: 5 x 60 min 
n = 19 
 
 
TAU (including: CBT, 
EMDR, prolonged 
exposure and medication) 
Duration: varied 
n = 10 
 
 
 
 
 
 
Diagnosis: SCID-I, SCL-90 
Symptomatology: AQ, ATHQ, 
BAT 
 
 
 
 
 
 
 
 
 
Diagnosis: The MINI, SCL-90 
Symptomatology: FAS, FAM 
Coping: CERQ-F, and a newly 
designed self-efficacy 
questionnaire.  
 
 
 
 
 
 
 
 
 
Diagnosis: The MINI, The 
CAPS 
Symptomatology: The CAPS 
 
 
 
 
 
 
 
 
Both VRE and IVE significantly 
reduced anxiety and 
avoidance on all measures. 
No significant differences in 
treatment efficacy between 
VRE and IVE.  
 
 
 
 
 
 
VRE and CBT groups showed 
reduced scores on the FAS 
and FAM compared to BIB. 
VRE and CBT not statistically 
different in symptom 
reduction. CBT group showed 
more positive coping 
cognitions than VRE group. 
The addition of GBCT had less 
effect on VRE than CBT 
efficacy. CBT followed by 
GBCT was most efficacious 
treatment.   
 
VRGET group showed 
significant reduction in 
symptomatology compared 
to TAU.  
 
 
 
 
 
 
 
6 months: Symptom 
reduction maintained 
for both groups. No 
significant difference 
in treatment efficacy 
between VRE and IVE 
groups.  
 
 
 
 
 
None 
 
 
 
 
 
 
 
 
 
 
 
 
 
None 
 
 
 
 
 
 
 
 
 
 
16 
 
 
 
 
 
 
 
 
 
 
 
17 
 
 
 
 
 
 
 
 
 
 
 
 
 
18 
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Michaliszyn 
et al. (2010) 
 
 
 
 
 
 
 
 
Mühlberger 
et al. (2003) 
 
 
 
 
 
 
 
 
 
 
 
Perez-Ara et 
al. (2010) 
 
 
 
 
 
 
 
 
Robillard et 
al. (2010) 
 
 
Arachnophobia  
 
 
 
 
 
 
 
 
 
Aviophobia 
 
 
 
 
 
 
 
 
 
 
 
 
PDA 
 
 
 
 
 
 
 
 
 
Social anxiety 
disorder 
 
 
Students  
Total N = 43 
Female = 98% 
Age M = 29 
Therapists: 
Doctoral students  
 
 
 
 
Volunteers 
Total N = 47 
Female: 74% 
Age M = 42.2 
Therapist: 
Psychologist with 
advanced training 
in CBT 
 
 
 
 
 
Clinic attendees 
Total N = 29 
Female: 79.3% 
Age M =  32.8 
Therapists:  
characteristics 
unspecified 
 
 
 
Clinic attendees  
Total N = 45 
Female: 71% 
Age M = 34.9 
VRE (to spiders) with non-
VR education/cognitive 
restructuring/RP 
Duration: 8 x 90 min 
n = 16 
 
 
 
 
 
(a) VRE with motion 
simulation (MS) with non-
VR CT (educational 
booklet/CT techniques) 
Duration: CT 1 x 60, VRE 4 x 
18 min 
n  = 13 
(b) VRE without MS 
following CT  
Duration: 5 sessions (1 x 60 
min CBT, 4 x 18 min VRE)  
n = 13 
 
VR interoceptive exposure 
(VRIE) with non-VR CBT 
(education/cognitive 
restructuring/VR-based 
exposure to feared 
situations) 
Duration: maximum 8 x 60 
min  
n = 14 
 
VRE (to social situations) 
with non-VR CBT 
Duration: 16 x unknown 
length 
(a) In vivo exposure (IVE) 
with education/ cognitive 
restructuring/RP 
Duration: 8 x 90 min 
n = 16 
(b) WL, n = 11 
 
 
 
 
(a) CT (educational 
booklet/CT techniques) 
Duration: 1 x 60 min 
n = 11 
(b) WL, n = 11 
 
 
 
 
 
 
 
 
Traditional interoceptive 
exposure (TIE) with CBT 
(education/cognitive 
restructuring/VR-based 
exposure to feared 
situations) 
Duration: maximum 8 x 
60 min 
n = 15  
 
(a) IVE (to social 
situations) with CBT  
Duration: 16: x unknown 
length 
Diagnosis: SCID-I 
Symptomatology: FSQ, SBQ, 
BAT of tarantula  
 
 
 
 
 
 
 
Diagnosis: Clinical interview 
using DSM-IV criteria  
Symptomatology (a) Primary:  
FFS, GFFQ, BAT of flight 
reservation and taking a flight  
(b) Secondary: FGSQ, ASI, 
STAI  
 
 
 
 
 
 
Diagnosis: ADIS-IV 
Symptomatology: FAS, ASI, 
PDSS 
 
 
 
 
 
 
 
Diagnosis: Clinical interview 
using DSM-IV criteria  
Symptomatology: LSAS, SPD, 
ASCS, FNE, BDI, STAI, Self-
Statistically and clinically 
significant improvements 
observed in both VRE and IVE 
compared to WL. IVE group 
showed significantly greater 
reduction on SBQ than VRE 
indicating reduction in 
problematic beliefs about 
spiders.  
 
Only VRE conditions were 
associated with symptom 
improvement; significantly 
better than CT and WL. 
Motion simulation did not 
enhance effectiveness of VRE. 
The most effective ingredient 
in VRE was exposure to visual 
and acoustic stimuli.  
 
 
 
 
Both treatments equally 
effective in reducing PDA 
symptomatology on all 
measures. No significant 
between-group effects.  
 
 
 
 
 
Both active treatments 
significantly reduced 
symptoms on majority of 
outcome measures compared 
3 months: Benefits 
maintained in both 
groups compared to 
WL.  
 
 
 
 
 
 
6 months: 62% of VRE 
groups completed 
actual flights, 
compared to 50% WL 
and 45% CT group; 
differences NS.  
 
 
 
 
 
 
 
6 months: Treatment 
gains maintained or 
continued improving.  
 
 
 
 
 
 
 
None  
 
 
 
21 
 
 
 
 
 
 
 
 
 
17 
 
 
 
 
 
 
 
 
 
 
 
 
16 
 
 
 
 
 
 
 
 
 
10 
 
 
 
 39 
 
 
 
 
 
 
Rothbaum 
et al. (2006) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tortella-
Feliu et al. 
(2011) 
 
 
 
 
 
 
 
 
 
 
 
Wallach et 
al. (2009) 
 
 
 
 
 
Aviophobia  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aviophobia 
 
 
 
 
 
 
 
 
 
 
 
 
 
Public Speaking 
Anxiety (PSA) 
Therapists:  
characteristics 
unspecified 
 
 
Volunteers  
Total N = 75 
Female: 89% 
Age M = 39.6 
Therapists:  
characteristics 
unspecified  
 
 
 
 
 
 
 
 
 
Volunteers  
Total N = 60 
Female: 58.3% 
Age M = 37 
Therapists:  
unspecified 
characteristics  
 
 
 
 
 
 
 
Students    
Total N = 88 
n = 14 
 
 
 
 
VRE with non-VR anxiety 
management training 
(AMT)  
Duration: 8 sessions (VRE 4  
x  60 min, AMT 4 x 60 min)  
n = 29 
 
 
 
 
 
 
 
 
 
 
VRE with non-VR CT 
(education/cognitive 
restructuring) 
Duration: maximum 6 x 60 
min 
n = 19 
 
 
 
 
 
 
 
 
VRE with non-VR CT 
(education/ self-
n = 16  
(b) WL 
n = 15  
 
 
(a) IVE with AMT  
Duration: 8 sessions (IVE 
4 x 60 min, AMT 4 x 60 
min)  
n = 29 
(b) WL  
n = 17 
 
 
 
 
 
 
 
 
 
(a) Computer-assisted 
exposure (CAE) and CT 
(education/cognitive 
restructuring) with 
therapist 
Duration: maximum 6 x 
60 min 
n = 21 
(b) CAE and CT without 
therapist.  
Duration: maximum 6 x 
60 min 
n = 20 
 
(a) Traditional CBT 
(education/self-
efficacy single item measure 
 
 
  
 
Diagnosis: SCID-I  
Symptomatology: FFI, QAF, 
BAT to book flight and go on 
actual flight. 
Treatment satisfaction: CSQ 
 
 
 
 
 
 
 
 
 
 
 
Diagnosis: ADIS-IV 
Symptomatology: FFQ; FFS; 
clinician ratings of symptom 
severity 
Treatment satisfaction: CAS 
 
 
 
 
 
 
 
 
 
Diagnosis: Clinical interview 
using DSM-IV criteria  
to WL. No significant 
differences in efficacy 
observed between active 
treatments. 
 
Both active treatments 
significantly superior to WL 
on willingness to fly, anxiety 
ratings and treatment 
satisfaction.  No significant 
differences between active 
treatments on outcome 
measures or satisfaction.  
 
 
 
 
 
 
 
 
All treatments yielded large 
effect sizes for 
symptomatology reduction. 
No significant differences 
between three treatment 
groups on symptomatology 
outcomes.  
VRE participants rated higher 
levels of approval and 
satisfaction with treatment.  
 
 
 
 
VR-CBT and traditional CBT 
equally effective in reducing 
 
 
 
 
 
6 months: Treatment 
benefits equivalent 
and maintained in 
both active treatment 
groups. 
12 months: 
Treatment benefits 
maintained in both 
groups. Participants 
in active treatment 
groups were 
significantly more 
likely to have taken 
subsequent flights 
than WL.  
 
12 months: 
Treatment benefits 
maintained in all 
treatment groups. No 
longer any 
differences between 
groups in levels of 
treatment approval 
or satisfaction.  
 
 
 
 
 
None 
 
 
 
 
 
 
25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 
 
 
 
 
 
 
 
 
 
 
 
 
 
18 
 
 40 
 
 
 
 
 
 
 
 
 
 
 
 
 
Wiederhold 
et al. (2002) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PAIN 
 
Gershon et 
al. (2004) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aviophobia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Procedural Pain 
(cancer victims) 
 
 
 
 
 
Female: 77.3% 
Age M = 27 
Therapists: Clinical 
Psychology 
students with 
training in 
treatment protocol   
 
 
 
 
 
Volunteers 
Total N = 30  
Female: 60% 
Age M = 39.8 
Therapists:  
characteristics 
unspecified  
 
 
 
 
 
 
 
 
 
 
 
Hospital attendees 
(child cancer 
patients) 
Total N = 59 
Male = 51% 
Age: M = 12.7 
Therapists: None – 
monitoring/cognitive 
restructuring/homework)  
Duration: 12 x 60 min (7 of 
these included VRE) 
n = 28 
 
 
 
 
 
 
 
(a) Graded VRE without PF 
following non-VR education 
and relaxation training 
Duration: 8 sessions (2 x 45 
min education/relaxation, 
6 x 30 min VRE) 
n = 10 
(b) Graded VRET with 
physiological feedback (PF) 
following non-VR education 
and relaxation training   
Duration: education/ 
relaxation: 2 x 45 min, 
 VRE: 6 x 30 min 
n = 10 
 
 
 
VR distraction (VRD)  
Duration 1 x 5-10 min 
n = 22 
 
 
 
 
monitoring/cognitive 
restructuring/IVE/ 
homework) 
Duration:  12 x 60 min 
n = 30 
(b) WL, n = 30 
 
 
 
 
 
 
Imaginal Exposure 
Therapy (IET) following 
education and relaxation 
training  
Duration: 8 sessions (2 x 
45 min education/ 
relaxation,6 x 30 min IET) 
n = 10 
 
 
 
 
 
 
 
 
 
 
(a) non-VR distraction 
Duration: 1 x 5-10 min 
n = 15 
(b) Treatment as usual 
(TAU) without distraction  
n = 22 
 
Symptomatology: LSAS, SSPS, 
FNE, BAT presentation to 
strangers 
 
 
 
 
 
 
 
 
Diagnosis: Clinical interview 
using DSM-IV criteria  
Symptomatology a) 
Physiological: skin resistance, 
respiration, heart-rate  
(b) self-report: FOF, VAS of 
therapy efficacy, QAF, STAI, 
self-survey of stress 
response, SUD’s of anxiety 
(c) behavioural: telephone 
call at 3 month f/u 
 
 
 
 
 
 
 
Diagnosis: Childhood cancer 
Symptomatology: VAS for 
pain intensity, CHEOPS, pulse 
rate, behavioural 
observations by nurse.  
 
PSA compared to WL. Large 
effect sizes for anxiety 
reduction were obtained in 
both active treatments. 
Clinically significant remission 
was observed on for both 
VRCBT and CBT on avoidance 
scales but not fear scales. 
Twice as many participants 
dropped out of the CBT group 
than VR-CBT.  
 
Both VRE conditions were 
significantly associated with 
improved outcomes and 
superior to IET. VRE with PF 
was superior to VRET 
without, suggesting that PF 
strengthens VRE efficacy. 
 
 
 
 
 
 
 
 
 
 
 
VRD group showed reduced 
pain and anxiety (self-report 
and physiologically) 
compared to non-VR 
distraction and TAU during 
and after procedure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
None  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
None  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
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Mott et al. 
(2008) 
 
 
 
 
 
 
 
 
 
Leibovici et 
al. (2009) 
 
 
 
 
 
 
 
 
 
 
 
Patterson et 
al. (2006) 
 
 
 
 
 
 
 
 
 
 
 
Procedural pain 
(burn victims) 
 
 
 
 
 
 
 
 
 
Pain: chronic 
non-procedural 
(pruritus 
patients) 
 
 
 
 
 
 
 
 
 
Experimental 
Pain (induced 
thermal pain) 
 
 
 
 
 
 
patients  trained by 
researcher then 
self-administered  
 
Hospital attendees  
(child burn victims) 
Total N = 42 
Male = 71% 
Age median  = 9 
Therapists: None – 
patients trained by 
researcher then 
administered with 
caregiver.  
 
Hospital attendees  
(patients with 
dermatitis 
and vulgaris) 
Total N = 24 
Male = 50% 
Age M = 44.5 
Therapists: None- 
trained by 
researcher then 
self-administered  
 
Students  
Total N = 103 
Female: 61% 
Age M = 19 
Therapists: None-
trained by 
researcher then 
self-administered.  
 
 
 
 
 
 
Augmented Reality 
distraction (ARD) following 
analgesia and sedation.  
Duration 1 x 10-30 min 
(according to procedure) 
n = 20 
 
 
 
 
 
VR distraction (VRD)  
Duration: 1 x 8 -12 min 
n = 12  
 
 
 
 
 
 
 
 
 
 
(a) VR distraction (VRD)  
Duration: 1 x 30 seconds 
n = 26 
(b) VRD following hypnosis  
Duration: 1 x 30 seconds 
n = 26 
 
 
 
 
 
 
 
Basic CT (relaxation/ 
attention-distraction/ 
positive reinforcement) 
following analgesia and 
sedation. 
Duration:1 x 10-30 min 
(according to procedure) 
n = 22 
 
 
 
Non VR distraction 
(audio-visual version of 
the VRD stimuli) 
Duration: 1 x 8-12 min 
n = 12  
 
 
 
 
 
 
 
 
(a) Hypnosis  
Duration: 1 x 30 seconds 
n = 25 
(b) NT  
n = 26 
 
 
 
 
 
 
 
 
Diagnosis:Child burn victims  
Symptomatology: (a) 
Subjective: 3-4 year olds:  
FLACC; 4-8 year olds: FPC-R; 
8-14 year olds: VAS 
(b) Parent pain ratings of 
child’s pain, respiration and 
pulse 
 
 
 
Diagnosis: Patients with 
pruritus related to dermatitis 
and vulgaris) 
Symptomatology: VAS of 
itching  
 
 
 
 
 
 
 
 
Diagnosis: N/A 
Symptomatology (a) Primary: 
self-reported worst pain 
intensity (10-cm scale) 
(b) Secondary: self-reported 
pain unpleasantness; time 
spent thinking about pain; 
amount of ‘fun’ experienced 
during procedure (10 cm 
 
 
 
 
ARD group showed 
significantly lower subjective 
and parental pain ratings 
compared to CT group. NS 
difference between groups 
on physiological measures.  
 
 
 
 
 
No significant difference in 
the levels of self-reported 
scratching between two 
groups. Less scratching noted 
by observers in the VRD 
group; but the actual results 
of these differences were not 
statistically analysed.  
 
 
 
 
 
VR significantly reduced pain 
regardless of suggestibility 
level compared to hypnosis 
and NT. Suggestibility 
moderated effects of 
hypnosis and VR with 
hypnosis. For high 
hypnotisability participants, 
VR with hypnosis showed a 
 
 
 
 
None  
 
 
 
 
 
 
 
 
 
 
None  
 
 
 
 
 
 
 
 
 
 
 
 
None 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
 
 
 
 
 
 
 
 
 
17 
 
 
 
 
 
 
 
 
 
 
 
 
14 
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BODY-
IMAGE/ 
OBESITY  
 
Manzoni et 
al. (2008) 
 
 
 
 
 
 
 
 
 
Riva et al. 
(2006) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Riva et al. 
(2001) 
 
 
 
 
 
 
 
Emotional 
distress in 
overeating 
(obesity) 
 
 
 
 
 
 
 
Body-image 
distortion & 
obesity  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Body-image 
distortion in  
 
 
 
 
 
 
 
Inpatients (obesity 
clinic) 
Total N = 60 
Female = 100% 
Age M = 43.67 
Therapists: Clinical 
psychologists and 
chartered 
psychotherapist 
 
 
Clinic attendees 
(obesity clinic) 
Total N = 211 
Female: 100% 
Age M = 36.1 
Therapists: Clinical 
psychologists and 
chartered 
psychotherapist 
 
 
 
 
 
 
 
 
Inpatients (obesity 
clinic) 
 
 
 
 
 
 
 
VR relaxation training (VR 
relaxing scenario and VRE 
to stress) following non-VR 
self-monitoring 
Duration: 12 x 60 min 
n = 20 
 
 
 
 
 
VR-CT (VR exposure and 
response prevention/ 
problem-solving relapse 
mechanisms/VR body 
image comparisons/ 
building coping strategies 
and emotional awareness) 
following non-VR 
Nutritional group (NG) 
Duration: 20 x 60 (VR-CT 15 
x 60 min, NT 5 x 60 min) 
n = 56 
 
 
 
 
 
VR-CT (VR exposure/ 
response prevention/ VR 
 
 
 
 
 
 
 
(a) Imagined relaxation 
(imagined relaxing 
scenario and imagined 
exposure to stress) with 
self-monitoring 
Duration: 12 x  60 min 
n = 20 
(b) WL , n = 20 
 
 
 
(a) CBT group (self-
monitoring/cognitive 
restructuring/goal 
setting) following NG 
Duration: 20 x 60 (CBT 15 
x 60 min, NG 5 x 60 min). 
n = 52 
(b) Nutritional group  
(NG; self-monitoring/ 
education/physical 
training/diet) 
Duration: 5 x 60 min 
n = 50 
(c) WL, N = 53 
 
 
 
CBT-based  
Psycho-nutritional 
scales) 
Moderator: Hypnotisability- 
SHCS 
 
 
 
 
Diagnosis: BMI >30, EOQ 
Outcomes: BDI, WELSQ, STAI, 
VAS of relaxation, heart rate  
 
 
 
 
 
 
 
 
Diagnosis: BMI>40 
Outcomes: Subjective: DIET, 
STAI, WELSQ, BIAQ, CDRS 
Objective: Amount of weight 
loss 
 
 
 
 
 
 
 
 
 
 
 
 
Diagnosis: BMI > 35, EDI-2 
Outcomes: DIET, STAI, AI, 
trend towards increased 
efficacy in pain reduction; but 
interaction was NS.  
 
 
 
 
VR-R and IR groups showed 
significantly increased self-
efficacy in eating control, 
decreased depressive/anxiety 
symptomatology and reduced 
post-session heart-rate 
compared to WL. No 
significant differences 
between VR and IR treatment 
efficacy.  
 
All active treatments 
associated with significant 
weight reduction and 
improved psychological 
outcomes compared to WL. 
Weight loss slightly greater in 
CBT group compared to NT 
and VR-CT but difference was 
NS.  VRCT and CBT both 
superior to WL on all obesity 
related outcomes.  
 
 
 
 
 
 
Both active treatments 
associated with improved 
 
 
 
 
 
 
 
None  
 
 
 
 
 
 
 
 
 
 
6 months: All three 
treatments 
maintained benefits 
though NT group 
were slightly heavier 
at post-treatment 
(NS). VR-CT superior 
to CBT, NT and WL in 
greater body image 
satisfaction and self-
efficacy. VR-CT group 
also showed trend 
towards greater 
weight loss compared 
to NT and CBT but 
differences were NS.  
 
None  
 
 
 
 
 
 
 
 
28 
 
 
 
 
 
 
 
 
 
 
22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
26 
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Riva et al. 
(2002) 
 
 
 
 
 
 
 
 
 
obesity  
 
 
 
 
 
 
 
 
 
 
Body-image 
distortion in  
Binge Eating 
Disorder  
 
 
 
 
 
 
 
Total N = 28 
Female: 100% 
Age M = 31.2 
Therapists: 
chartered 
psychologists and 
psychotherapist 
 
 
 
 
Clinic attendees 
(obesity clinic) 
Total N = 20 
Female: 100% 
Age M = 30.3 
Therapists: Clinical 
psychologists and 
chartered 
psychotherapist 
 
presented  desired miracle 
and body image distortions) 
with non-VR low calorie 
diet and physical training 
Duration: 7 x 50 min 
n = 14 
 
 
 
 
 
VR-CT (exposure/response 
prevention/viewing desired 
miracle/body image 
distortions) 
Duration: 7 x 50 min 
n = 10 
 
 
 
 
 
group (stress 
management/problem 
solving/education) with 
low calorie diet and 
physical training  
Duration: 7 x 50 min 
n = 14 
 
 
 
 
CBT-based nutritional 
group (stress 
management/problem 
solving/education) 
Duration: 7 x 50 min 
n = 10 
 
 
 
 
 
WELSQ, URICA, BSS, BIAQ, 
FRS, CDRS 
 
 
 
 
 
 
 
 
 
Diagnosis: DSM-IV criteria  
Outcomes: EDI-2, DIET, STAI, 
AI, WELSQ, URICA, BSS, BIAQ, 
FRS, CDRS 
 
 
 
 
 
outcomes. VR-CT significantly 
more effective than CBT 
nutritional group at 
improving body-satisfaction, 
self-efficacy, motivation and 
reduced over eating.  VR-CT 
participants showed trend 
towards greater weight loss 
than CBT group, but 
differences NS.  
 
VRT group showed 
significantly greater 
improvements on measures 
of body-satisfaction and self-
efficacy compared to CBT, 
but no differences in amount 
of binge-eating behaviour 
between treatments. Both 
treatments associated with 
significant reductions in binge 
eating.  
 
 
 
 
 
 
 
 
 
 
 
None  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 
 
 
 
 
 
 
 
 
 
 
¹Diagnostic measures: ADIS-IV (Anxiety Disorders interview Schedule-4
th
 Edition), SCID-I (Structured Clinical Interview for DSM-IV Disorders), SCL-90 (Symptom Checklist-90), MINI (Mini 
International Neuropsychiatric Interview), CAPS (Clinical Administered PTSD Scale), EDI-2 (Eating Disorders Inventory-2
nd
 Edition)  
Symptomatology measures: FAS (Fear & Avoidance Scales), BDI (Beck Depression Inventory), PANAS (Positive and Negative Affect Schedule), MS (Maladjustment Scale), PDSS (Panic Disorder 
Severity Scale), ASI (Anxiety Sensitivity Index), FQ (Fear Questionnaire), STAI (State-Trait Anxiety Inventory), ACQ (Agoraphobic Cognition Questionnaire), BSQ (Body Sensations Questionnaire), 
PBQ (Panic Belief Questionnaire), AQ (Acrophobia Questionnaire), ATHQ (Attitudes Towards Heights Questionnaire), BAT (Behavioural Avoidance Test), FAS (Flight Anxiety Situations 
Questionnaire), FAM (Fight Anxiety Modality Questionnaire), CERQ-F (Cognition Emotion Regulation Questionnaire–Flying), FSQ (Fear of Spiders Questionnaire), SBQ (Spider Beliefs 
Questionnaire), GFFQ (General Fear of Flying Questionnaire), PDSS (Panic Disorder Severity Scale), LSAS (Liebowitz Social Anxiety Scale), SPS (Social Phobia Scale), ASCS (Appraisal of Social 
Concerns Scale) FNE (Fear of Negative Evaluation), FAF (Fear of Flying Inventory), QAF (Questionnaire on Attitudes Towards Flying), SSPS (Self-Statements during Public Speaking), FNE (Fear of 
Negative Evaluation), FOF (Fear of Flying Inventory), QAF (Questionnaire on Attitudes Towards Flying), VAS (Visual Analogue Scale) CHEOPS (Children’s Hospital of Eastern Ontario Pain Scale), 
FLACC (The Faces, Legs, Activity, Cry and Consolability), FPC-R (Faces Pain Scale-Revised), EOQ (Emotional Overeating Questionnaire), WELSQ (Weight Efficacy Life-Style Questionnaire), DIET 
(The Dieters Inventory of Eating Temptations), BIAQ (Body Image Avoidance Questionnaire), CDRS (Contour Drawing Rating Scale), AI (Assertiveness Inventory), URICA (University of Rhode 
Island Change Assessment Scale), BSS (Body Satisfaction Scale), RFRS (Ray Figure Rating Scale) 
Secondary measures: FGSQ (Fear and General Symptoms Questionnaire), CAS (Credibility/Acceptance Scales), SHCS (Stanford Hypnotic Clinical Scale) 
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3.2.3 Participant characteristics  
Anxiety disorders: The total number of participants included from the 14 anxiety 
disorders studies was 645. All participants were adults, with an age range of 17 to 
72 years. Five studies recruited from clinic/hospital settings (Botella et al., 2007; 
Choi et al., 2005; McLay et al., 2011; Perez-Ara et al., 2010; Robillard et al., 2010) 
and the remainder from student and community volunteer samples. Females 
typically outnumbered males, usually by 2:1. The majority of participants were being 
treated for specific phobias (n = 435), of which 271 presented with aviophobia, 88 
with public speaking anxiety, 43 with arachnophobia and 33 with acrophobia. Of the 
remaining participants, 106 presented with panic disorder/agoraphobia, 45 with 
social anxiety disorder, and 59 with PTSD.   
Participants were diagnosed with anxiety disorders using either a well-
established diagnostic semi-structured interview, or by clinical interview/consultation 
of DSM-IV criteria. Specifically, three studies (Botella et al., 2007; Tortella-Feliu et 
al., 2011; Perez-Ara et al., 2010) used the Anxiety Disorders Interview Schedule-IV 
(ADIS-IV; Brown, DiNardo & Barlow, 1994),  two studies (Krijn et al., 2007; McLay et 
al., 2011) used the Mini International Neuropsychiatric Interview version 6 (the MINI 
6; Sheehan & Lecrubier, 1990) and three studies (Emmelkamp et al., 2002; 
Michalisyn et al., 2010; Rothbaum et al., 2006) used the Structured Clinical interview 
for DSM-IV Axis I Disorders (SCID-I; First, Spitzer, Gibbon & Williams, 2002). The 
remaining six studies (Banos et al., 2011; Choi et al., 2005; Muhlberger et al., 2003; 
Robillard et al., 2010; Wallach et al., Wiederhold et al., 2002) diagnosed participants 
using clinical interviews based on DSM-IV criteria.  
With the exception of Robillard et al. (2010), all anxiety disorders studies 
reported exclusion criteria, and there was considerable overlap in these criteria 
across studies (e.g. psychotic illness, drug/alcohol abuse, epilepsy). Of those 
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participants assessed for eligibility, 5% (Rothbaum et al., 2006), 24% (Banos et al., 
2011), 20% (Botella et al., 2007), 35% (Emmelkamp et al., 2007), 80% (Muhlberger 
et al., 2003) and 30% (Tortella-Feliu et al., 2011) were excluded. The numbers of 
excluded participants were not reported in the remaining anxiety disorders studies.  
 
Pain: The total number of participants included from the pain studies was 228. Of 
these, 127 were adults and 101 were children/adolescents. The gender split across 
trials was roughly equal. Participants’ ages ranged from 3.5 (Mott et al., 2008) to 84 
years (Leibovici et al., 2009). One-hundred-and-three participants were being 
treated for experimental pain, 101 for procedural pain and 24 for chronic pain. The 
majority of participants were recruited from hospitals (n = 104) and the remainder 
were students (n = 24). Fifty-nine participants had a diagnosis of cancer (Gershon et 
al., 2004), 42 had burn injuries (Mott et al., 2008), and 24 presented with chronic 
skin conditions (Leibovici et al., 2009). Participants undergoing experimental pain 
(Patterson et al., 2006) were student volunteers with no diagnoses.  
Two pain studies reported exclusion criteria (Gershon et al., 2004; Leibovici 
et al., 2009) and two did not (Mott et al., 2008; Patterson et al., 2006). Only Leibovici 
et al. (2009) reported the percentage of participants that were excluded (11%) from 
taking part.  
 
Body-image distortion/obesity:  The total number of participants included from body-
image distortion/obesity trials was 319. All were adult female inpatients and 
outpatients of obesity clinics. Age ranges were not reported. The mean ages of 
participants were 36.1 (Riva et al., 2006), 30.5 (Riva et al., 2002), 30.3 (Riva et al., 
2001) and 43.7 (Manzoni et al., 2008). All participants were being treated for 
psychological variables related to episodes of overeating, `including body-image 
distortion (n = 259) and emotional stress/distress (n = 60).  
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 Two-hundred-and-ninety-nine participants were classified as obese 
according to body mass index and 20 were diagnosed with binge eating disorder 
according to DSM-IV criteria. Three of the four body-image distortion/obesity studies 
reported exclusion criteria (Riva et al., 2001; Riva et al., 2002; Riva et al., 2006). 
Only Riva et al. (2006) reported the percentage of participants that were excluded 
from taking part (28%). 
 
3.2.4 VRT intervention characteristics 
Considering all studies in combination, VRTs consisted of between one 
(Gershon et al., 2004; Leibovici et al., 2009; Mott et al., 2008; Patterson et al., 2006) 
and 20 sessions (McLay et al., 2011). Session length varied from 30 seconds 
(Patterson et al., 2006) to 150 minutes (Choi et al., 2005). These treatment times 
represent an aggregate of all VRT components (e.g. both VR and therapist-
delivered components). 
Anxiety disorders: The anxiety disorders VRTs had between three (Emmelkamp et 
al., 2003) and 20 sessions (McLay et al., 2011), varying from 30 minutes 
(Wiederhold et al., 2002) to 150 minutes (Choi et al., 2005). Robillard et al. (2010) 
did not report session duration. With the exception of Emmelkamp et al. (2002) who 
delivered VRET in isolation, all VRT interventions included therapist-facilitated 
cognitive therapy (e.g. education, cognitive restructuring) alongside VRET. In most 
cases, cognitive therapy was delivered during VRET sessions, but in four studies it 
was conducted in separate sessions (Choi et al., 2005; Krijn et al., 2007; Rothbaum 
et al., 2006; Wiederhold et al., 2002).  
The majority of anxiety disorder studies (n = 12) included one VRT 
intervention condition, whilst two studies assigned participants to one of two VRT 
interventions. Muhlberger et al. (2003) had two VRET interventions for aviophobia; 
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one with motion simulation and one without. Wiederhold et al’s. (2002) two VRT 
interventions for aviophobia consisted of VRET with, and without physiological 
feedback.  
In terms of the therapist characteristics, two studies used a combination of 
doctoral level students and qualified doctors/psychologists (Banos et al., 2011; 
Emmelkamp et al., 2002), three used clinical psychologists/psychotherapists trained 
in CBT, or CBT-therapists (Botella et al., 2007; McLay et al., 2011; Muhlberger et 
al., 2003) and two used doctoral level students (Michaliszyn et al., 2010; Wallach et 
al., 2009). Seven studies did not report therapists’ characteristics (Choi et al., 2005; 
Krijn et al., 2007; Perez-Ara., 2010; Robillard et al., 2010; Rothbaum et al., 2006; 
Tortella-Feliu et al., 2011; Wiederhold et al., 2002). 
Pain: VRTs for pain management were single sessions, ranging in length from 30 
seconds (Patterson et al., 2006) to 30 minutes (Mott et al., 2008). All interventions 
consisted of VR distraction and were self-administered following brief training on 
equipment use by a researcher. Gershon et al. (2004), Mott et al. (2008) and 
Leibovici et al. (2009) included one VRT condition. Patterson et al. (2006) assigned 
participants to either VR distraction in isolation, or VR distraction following hypnosis.  
Body-image distortion/obesity:  VRTs for body-image distortion/obesity had between 
seven (Riva et al., 2001; Riva et al., 2002) and 20 sessions (Riva et al., 2006), 
ranging in length from 50 minutes (Riva et al., 2001; Riva et al., 2002) to 60 minutes 
(Manzoni et al., 2008; Riva et al., 2006). All four interventions were based on CBT 
treatment principles and included exposure to overeating triggers and response 
prevention training. Manzoni et al. (2008) also included VR-based relaxation training 
and therapist-assisted self-monitoring, conducted in separate sessions. The 
remaining three studies (Riva et al., 2001; Riva et al., 2002; Riva et al., 2006) 
included VR-based body image comparisons/distortions and accompanying 
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cognitive techniques, facilitated by therapists during VRT. Therapists across studies 
were either clinical psychologists or chartered psychotherapists. 
3.2.5 Comparative intervention characteristics   
Anxiety disorders: Comparative treatments had between one (Muhlberger et al., 
2003) and sixteen (Robillard et al., 2010) sessions. Session length varied from 30 
minutes (Wiederhold et al., 2002) to 120 minutes (Choi et al., 2005). Most 
comparative interventions (n = 11) were equal in number and length of sessions to 
their VRT counterparts. This was with the exception of Choi et al. (2005) in which 
the length of comparative treatment was greater than that of VRT, and Muhlberger 
et al. (2003) for which the opposite was true. McLay et al. (2011) did not report the 
number and length of comparative treatment sessions.  
All comparative anxiety disorder interventions were based on cognitive 
and/or behavioural treatment. With the exception of Muhlberger et al. (2003), all 
included in vivo or interoceptive exposure (in the case of panic disorder). 
Muhlberger et al.’s (2003) intervention consisted of purely cognitive techniques and 
psychoeducation. Conversely, Emmelkamp et al.’s (2002) comparative intervention 
was exclusively exposure-based. Comparative interventions often included 
psychoeducation, cognitive restructuring, relaxation training and relapse prevention 
strategies.  
 Six studies had one comparative intervention (Banos et al., 2011; Choi et al., 
2005; Emmelkamp et al., 2002; McLay et al., 2011; Perez-Ara et al., 2010; 
Weiderhold et al., 2002). Two studies included two comparative treatments: Krijn et 
al. (2007) assigned participants to either CBT or bibliotherapy; Tortella-Feliu et al. 
(2011) delivered computer-assisted exposure and cognitive therapy either in the 
presence of the therapist, or via self-help. McLay et al.’s comparative treatment 
condition was treatment-as-usual (TAU) but the number of participants who received 
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different components of TAU (CBT, EMDR, exposure and medication) was not 
reported. Six studies included a no-treatment/wait-list condition in addition to a 
comparative treatment (Botella et al., 2007; Michaliszyn et al., 2010; Muhlberger et 
al., 2003; Robillard et al., 2010; Rothbaum et al., 2006; Wallach et al., 2009). 
Therapists’ characteristics across the studies were synonymous with those involved 
in VRT treatment delivery.  
Pain: The comparative interventions were single sessions, varying in length between 
30 seconds (Patterson et al., 2006) and 30 minutes (Mott et al., 2008). Gershon et 
al. (2004) and Leibovici et al. (2009) used distraction-based treatments. Mott et al. 
(2008) also included distraction in their broader CBT comparative intervention. 
Patterson et al.’s (2006) intervention was hypnosis. All comparative interventions 
were equal in number and length to their VRT counterparts and were self-
administered. Gershon et al. (2004) and Patterson et al. (2006) included additional 
no-treatment conditions. 
Body-image distortion/obesity: Comparative treatments were between seven (Riva 
et al., 2001; Riva et al., 2002) and 20 sessions (Riva et al., 2006), ranging in length 
between 50 minutes (Riva et al., 2001; Riva et al., 2002) and 60 minutes (Riva et al., 
2006; Manzoni et al., 2008). Three studies (Riva et al., 2001; Riva et al., 2002; Riva 
et al., 2006) delivered group CBT and one study (Manzoni et al., 2008) taught 
relaxation and self-monitoring practices. Riva et al. (2001) and Riva et al. (2002) 
included one comparative intervention, whilst Riva et al. (2006) assigned 
participants to either a CBT or nutritional group. Two of the four studies also 
included no-treatment conditions (Manzoni et al., 2008; Riva et al., 2006). 
Therapists’ characteristics were the same as those involved in VRT delivery.  
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3.2.6 Outcome measures characteristics  
Anxiety disorders: All anxiety disorders studies used well validated self-report 
measures of primary symptomatology, with the majority administering four or more 
different measures. Two studies included validated secondary outcome measures 
(Muhlberger et al., 2003; Patterson et al., 2006), whilst others indexed behavioural 
(e.g. a behavioural avoidance test) and physiological outcomes. Three studies also 
administered self-report measures of treatment satisfaction (Botella et al., 2007; 
Rothbaum et al., 2006; Tortella-Feliu et al., 2011).  
Eight anxiety disorder trials measured long-term outcomes; Michaliszyn et al. 
(2010) took measurements at three-months. Four studies assessed outcomes at six-
months (Choi et al., 2005; Emmelkamp et al., 2002; Muhlberger et al., 2003; Perez-
Ara et al., 2010), two at 12 months (Botella et al., 2007; Tortella-Feliu et al., 2011) 
and one study obtained outcomes at both six and 12 months (Rothbaum et al., 
2006).  
 
Pain: All four studies used scales (Likert or visual analogue) of pain intensity as 
outcome measures. Three of these were subjective scales completed by the 
participants (Gershon et al., 2004; Leibovici et al., 2009; Patterson et al., 2006) and 
one obtained parental estimates (Mott et al., 2008). Two studies also administered 
validated self-report primary outcome measures (Gershon et al., 2004; Mott et al., 
2008). Long-term follow-up outcomes were not obtained in any of the pain studies.  
 
Body-image distortion/obesity: All studies used multiple outcome measures of 
symptomatology. Three studies (Riva et al., 2001; Riva et al., 2002; Riva et al., 
2006) included measures of body image satisfaction and distortion, and all four 
administered the weight efficacy lifestyle questionnaire (Clark, Abrams, Niaura, 
Etton & Rossi, 1991). Riva et al. (2006) also included weight loss as a primary 
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outcome. Additionally, all studies administered validated self-report measures of 
mood (e.g. the State-Trait Anxiety Inventory; Spielberger, 1968). Manzoni et al. 
(2008) used physiological measurement in addition to self-report tools. Riva et al. 
(2006) measured outcomes at six-month follow-up.  
 
3.3 Risk of bias of included studies  
3.3.1 Sequence generation 
Anxiety disorders: Two studies adequately described the method of allocation, with 
no bias possible (Wiederhold et al., 2002; McLay et al., 2011). The remaining 12 
studies did not provide full details of the method of allocation and some bias was 
believed to be possible from the descriptions given.  
Pain: Two studies adequately reported the allocation method and were therefore 
judged to be free of bias (Gershon et al., 2004; Mott et al., 2008). Bias was possible 
in the remaining two studies (Leibovici et al., 2009; Patterson et al., 2006).  
Body-image distortion/obesity: Manzoni et al. (2008) and Riva et al. (2006) reported 
the method of allocation such that no bias was possible. Riva et al. (2001) and Riva 
et al. (2002) did not report details of allocation.  
 
3.3.2 Allocation concealment  
Anxiety disorders: Most studies did not provide full details of the method of 
randomisation and therefore concealment was unclear or inadequate in 12 studies. 
There was reporting of adequate concealment procedures in two studies (McLay et 
al., 2011; Wiederhod et al., 2002). 
Pain: The method of concealment was not described in any of the four pain studies 
and therefore bias was possible.  
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Body-image distortion/obesity: Only Riva et al. (2006) described the method of 
allocation concealment sufficiently.  
3.3.3 Blinding  
A double blind methodology for studies of psychological treatment is 
impossible as it is clear to participants what treatment they are receiving. However, 
a well-designed study should ensure blinding of the assessor of outcome measures.  
Anxiety disorders: Blinding of assessors was clearly demonstrated in five of the 
anxiety disorder studies (Banos et al., 2011; Botella et al., 2007; McLay et al., 2011; 
Rothbaum et al., 2006; Tortella-Feliu et al., 2011).  
Pain: Of the four pain studies, only Patterson et al. (2006) attempted to blind 
assessors to treatment conditions.  
Body-image distortion/obesity: All four studies (Manzoni et al., 2008; Riva et al., 
2001; Riva et al., 2002; Riva et al., 2006) clearly demonstrated blinding of 
assessors.  
3.3.4 Loss to follow-up 
Anxiety disorders: Attrition rates were reported in all except one study (Robillard et 
al., 2010). There was no attrition in three studies (McLay et al., 2011; Perez-Ara et 
al., 2010; Wiederhold et al., 2002). The highest reported drop-out rate was 33% 
(Tortella-Feliu et al., 2011). Reasons for attrition were only sometimes reported. 
Krijn et al. (2007), Michaliszyn et al. (2010), Rothbaum et al. (2006) and Tortella-
Feliu et al. (2011) provided explanations for drop-out and conducted intention-to-
treat (ITT) analysis using last-observation carried forward. Emmelkamp et al. (2002), 
Muhlberger et al. (2003) and Wallach et al. (2009) described reasons for attrition but 
did not undertake ITT analysis. In other studies, the numbers of withdrawals were 
recorded but reasons were not provided.  
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Pain: There was no attrition in any of the pain studies. 
Body-image distortion/obesity: There was no attrition in any of the studies. 
3.3.5 Additional methodological and reporting issues  
The quality of studies in relation to other methodological and reporting criteria was 
variable (see Table 4). The average level of Downs and Black (1998) criteria fulfilled 
by studies was 59.8%. Overall, levels of reporting were generally high (M = 73.1). 
With the exception of Mott et al. (2008) all studies were considered to have clear 
aims, and with the exception of Robillard et al. (2010), all had well-defined inclusion 
criteria and description of measures. However, estimates of random variability (e.g. 
standard deviations) were not provided in two pain studies (Gershon et al., 2004; 
Patterson et al., 2006) or in two body-image distortion/obesity trials (Riva et al., 
2001; Riva et al., 2002). Also of concern is that of the 22 studies included in the 
review, only one (Michaliszyn et al., 2010) reported on potential adverse 
consequences of the intervention.  
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Table 4: Percentage of Downs & Black criteria fulfilled by included studies  
 
 
 
Comparative VRT  
disorder type  
Quality criteria 
 
Reporting  
    
      % 
 
External  
validity  
  %    
 
Internal  
validity: bias  
      % 
 
Internal validity: 
confounding     
       %    
 
Power   
    
  % 
 
Overall  
     
    % 
 
Anxiety (n = 14) 
 
Body-image (n = 4) 
 
Pain (n = 4) 
 
M (N = 22) 
 
74.0 
 
79.5 
 
63.6 
 
73.1 
 
11.9 
 
75.0 
 
25.0 
 
26.1 
 
72.4 
 
85.7 
 
60.7 
 
72.0 
 
66.7 
 
79.1 
 
79.1 
 
70.3 
 
14.3 
 
75.0 
 
0.00 
 
26.1 
 
 
 
 
 
 
55.4 
 
75.0 
 
48.5 
 
59.8 
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Levels of internal validity-bias and confounding were generally good (M = 
72.0 and M = 70.3, respectively), indicating high scores on items such as 
appropriate statistical analyses, and synonymous methods of recruitment for active 
treatment groups. Conversely, external validity scores were low (M = 26.1), which 
was unsurprising given the inherent characteristics of RCTs. However, external 
validity was relatively high across body-image distortion/obesity studies, which 
reflects the fact that participants were mainly unselected consecutive samples, and 
treatment took place at the hospitals that participants normally attended.  
Of note were the overall low levels of power (M = 26.1), which reflected the 
fact that this item on the Downs and Black (1998) checklist required power 
calculations to be performed. Only five studies demonstrated this; two were anxiety 
disorders (Botella et al., 2007; Rothbaum et al., 2006) and three were body-image 
distortion/obesity trials (Manzoni et al., 2008; Riva et al., 2001; Riva et al., 2002). 
3.4 Effects of interventions  
Eighteen of the 22 studies provided data available for analysis. For the four 
studies in which insufficient data was provided (Muhlberger et al., 2003; Gershon et 
al., 2004; Riva et al., 2001; Riva et al., 2002), attempts were made to contact the 
authors in order to obtain data but these were unsuccessful.   
3.4.1 Anxiety disorders  
Comparison one: Post-treatment comparative efficacy for anxiety disorders 
outcomes  
Thirteen of the 14 anxiety disorder studies were included in the analysis of post-
treatment outcomes. Muhlberger et al. (2003) did not provide estimates of 
population variance for analysis. The primary outcome measures used in the 
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analysis are listed in Figure 2. Lower scores on all measures represent 
improvements in symptomatology.  
There was no evidence of statistical heterogeneity (χ² = 13.03; df = 12; p = 
.37; I² = 8%), therefore a fixed effects model was used (see Figure 2). Post-
treatment, there was no significant difference between VRT and comparative 
psychological treatment for primary symptomatology outcomes (k=13, n=473; SMD 
= 0.08, 95% CI -0.10-0.26, p =.40).  
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Figure 2: Post-treatment comparative efficacy for anxiety disorder outcomes  
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Figure 3 shows that the studies included in comparison one were distributed 
roughly symmetrically around the combined effect size, indicating a low risk of 
publication bias (Borenstein, 2005). 
  
Figure 3: Funnelplot to detect for publication bias in post-treatment anxiety 
disorders studies 
Comparison two: Long-term follow-up comparative efficacy for anxiety disorder 
outcomes 
 
Six anxiety disorder studies were included in the analysis of long-term follow-
up outcomes. Choi et al. (2005) did not provide sufficient numerical outcome data 
(means and Standard Deviations not reported) to be included in the analysis. The 
same primary outcome measures were used in the analysis as those selected for 
comparison one. Long-term follow-up measures were obtained at three months 
(Michaliszyn et al., 2010), six months (Emmelkamp et al., 2002; Muhlberger et al., 
2003; Perez-Ara., 2010) and 12 months (Rothbaum et al., 2006; Tortella-Feliu et al., 
2011). There were an insufficient number of studies to check for publication bias.  
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There was no evidence of statistical heterogeneity (χ² = 1.62; df = 5; p = .90; 
I² = 0%), therefore a fixed effects model was used (see Figure 4). At follow-up (3, 6 
or 12 months), there was no significant difference between VRT and comparative 
psychological treatment on primary symptomatology outcome measures (k=6, 
n=183; SMD = 0.13, 95% CI -0.16-0.43, p = 0.37). 
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 Figure 4: Long-term follow-up comparative efficacy for anxiety disorder outcomes 
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3.4.2. Pain  
Only one comparison was run for the pain studies as follow-up data was not 
gathered by any of the included studies. Three of the four pain studies were 
included in the analysis (Liebovici et al., 2009; Mott et al., 2008; Patterson et al., 
2006). Gershon et al. (2004) did not provide sufficient numerical data (no estimates 
of population variance) to be entered. Outcome measures selected for inclusion are 
detailed in Figure 5. Lower scores on all measures represent reductions in 
symptomatology. There were an insufficient number of studies to check for 
publication bias.  
Statistical heterogeneity was observed (χ² = 22.51; df = 2; p < .01; I² = 91%), 
therefore a random effects model was used (see Figure 5). Following treatment, a 
significant difference was just reached between VRT and comparative psychological 
treatment, with VRT resulting in greater reductions of pain symptomatology (k=3, 
n=118; SMD = -1.56, 95% CI -3.08-0.02, p = .05).  
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Figure 5: Post-treatment comparative efficacy for pain outcomes 
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3.4.3 Body-image distortion/obesity  
 
Comparison one: Post-treatment comparative efficacy for body-image  
distortion/obesity outcomes  
Only two of the four body-image distortion/obesity studies were included in 
the analysis (Manzoni et al., 2008; Riva et al., 2006). Riva et al. (2001) and Riva et 
al. (2002) did not provide sufficient numerical data (no estimates of population 
variance) for inclusion. Outcome measures selected for inclusion are detailed in 
Figure 6. Lower scores on all measures represent reductions in symptomatology. 
There were an insufficient number of trials to check for publication bias within the 
comparison. 
There was no evidence of statistical heterogeneity (χ² = 0.06; df = 1; p = .80; 
I² = 0%), therefore a fixed effects model was used (see Figure 6). Following 
treatment, there was no difference between VRT and comparative psychological 
treatment on primary symptomatology outcome measures (k=2, n=150; SMD = -
0.30, 95% CI -0.62-0.03, p = .07). There was however a trend towards increased 
VRT efficacy. 
Comparison two: Long-term follow-up comparative efficacy for body-image 
distortion/obesity  
Only one body-image distortion/obesity study measured outcomes at long-
term (six months) follow-up (Riva et al., 2006). The inclusion of only one study 
precluded assessment of publication bias and heterogeneity. Since only one study 
was included in the comparison, checks for heterogeneity were not applicable, and a 
fixed effects model was used. At six-month follow-up, there was no significant 
difference between VRT and comparative psychological treatment on primary 
symptomatology outcome measures for body-image distortion/obesity (k=1, n=40; 
SMD = -0.62, 95% CI -1.25-0.02, p = .06). There was however a trend towards 
increased VRT efficacy, which nearly reached significance. 
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Figure 6: Post-treatment comparative efficacy for body-image distortion/obesity outcomes  
 
Figure 7: Long-term follow-up comparative efficacy for body-image distortion/obesity outcomes 
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4. DISCUSSION 
4.1 Main findings   
Twenty-two RCTs were identified that compared VRTs with established 
psychological interventions for treating anxiety disorders, body-image 
distortion/obesity and pain. These studies included a total of 1192 participants. 
Eighteen studies, with 741 participants provided data for analysis. There was no 
difference between VRTs and traditional treatments for anxiety disorder symptom 
reduction either at post-treatment or follow-up. There was an observable post-
treatment difference in pain outcomes that just reached significance, favouring VRT 
over traditional interventions. Follow-up data for pain symptomatology was not 
obtained by any of the included trials. Non-significant trends were observed for 
body-image distortion/obesity symptomatology, favouring VRT over traditional 
treatments both at post-treatment and follow-up.  
4.2 Overall completeness and applicability of the evidence  
The studies included in this review enabled the primary research question to 
be addressed; it was possible to perform a meta-analysis of RCTs that compared 
VRTs against established therapies aimed at reducing mental health 
symptomatology. However, analyses could not be performed for four studies 
(Muhlberger et al., 2003; Gershon et al., 2004; Riva et al., 2001; Riva et al., 2002) 
that provided insufficient data.  
The current findings tentatively indicate that VRTs are at least as effective – 
and in some cases superior to – traditional psychological treatments for alleviating 
mental health symptomatology. However, it is unclear whether traditional 
comparative interventions were state-of-the-art, whether they were manualised and 
if so, therapists’ fidelity to protocols. Thus it remains possible that VRTs are 
comparable in efficacy to ‘low grade’ traditional treatments but inferior to cutting-
edge counterparts. Additionally, credibility and expectancy may have influenced the 
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outcomes of comparisons, as these variables are known to influence treatment 
responsivity (Jacobson & Baucom, 1977; Kazdin, 1979; Kazdin & Krouse, 1983).  
For anxiety disorder and body-image distortion/obesity symptomatology, 
VRTs appeared to be comparable – but not superior – to traditional interventions, 
both in the short- and longer-term. However, within these domains clinical conditions 
were heterogeneous, meaning that there remains uncertainty regarding the 
comparative efficacy of VRTs for specific anxiety disorders and specific obesity-
related psychological outcomes. Additionally most VRTs were multifaceted and 
included non-VR therapeutic components. It is therefore unclear whether VRTs are 
efficacious as standalone treatments, or when used in conjunction with traditional 
treatments. Furthermore, the analyses of anxiety disorders and body-image 
distortion/obesity outcomes did not include the results of behavioural avoidance 
tests, meaning that generalisability to real life cannot be readily inferred.  
The results of the pain analyses provide preliminary support for VRT as a 
more efficacious method of pain reduction than established psychological 
approaches. In addition to credibility and expectancy, there are a number of 
potential explanations for this observed effect. First it is possible that there was a 
weak response to traditional treatments due to poor design and delivery of 
comparative interventions. Second, VRTs may have included hidden treatment 
components (e.g. relaxation) over and above distraction, rendering traditional 
distraction an ill-matched comparison. Third, only one pain study (Patterson et al., 
2006) attempted to blind outcome assessors, meaning that researcher allegiance 
could have influenced outcomes. Fourth, the study with the most promising data in 
support of VRT (Mott et al., 2008) used proxy parental pain ratings, which could be 
less accurate than patients’ self-reports. Finally, VRT may simply be a more efficient 
method for consuming attentional resources than traditional distraction. These 
competing explanations require continued research (see implications below).  
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Across all three mental health domains, only one outcome measure from 
each study was selected for analysis; this is a limitation given that most studies 
administered multiple measures of symptomatology. To address this, effect sizes for 
all outcomes could have been aggregated using Hedges G, but this method 
introduces problems of its own. Only one study reported on potential adverse effects 
of interventions (Michaliszyn et al., 2010) and it is unclear whether adverse 
consequences resulted from interventions in the other studies. This is concerning in 
light of knowledge that VR can induce simulation-sickness and visual disturbance 
(Griffin, 1990). These limitations coupled with the small number of studies in most of 
the comparisons, their small sample sizes, and heterogeneity (see below) 
complicate interpretation. 
 
4.3 Quality of evidence 
Thirteen RCTs with 473 participants were included in the meta-analysis of 
anxiety disorders at post-treatment, suggesting that the results may be robust. 
However, this must be considered in light of heterogeneity and methodological 
quality issues. Other comparisons included fewer RCTs and participants and 
therefore the results are likely to be less robust, with an increased risk of chance 
findings. Consequently, significant findings and trends in the realms of pain and 
body-image distortion, respectively, should be interpreted with caution. 
4.3.1 Heterogeneity  
Clinical heterogeneity was noted within all three mental health domains. 
Although all trials attempted to reduce symptomatology, the nature of the 
interventions and clinical characteristics of participants were diverse. Whilst all the 
anxiety disorders VRT interventions included exposure, they also had varying 
degrees of cognitive therapy and therapist involvement. Similarly, although all 
traditional comparative interventions were based on CBT principles, they were 
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diverse in terms of treatment components, method of delivery and number/duration 
of sessions. It is very difficult to compare such trials and there did appear to be 
some substantial differences in outcomes. For example, Wiederhold et al. (2002) 
obtained a moderate effect size in favour of VRT, whereas Botella et al. (2007) 
obtained a moderate effect size in the opposite direction.  
Within the analysis of pain studies statistical heterogeneity was apparent, 
with the I² value indicating inconsistencies between trials that were grouped 
together. Consequently a random effects model was applied in order to calculate 
more conservative confidence intervals. Clinical heterogeneity was also present in 
the pain studies, including child and adult participants with acute procedural pain, 
experimental pain and chronic pain. The appropriateness of aggregating these 
results is debatable and unfortunately it was not possible to perform sensitivity 
analysis owing to the small number of included trials. Nevertheless, it is encouraging 
that the effect sizes from all three trials analysed were medium or large, suggesting 
that the overall significant finding was not artificially elevated by the results of one 
study.   
Clinical heterogeneity was also present in the two body-image 
distortion/obesity trials. Although both studies included women diagnosed as 
clinically obese, they were addressing different psychological constructs. Riva et al. 
(2006) specifically targeted body image distortion, whilst Manzoni et al. (2008) 
targeted broader eating-related self-efficacy. Furthermore the VRT and comparative 
interventions varied considerably between trials; Manzoni et al. (2008) relied almost 
exclusively on relaxation methods whereas Riva et al. (2006) delivered 
comprehensive CBT packages. Such heterogeneity coupled with the small 
combined samples sizes both at post-treatment (n = 150) and follow-up (n = 40) limit 
the utility of these findings.  
In spite of heterogeneity across trials, all studies were attempting to measure 
mental health symptom reduction in response to VRT compared to established 
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treatments. Consequently it remains worthwhile summarising their combined results, 
but means that caution should be exercised when interpreting findings.  
 
4.3.2 Methodological quality 
The overall quality of the studies was variable. Several issues were apparent 
in many of the studies including lack of information on the randomisation process, 
incomplete reporting and analyses of attrition, lack of follow-up data and insufficient 
statistical power. The small sample sizes of many of the studies are also a notable 
limitation. However, the VRT and comparative intervention participants in most 
studies appeared well matched at baseline, reducing the risk of the reported 
unadjusted means being influenced by pre-treatment differences. Additionally, the 
overall ratings obtained on the Downs and Black (1998) checklist suggested that the 
methodological quality of trials was generally acceptable.  
 
4.4 Potential biases in the review process  
This review was guided by Cochrane Collaboration guidelines, which would 
have reduced potential bias. Methodological quality of studies was assessed using a 
validated tool (the Downs & Black checklist, 1998), further reducing risk of bias. 
Nevertheless bias would have occurred towards published as opposed to 
unpublished studies and English language manuscripts. Full data were not available 
for all studies, and although attempts were made to contact authors, these were 
unsuccessful. The clearly defined inclusion and exclusion criteria helped to correctly 
identify studies. However, by virtue of these selection criteria, only RCTs with 
sample sizes of great than 10 were included. Selection and quality assessment of 
studies was performed by only one reviewer, which represents a further source of 
potential bias. 
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4.5 Agreement/disagreement with other reviews 
Consistent with Gregg et al. (2006), the current review endorses the finding 
that VRTs are equally efficacious as established psychological interventions for 
reducing anxiety disorder symptomatology. These results are also in line with the 
most recent – and methodologically robust – review (Meyerbroker et al., 2010), 
which concluded that currently there was no evidence to support the notion that 
VRTs are superior to traditional therapies for the majority of anxiety disorders. 
However, contrary to two previous meta-analyses (Powers & Emmelkamp, 2008; 
Parsons & Rizzo, 2008), the present review did not find VRTs to outperform 
traditional interventions in alleviating anxiety symptomatology. There are a number 
of potential explanations for this discrepancy.  
First, this review exercised stringent methodological criteria for included 
studies, limiting results to RCTs with sample sizes of greater than ten. Conversely, 
in addition to RCTs Parsons and Rizzo (2008) included case reports and Powers 
and Emmelkamp (2008) reviewed uncontrolled trials; combining such disparate 
methodologies is questionable. Second, the current review analysed the outcomes 
of only one measure from each trial, whereas both previous meta-analyses 
aggregated results from all symptomatology outcomes, which may have produced 
different findings. Third, both previous meta-analyses mainly concerned specific 
phobias whereas the present review included a greater number of trials relating to 
social anxiety disorder, PTSD and panic disorder. It may be that feared stimuli in 
these more complex conditions are too idiosyncratic to rebuild in virtual 
environments and therefore better suited to traditional exposure methods 
(Meyerbroker et al., 2010). Indeed, examination of individual effect sizes shows that 
with the exception of one PTSD study (McLay et al., 2011), the most substantial 
effect sizes in favour of VRT came from three trials of specific phobias (Wiederhold 
et al., 2003; Tortella-Feliu et al., 2011; Emmelkamp et al., 2002). Similarly, with the 
exception of one aviophobia trial (Krijn et al., 2007) the three most sizable effects in 
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favour of traditional treatments came from studies of panic disorder and 
agoraphobia. It is therefore plausible that more complex conditions were less 
responsive to VRT, though continued controlled research is required to investigate 
this notion. 
Consistent with previous reviews (e.g. Shahrbanian et al., 2009; Malloy & 
Milling,  2010), the present findings tentatively suggest that VRT shows promise in 
treating acute pain (experimental and procedural) but highlight a general paucity of 
controlled research, particularly for chronic conditions. Similarly, the findings from 
body-image distortion/obesity comparisons are in line with Gregg and Tarrier’s 
(2007) conclusions that there is preliminary support for VRT as a comparatively 
efficacious treatment for obesity-related psychological outcomes. However, the 
results provide a less definitive and optimistic view of the literature than Riva et al. 
(2010) by highlighting the variable quality of trials and the lack of research in this 
domain. It is noted that Riva and colleagues have been responsible for most of the 
research into VRTs for eating disorders, which raises questions about the objectivity 
of their review.   
 
4.6 Implications  
 
4.6.1 Implications for practice  
 
Anxiety disorders: Based on the current findings alone, it could be argued that 
there is no justifiable reason for introducing VRTs into routine clinical practice for 
anxiety disorders. VRT remains a relatively expensive alternative and does not 
appear to reduce symptomatology over-and-above traditional treatments, for which 
there is a strong existing evidence-base (Deacon & Abramowitz, 2004). However, 
the narrow focus of this review coupled with methodological imitations renders such 
conclusions premature. As aforementioned, the comparative efficacy of specific 
VRTs for specific anxiety disorders remains uncertain. For some conditions (e.g. 
specific phobias) VRTs may outperform traditional approaches both in terms of cost-
 72 
 
effectiveness (e.g. in aviophobia) and by way of exposing patients to scenarios that 
would be impossible to recreate in-vivo.  
 Conversely, it is possible that some anxiety-provoking stimuli may be too 
idiosyncratic to rebuild within the constraints of virtual environments and are 
therefore better suited to traditional approaches. However, as virtual environments 
become more readily amenable to therapeutic manipulation, there may be scope to 
recreate these highly idiosyncratic situations within the safety of a therapist’s office. 
It is also possible that VRTs are better placed to target hard-to-reach patients such 
as those presenting with severe agoraphobia, unable to leave home to commence 
treatment. VRT offers the potential to introduce initial treatment sessions via home 
internet port-access (Meyerbroker et al., 2010), which may prove more cost-effective 
in the long-run. Conceptually this would fit well with existing self-administered 
interventions in the NHS, such as computerised CBT packages. However, continued 
research is required into each of these theoretical benefits before recommendations 
for practice can be made. Indeed, as highlighted by Cote and Bouchard (2008), 
VRTs were originally intended to address the shortcomings of traditional approaches 
rather than outperform them per se. 
Pain: The present review provides tentative evidence that VRTs are superior 
to established methods of distraction in the management of acute and potentially 
chronic pain. Although preliminary, these findings suggest that VRT may offer 
exciting potential in routine practice, which could be particularly welcome in the remit 
of chronic pain. Unlike acute pain in which it is often possible to arrange in advance 
for a clinician to be present to deliver psychological interventions, chronic pain is 
largely reliant on self-management (Malloy & Milling, 2010). Consequently it is a 
particularly intractable, time-consuming and costly health problem.  As the price of 
VR technology continues to fall, VR distraction may become an increasingly 
affordable and effective self-management tool for chronic pain patients. At present 
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however, a greater number of controlled trials are required in both acute and chronic 
pain before VRT initiatives can be trialled with confidence in clinical practice.  
Body-image distortion/obesity: The present findings provide cautionary 
support for VRT as a comparable – possibly more effective – means of improving 
psychological outcomes related to obesity.  The main theoretical advantages are the 
scope to manipulate a concept as subjective and hard to treat as body-image and 
provide patients with therapist-independent information about inaccurate internal 
representations of their body-image (Ferrer-García & Gutiérrez-Maldonado, 2012). 
This holds exciting potential not only in the clinical management of obesity outcomes 
but in anorexia and bulimia nervosa, for which body-image disturbance is implicated 
in the onset, maintenance and prognosis (Cash & Brown, 1987). These conditions 
are amongst the most prevalent in adolescents and young adults, and the current 
findings suggest that VRT could provide a means of targeting associated 
psychological outcomes. Future large-scale controlled trials are required to ascertain 
the effects of VRT on body-image distortion across the full spectrum of eating 
disorders. In particular, research is required beyond the work of Riva and 
colleagues, who have largely dominated this arena to date.  
 
 
4.6.2 Implications for research  
The current review highlights the need for greater number of large-scale and 
methodologically robust comparative efficacy trials with follow-up data, particularly in 
the domains of pain and obesity/body-image distortion. Thereafter separate meta-
analyses are required for discrete psychological conditions in order to assess 
comparative efficacy of VRT for specific disorders. It will be important for future 
reviews to track changes in efficacy as VR equipment becomes more amenable to 
precise therapeutic manipulation and is increasingly trialled with complex clinical 
presentations and hard-to-access populations. Future research would benefit from 
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ensuring blinding of outcome assessors and gathering data on credibility and 
expectancy rates.  
This review indicates a need for dismantling research in order to ascertain 
the relative contribution of different therapeutic components in VRT and assess its 
efficacy as a standalone treatment. Future studies may also benefit from including 
data on moderators such as ‘presence’. If for example VR-exposure reduces fear by 
activating a fear structure (Foa & Kozak, 1986) then it is likely that the more ‘real’ 
VRT is, the more efficacious it will be (Powers & Emmelkamp., 2008). Given that 
presence is affected by a range of variables such as the sophistication of VR 
technology, future moderator analysis could inform decisions about whether to 
purchase immersive or non-immersive equipment and inform an understanding of 
the types of patients who may or may not be responsive to treatment.  
Although symptomatology is an important outcome in establishing treatment 
efficacy, any decision to begin treatment would depend on a multitude of factors 
including patient preference, cost to the healthcare system, the impact of 
comorbidities and the severity of the disorder. Future research is required to 
understand how these factors can be considered alongside efficacy data in order to 
inform decisions about the utility of VRT in clinical practice. Data from behavioural 
avoidance tests, particularly in the anxiety disorders and obesity/body-image 
domains, also requires evaluation to better understand generalisability of effects to 
everyday life. 
This review highlights some notable gaps in the literature such as the 
absence of comparative efficacy trials of VRT for anger management. Performance-
based methods are a powerful means of producing therapeutic change across 
behavioral, cognitive, and affective modalities (Bandura, 1989) and accordingly CBT 
for anger typically includes role-play (Miyahira, Folen, Stetz & et al., 2010). VRTs 
have the potential to recreate ecologically valid anger-provoking scenarios in a safe 
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and ethical environment. Recent research indicates that aggressive virtual 
environments are an effective means of priming anger (Miyahira et al., 2010; 
Brinkman, Hattangadi, Meziane, & Pul, 2011). Therefore patients could gradually 
learn to manage arousal and negotiate prosocial responses with virtual characters. 
Developments in this arena could have far reaching consequences for the treatment 
of specific clinical conditions including oppositional defiance disorder, conduct 
disorder and antisocial personality disorder. This represents an exciting area for 
future development and comparative efficacy trials will be an important component 
of this research.  
4.7 Summary 
The current review suggests that VRTs are comparable – and in some 
instances more efficacious – than traditional interventions for reducing mental health 
symptomatology. However these conclusions are tentative in light of heterogeneity 
and methodological issues, coupled with limitations of the review process. There is a 
need for a greater number of methodologically robust large-scale studies, with 
follow-up data, particularly in the domains of pain and body-image distortion/obesity. 
Although this review provides a more sobering look at the literature than previous 
meta-analyses, outcomes other than symptomatology warrant further investigation 
in order to better understand the utility and cost-effectiveness of introducing VRTs 
into routine practice. There is also a need for research into treatment mediators and 
moderators; this would support the implementation of VRTs by making treatment 
outcomes more predictable. Finally, VRTs may offer exciting potential in new clinical 
applications, such as the full spectrum of eating disorders and in the treatment of 
anger.  
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ABSTRACT 
Background: Robust differences have been observed between aggression-prone 
and non-aggression-prone groups in their emotional and behavioural reactivity 
during stress and provocation. However, there is a lack of ecologically valid 
research, particularly with regard to individuals with antisocial personality disorder 
(ASPD). 
Aims: To investigate whether individuals diagnosed with ASPD, relative to healthy 
volunteers, show increased negative emotional reactivity and more aggressive 
behaviour during virtual-reality (VR) provocation.  
Method: Fifteen individuals diagnosed with ASPD and 20 healthy volunteers 
witnessed aggression escalating between characters in a virtual ‘pub’. Emotional 
reactivity was indexed across affective, cognitive and behavioural domains using 
questionnaires, interview and observation.  
Results: Following VR provocation, participants showed significant elevations in 
negative affect but no changes in positive affect. Clinical participants displayed 
greater increases in negative affect, more anger-oriented cognitions, less victim-
empathic cognitions, less conciliatory/prosocial behaviour, and a trend towards more 
aggressive behaviour than healthy volunteers. 
Conclusions: It is tentatively concluded that participants with ASPD experienced 
more marked negative emotionality in response to VR provocation than healthy 
volunteers, contributing to a reduction in prosocial behaviour and a trend towards 
more impulsive aggression. Potential clinical moderators and methodological factors 
are considered as explanations for aggressive behavioural differences failing to 
meet significance. Implications for how ASPD aggression is conceptualised, which 
interventions may be indicated and how to assess and monitor risk are discussed. 
Findings are exploratory and methodologically robust modified replications are 
required before firm conclusions can be reached about the role that emotional 
reactivity plays in aggression within this population.  
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“Anybody can become angry – that is easy, but to be angry with the right person, 
and to the right degree, and at the right time, and for the right purpose, and in the 
right way – that is not within everybody's power and is not easy”: Aristotle  
 
 
1. INTRODUCTION  
1.1 Antisocial Personality Disorder  
Antisocial personality disorder (ASPD) is characterised by “a pervasive 
pattern of disregard for, and violation of the rights of others” (Diagnostic and 
Statistical Manual of Mental Disorders, revised 4th edition [DSM-IV]; American 
Psychiatric Association [APA], 2000). In the UK, the prevalence of ASPD amongst 
men and women is estimated at 1% and 0.2%, respectively (Coid, Tyer & Roberts, 
2006). Comorbidity studies suggest that 90.4% of people who meet criteria for 
ASPD have at least one other psychiatric condition (Swanson, Bland & Newman, 
1994), most commonly substance misuse (Robins & Price, 1991).  
ASPD is associated with profound interpersonal and social disadvantage 
across the lifespan, including low educational attainment, imprisonment and 
premature mortality (Swanson et al., 1994). Thus whilst criminality is central to the 
definition of ASPD (DSM IV; APA, 2000), it is often the consequence of long-
standing difficulties and is not the only feature. Consequently, ASPD is 
conceptualised as distinct from criminal behaviour/violence per se (NICE CG 77, 
2009), evidenced by the fact that roughly 50% of prisoners do not meet diagnostic 
criteria (e.g. Fazel & Danesh, 2002). A further distinction to be made is between 
ASPD and psychopathy. Psychopathy is characterised by a cluster of 
interpersonal/affective features (e.g. callous/lacking empathy) and marked social 
deviance (e.g. parasitic lifestyle) (Hare, 2003). Whilst the two are associated, only 
10% of those with ASPD fulfil criteria for psychopathy (NICE CG 77, 2010). 
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1.2 Emotional processing in aggressive populations 
Research into the processes underlying aggression and violence in criminal 
populations has focused almost exclusively on psychopathy, in which chronic 
physiological under-arousal is a well-replicated correlate of stress (e.g. Patrick, 
Cuthbert & Lang, 1994). By implication, aggression/violence committed by this 
subgroup is considered primarily ‘instrumental’ and premeditated (e.g. Crick & 
Dodge, 1996), without anger necessarily playing a crucial role (Porter, Woodworth, 
Earle, Drugge & Boer, 2003). However, this cannot be assumed applicable to 
ASPD, which by definition entails deregulated and uncontrollable anger (APA, 
2000). Indeed, research suggests that whilst psychopathic offenders show reduced 
behavioral and physiological responses to emotional stimuli (Levenston, Patrick, 
Bradley, & Lang, 2000) such deficits do not emerge for individuals diagnosed with 
ASPD (Vaidyanathan, Hall, Patrick, & Bernat, 2011). This implies that emotional 
hyper-responsivity may play a more pivotal role in ASPD aggression, by way of 
impulsive reactions to provocation or stress.  
In support of this, brain-imaging studies of violent criminals show dysfunction 
in the frontocortical (e.g. Blake, Pincus & Buckner, 1995) and limbic regions (e.g. 
Raine, Buchsbaum & LaCasse, 1997) that mediate emotional processing. Research 
also demonstrates that the impulsive traits of ASPD are associated with negative 
emotional reactivity (Hicks & Patrick, 2006), and with deficits in brain regions that 
govern inhibitory control (Morgan & Lilienfeld, 2000). Further evidence indicates that 
aggressive children show autonomic acceleration during stress (Lorber, 2004) and 
that weak vagal control is associated with externalising problems in at-risk children 
(e.g. El-Sheikh, Harger & Whitson, 2001).  
Experimental research also implicates emotional hyper-responsivity in 
aggressive behaviour. Verona, Patrick & Lang (2002) subtyped healthy volunteers 
into those scoring ‘high’ and ‘low’ trait negative emotionality and induced negative 
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affect via a series of aversive air blasts. Participants who scored high on trait 
negative emotionality exhibited enhanced tonic distress and delivered more intense 
electric shocks to an experimental confederate during air blast intervals than low 
scorers. This suggested that sustained negative affect biases high stress-reactive 
individuals towards more intense and prolonged acts of aggression. Similarly, 
correlational research indicates that high levels of trait negative emotionality are 
characteristic of domestic assaulters (Farrington, 1980) and partner abuse is more 
likely to occur in times of stress (Rosenbaum & O’Leary, 1981).  
These findings can be understood in terms of Berkowitz’s (1990) cognitive-
neoassociationist model of aggression, which conceptualises emotional states as a 
collective network in which affect, cognitions, physiological reactions and motor 
responses are all linked together. Because these interconnected components 
involve adaptive mobilisation for defensive action (Lang, Bradley, & Cuthbert, 1990), 
negative affect primes aggressive behaviour during provocation or stress 
(Berkowitz, 1983, 1994). By implication, individuals who are vulnerable to emotional 
hyper-responsivity are particularly likely to display aggression under provocative 
conditions.  
 
1.2.1 Emotional reactivity in ASPD 
The aforementioned findings raise the possibility that unlike psychopathy, 
ASPD entails difficulties regulating anger (and other emotional reactions), with 
consequential enhancement of defensive reactivity under conditions of perceived 
threat. However, only one study to date is known to have directly investigated 
emotional responsivity in relation to ASPD. Lobbestael, Arntz, Cima & Chakhssi 
(2009) compared ASPD participants to healthy volunteers and a borderline 
personality disorder group on indices of emotional reactivity at baseline and 
following an anger-induction interview. Compared with control groups, ASPD 
participants displayed comparative cognitive hyper-responsivity and physiological 
 96 
 
hypo-responsivity but no differences in self-reported anger. These findings were 
understood in two ways. First, because lying is a central characteristic of ASPD, 
questionnaire data may have reflected ‘text appropriate’ ratings (Herpertz, Werth, 
Lukas et al., 2001), thereby artificially reducing ASPD anger scores. Second, the 
discrepancy between cognitive hyper-responsivity and physiological hypo-
responsivity within the ASPD group was seen to reflect animal defences, in which 
the ‘fight phase’ is preceded by an ‘orienting phase’ (e.g. Lacey & Lacey, 1958). 
Because orientation is characterised by cognitive vigilance and decelerated heart 
rate (Lang, David & Ohman, 2000), it was tentatively concluded that ASPD 
participants remained in this phase longer than control participants. This was 
attributed to the anger-induction interview representing a ‘remote threat’ (e.g. the 
object of aggression was far away and therefore not set up to provoke a counter-
attack) that was insufficient to provoke a fight response in ASPD participants. 
Lobbestael et al. (2009) recommended that future research utilise 
imminent/intense anger-induction methods, in order to establish whether ASPD 
participants switch from physiological hypo-responsivity into an extreme defensive 
response, resulting in impulsive aggression/violence. However until recently the 
scope of experimental anger induction has been limited, reflecting the tension 
between ethics, safety and generalisability (Ferguson & Rueda, 2009). Virtual reality 
(VR) offers a novel potential means of balancing these priorities within a controlled 
laboratory environment. 
1.3 Virtual reality  
An immersive virtual environment is a computer-generated real-time 
surrounding that displays virtual sensory data from a viewpoint determined by the 
tracked position and orientation of the occupant’s head (Rizzo & Kim, 2005). This 
delivers a life-sized VR within which a person can experience events and interact 
with virtual objects and characters (avatars). Research indicates that people 
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respond realistically to virtual environments (Rovira, Swapp, Spanlang & Slater, 
2009), even in extreme social situations (Slater, Antley, Davison, et al., 2006). This 
has been capitalised on in the treatment of a range of psychological disorders (e.g. 
Muhlberger, Wiedermann & Pauli, 2003) and in investigations into the processes 
underlying these conditions (for a detailed review see Bohil, Alicea & Boicca, 2012).  
There have been a number of recent developments in the field of VR-
simulated violence and aggression. Rovira and colleagues (2009) developed a 
virtual ‘pub’ to study participants’ responses to a violent dispute between two 
avatars. An exploratory study indicated that most participants attempted to 
physically or verbally intervene in the confrontation, despite awareness that the 
avatars were not real. Two recent studies have directly substantiated the anger-
arousal potential of VR using physiological measurement (Brinkman, Hattangadi, 
Mezinae & Pul, 2011), behavioural observations and self-report (Miyahira, Folen, 
Hoffman, Garcia-Palacios & Schaper, 2010). Together these findings indicate that 
VR provides an ecologically valid means of studying how people respond to 
provocation, enabling researchers to observe complex behaviour and decision-
making, rather than being restricted to more arbitrary measures.  
In summary, there is some evidence to suggest that ASPD aggression may 
reflect emotional hyper-responsivity but previous research has focused almost 
exclusively on psychopathic and aggression-prone individuals. The only study 
known to have investigated anger induction in ASPD (Lobbestael et al., 2009) did 
not measure behaviour, meaning that the link between emotional reactivity and 
actual aggression remains unclear. Moreover, the stress-induction interview used 
was a remote threat unlikely to typify the real-life triggers of reactive anger, which 
leaves outstanding questions about the emotional and behavioural reactivity of 
individuals with ASPD during ecologically valid conditions of imminent threat. VR 
offers a method for addressing these gaps in the literature. Improved understanding 
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could have implications for how ASPD aggression is conceptualised, which 
interventions are best indicated and how to assess and monitor risk.  
1.4 The current research  
The present study aimed to investigate differences between individuals with 
a diagnosis of ASPD and healthy volunteers in their emotional and behavioural 
responses to experimentally induced provocation. Specifically it aimed to establish 
whether the former displayed more negative affect, anger-oriented cognitions and 
aggressive behaviour when exposed to violence in a VR pub scenario (Rovira et al., 
2009). The original research intention was to index the full associative network 
comprising emotions (Berkowitz, 1990), including autonomic arousal (via 
electrocardiogram) and motor activity (via electromyogram). However, unfortunately 
both strands of physiological data proved uninterpretable due to an equipment 
failure that was not detected until completion of testing. Consequently, the final 
sources of data comprised (i) affective states measured by the Positive and 
Negative Affect schedule (PANAS; Watson, Clark & Tellegen, 1988), (ii) cognitive 
appraisals/interpretations elicited via semi-structured interview, and (iii) behavioural 
reactions during VR.  
1.4.1 Hypotheses  
The hypotheses were informed by previous research demonstrating 
differences between aggression-prone and non-aggression-prone groups in their 
emotional reactivity during provocation (Lobbestael et al., 2010), and their 
propensity to behave aggressively when exposed to stress (Verona et al., 2002). 
Accordingly it was predicted that participants with ASPD, relative to healthy 
volunteers, would display:  
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1. Affect: A greater increase on the negative scale, and a greater decrease on the 
positive scale of the PANAS between baseline and post-VR.  
2. Cognitions: More anger-oriented and less victim-empathic cognitions during 
interview.  
3. Behaviour: More aggressive/antagonistic behaviour and less 
conciliatory/prosocial behaviour during VR.  
In addition to the foregoing, the relationship between emotional reactivity and 
behaviour was investigated based on the following subsidiary hypothesis:  
4. Relationship between outcomes: Regardless of group membership, antagonistic 
behaviour will correlate with negative affect and anger-oriented cognitions, and 
conciliatory behaviour will correlate with positive affect and victim-empathic 
cognitions. 
2. METHOD 
2.1 Design 
This research utilised a 2x2 group-comparison mixed design. The between-
groups variable was ‘clinical group’ (ASPD vs. healthy volunteers) and the repeated-
measures variable ‘point of measurement’ (baseline vs. post-VR). Dependent 
variables were ‘affective states’, ‘cognitions’ and ‘VR intervention behaviours’. All 
participants took part in the same VR scenario and completed self-report 
questionnaires and an interview. 
2.2 Participants  
Clinical participants were 15 males, aged 24-62 years (M = 44). All had an 
established primary diagnosis of ASPD (DSM-IV; APA, 2000) or Dissocial 
Personality Disorder (ICD-10; WHO, 1992), previously diagnosed by a psychiatrist 
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using the Structured Clinical Interview for DSM-IV Axis II Personality Disorders 
(SCID-II; First, Williams, Spitzer & Gibbon, 1997) and/or the International 
Personality Disorder Examination (IPDE; Loranger, Sartorius, Andreoli, Berger et al., 
1994). Clinical participants were recruited from three specialist forensic personality 
disorder services (inpatients n = 4, community patients n = 9), one generic forensic 
service (community patient n = 1) and one non-forensic personality disorder service 
(community patient n = 1). Inclusion criteria were: (1) a well-defined psychiatric 
diagnosis of ASPD, (2) one or more conviction(s) for a criminal offence, and (3) 
capacity to consent to the research. Inpatients detained under the Mental Health Act 
(1983) also required community leave (agreed by the Ministry of Justice and 
respective clinical team) of a sufficient allowance to participate in the study. 
Exclusion criteria were active symptoms of major mental illness and/or a diagnosed 
learning disability.  
Healthy volunteers were 20 male students of University College London 
(UCL) and members of the wider London community aged 20-47 years (M = 28), 
recruited from UCL participant panels and via advertisements placed around 
campus (Appendix 2). Exclusion criteria were: a psychiatric and/or violent offending 
history.  
General inclusion criteria for clinical and non-clinical groups were: male 
participants, aged 18-65, with sufficient command of the English language to 
understand the VR scenario and questionnaires. Participants with epilepsy were 
excluded because VR can trigger seizures. Demographic and clinical characteristics 
of participants are displayed in Table 1 and Table 2 in the Results section.  
2.3 Sample size and statistical power 
Power analysis for this study was informed by prior work by Lobbestael et al. 
(2009). In their study an anger-induction interview was used to compare individuals 
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with ASPD and control groups on various indices of emotional reactivity. On a 
measure of self-reported anger, ASPD participants compared to healthy volunteers 
showed a between-groups effect size of d = 0.53 (Cohen’s d = medium). Power 
calculations for a repeated-measures, between-factors ANOVA were conducted in 
G*Power 3.1.2 (Faul, Erdfelder, Lang and Buchner, 2007), specifying α = 0.05 and 
desired power at 0.80. For a comparison between two groups, with two levels of 
measurement, the required sample size was 24 (12 per group). The achieved 
sample size was 35 (15 ASPD and 20 healthy volunteers).   
2.4 Procedure  
2.4.1 Participant identification and recruitment 
The project was approved by Camberwell & St Giles NHS Research Ethics 
Committee (Appendix 3) and UCL Ethics Committee (Appendix 3). To recruit clinical 
participants, the researcher circulated a letter (Appendix 2) to clinicians in respective 
services requesting referrals for the research. Potential participants’ medical records 
were screened by a member of their clinical team, who approached eligible 
candidates with the information sheet (Appendix 4) to ascertain whether they were 
interested in taking part.  
The names of interested participants were passed to the researcher, who 
sought permission from the Responsible Clinician/Consultant Psychiatrist to meet 
with the participant directly. The purpose of this initial meeting was to describe the 
research in full, explain the process of informed consent and provide an opportunity 
for questions. For inpatients this introduction took place on hospital premises, 
facilitated by a member of their clinical team. Initial introductions with community 
patients occurred either at their respective hostels or by telephone. Thereafter 
research appointments were scheduled with participants to attend UCL and the 
Responsible Clinician/Consultant Psychiatrist was informed of their involvement 
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(Appendix 2). Healthy volunteers were a self-selecting sample recruited via 
participant panels and advertisements at UCL. Participants were asked to contact 
the researcher directly, whereupon they were sent a copy of the information sheet 
(Appendix 4) and a research appointment was scheduled. A TREND diagram (Des 
Jarlais, Lyles & Crepaz, 2006) of non-randomised recruitment is shown in Figure 1. 
 
 
 
 
 
  
 
 
Did not consent  
 
Clinical (n = 8):  
 Loyalty to football team (n =2) 
 Unspecified (n = 5) 
 
Healthy volunteers (n =2):  
 Did not attend (n = 2) 
 
 
  
Figure 1: TREND diagram of the non-randomised recruitment process  
2.4.2 Testing procedure 
Testing took place in the Department of Computer Science, UCL where the 
VR suite was situated. Written informed consent (Appendix 4) and basic 
Assessed for eligibility 
       Clinical (n = 29) 
       Healthy volunteers (n = 22) 
Excluded 
Clinical (n = 6): 
 Epilepsy (n = 2) 
 Leave rescinded (n = 2) 
 Clinically destabilised (n = 2) 
 
Healthy volunteers (n = 0) 
 
Eligible 
Clinical (n = 23) 
Healthy volunteers (n = 22)  
Participated 
Clinical (n = 15) 
Healthy volunteers (n = 20) 
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demographic information were obtained from all participants prior to testing. Testing 
took 60-90 minutes and occurred in three main stages. Prior to entering VR, 
participants completed the baseline PANAS; physiological measures were also 
obtained at this stage. Stage two involved entering the VR environment. There was 
an initial three-minute period in which participants became accustomed to the VR 
pub and familiarised themselves with the equipment. Participants then took part in 
the experimental environment, which depicted escalating violence between an 
aggressor and a victim in the pub. Participants were asked to wear an Arsenal scarf 
(Arsenal is a London-based football team) in order to increase their sense of 
affiliation with the ‘victim’ (who was an Arsenal supporter) and were warned that the 
scenario contained strong language. Participants were instructed to: “imagine you 
are an avid Arsenal supporter; please respond to the situation and characters you 
meet as you would in everyday life”. The experimental scenario lasted for 140 
seconds, during which the participants’ verbal and behavioural responses were 
video-recorded. Autonomic arousal and motor activity were indexed throughout the 
scenario.  
In the third stage participants recompleted the PANAS and took part in a 
semi-structured interview (Appendix 5) about their experiences of the experimental 
scenario. Lastly, participants engaged in a progressive muscular relaxation exercise 
(Appendix 5) and listened to a vignette that described the scenario ending amicably 
between the characters (Appendix 5). This final phase constituted part of the risk 
management protocol and was specifically intended to reduce any residual arousal 
or negative feelings participants may have experienced. Participants were debriefed 
and paid £18.00 (plus travel expenses for the clinical group) for their time. Following 
participation, the researcher contacted a member of the participants’ clinical teams 
in order to obtain further demographic and clinical information.  
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2.5 Virtual environment   
2.5.1 Apparatus 
The VR environment was displayed in an immersive projection system, in 
which participants were presented with high-resolution images, projected in real-
time onto three back-projected wall screens (3 m x 2.2 m) and a floor screen (3 m x 
3 m). A stereo presentation of the virtual world was delivered via Lightweight 
CrystalEyes shutter-glasses worn by participants. These glasses presented 
separate images to the left and right eyes, producing the illusion of 3D objects both 
within and beyond the walls of the laboratory. An inertial/ultrasonic head-tracking 
device was contained within the glasses, which enabled images to be presented 
with reference to the participants’ viewpoint and orientation. This supported almost 
natural sensorimotor contingencies for visual perception meaning that as 
participants moved around, the environment displayed perspective-correct 
information. Spatialised audio was delivered via eight corner speakers which 
allowed sounds to be appropriately "located", as if emanating from particular objects 
in the environment. 
2.5.2 Environment 
The VR environment (Rovira et al., 2009) depicted a virtual pub in which an 
aggressive interaction escalated between two computer-generated avatars (see 
Figure 2). Background visual (e.g. pint glasses, bar stools) and auditory (television) 
stimuli were designed to reflect a typical pub environment. The scenario began with 
an avatar (V) approaching the participant (X) and establishing a friendly 
conversation with him about football. Avatar V wore an Arsenal football shirt and 
principally discussed the Arsenal team with the participant, who had been previously 
instructed to imagine that they were an Arsenal supporter. In this initial conversation 
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V talked to participants in a seemingly ad-lib way as illustrated in the following 
extract taken from Rovira et al’s (2009) exploratory study:  
V: You alright mate?  
X: Oh hello, yes. 
V: Where you from? 
X: Uh, Kent originally. 
V: You’re Arsenal yeah? 
X: Yea, Yeah sure.  
V: Get you!  
X (laughing) 
V: What did you think of the team last year? 
X: Well they got better as the season progressed.  
V: Totally agree with ya.  
 
Following this brief conversation, a second male avatar (M) who had been 
sitting alone at the bar promptly stood up and moved towards V. The conversation 
between M and V commenced as follows:  
M: Hey, you got a problem?  
V: Sorry? 
M: I said, have you got a problem? 
V: No mate. 
M: But I saw you looking at me. 
V: I didn’t look at you. 
M: bBut I saw ya… I saw ya staring. 
V: No, I wasn’t.. I wasn’t staring even. 
M: Something to get off your chest? 
V: No 
M: You sure about that? 
V: There’s nothing wrong mate, there’s no trouble, I’m just trying to enjoy a  quiet 
pint. 
M: Yeah, that’s was I was doing, enjoying a quiet pint 
V: Get back to your table and enjoy your quiet pint 
M: Don’t fucking tell me to go back to my table.  
 
As the scenario progressed, M’s behaviour became increasingly threatening 
both verbally (e.g. shouting and swearing), and non-verbally (e.g. waving arms, 
invading V’s personal space):  
M: Why don’t you fuck off now? Why don’t you leave now?  
V: But.. but… 
M: Take your pint and fuck off! 
V: Why? 
M: Because you offend me, that shirt offends me. I told ya, take it off and you can 
stay here. 
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V: I’m not gonna take it off. 
M: Take it off and you may have a drink. 
V: I’m not going… 
M: TAKE THE FUCKING SHIRT OFF.  
V: Leave it alone… What’s going on here? 
M: DON’T FUCKING TELL ME TO LEAVE IT OUT! (starts pushing V) 
V: What have I done?  
M: YOU FUCKING TELL ME TO LEAVE IT OUT? (keeps pushing V) 
Throughout the interaction M’s body size, gestures and tone indicated a 
threatening and aggressive demeanour, whereas V appeared submissive and 
deliberately avoidant of trouble. However V responded during the interaction, M 
escalated the argument to a more dangerous level. This culminated in M violently 
pushing V against the wall at which point the scenario ends. Participants were able 
to respond to M and V both verbally and non-verbally (e.g. reaching out as if to 
touch an avatar) throughout the altercation but were unable to influence the eventual 
outcome of the scenario. Participants were unaware that their interventions would 
be ineffective. 
 
Figure 2: A volunteer with two avatars in the VR pub scenario 
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2.5.3 Avatars 
The avatars were designed to be as realistic as possible and were therefore 
life-sized (see Figure 2) and displayed in 3D stereo. Two actors provided the 
avatars’ voices and their movements were captured through the use of a Vicon 
motion picture system. Since participants wore head-tracking equipment, the 
characters were able to look them in the eye. Avatars were controlled by a hidden 
operator who selected their utterances and timings from an array of pre-recorded 
phrases. Typically the conversation followed a predefined pattern, but the system 
was designed to be flexible enough for the operator to trigger a set of general 
responses (e.g. “Totally agree with you”) when participants said something 
unexpected during their initial interaction with V. 
2.6 Measures  
2.6.1 Pre-virtual reality assessment  
Basic demographics: Following informed consent, participants provided their 
age, ethnicity, first language, number of years in education, highest educational 
qualification and current affiliation with any football team.  
The Positive and Negative Affect Schedule (PANAS; Watson, Clark & 
Tellegen, 1998): The PANAS was administered to measure changes in participants’ 
affective states before and after VR. Consequently participants were instructed to 
complete it with reference to the present moment. The PANAS is a 20-item measure 
yielding subscale scores for positive and negative affect. Positive and negative 
items are presented as single words such as ‘excited’ and ‘hostile’, to indicate the 
extent to which the respondent has felt that emotion within the specified time-frame. 
Items are rated on a 5-point scale ranging from 1 (very slightly or not at all) to 5 
(extremely) with a total score in the range of 20-100. The PANAS possesses robust 
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reliability and validity for adults, and large-scale normative data is available to assist 
interpretation (Crawford & Henry, 2004).  
2.6.2 Post virtual reality assessment  
The PANAS: The PANAS was re-administered following VR in order to 
measure changes in participants’ affective states.  
Semi-structured interview: A semi-structured interview schedule (Appendix 
5) was developed based on the results of a pilot study in which the researcher 
conducted an unstructured interview with three volunteers following VR. The 
interview schedule consisted of 10 questions with additional prompt items, which 
took approximately 15 minutes to administer. The interview contained two Likert-
scale (10-point) items that were designed to gauge the realism of the scenario and 
the authenticity of participants’ behavioural responses. The remaining questions 
were fixed-choice and open-ended items which focused on participants’ thoughts 
and feelings about the VR experimental scenario. In particular the questions were 
designed to elicit participants’ attributions about the unfolding events, their 
perceptions of – and feelings towards – the aggressor and victim, and the thoughts 
that underpinned their emotional responses.  
Clinical information: After clinical participants had completed all research tasks, 
the researcher contacted a member of their clinical team to obtain the following 
information: 
(a) The number and type (e.g. violent, sexual or acquisitive) of previous criminal 
convictions. This information was gathered by the clinician from past structured risk 
assessments (e.g. the HCR-20; Webster, Douglas, Eaves & Hart, 1997) and/or 
Police National Computer records. 
 109 
 
(b) Index offence (e.g. the offence that precipitated current contact with mental 
health services). 
(c) Approximate number of years: (i) in contact with mental health services and/or (ii) 
in receipt of mental health treatment in prison. 
(d) Comorbid (i) Axis-I and (ii) Axis-II diagnoses; these had been previously 
diagnosed according to ICD-10 (WHO, 1992) or DSM-IV (APA, 1994) criteria.  
2.7 Data scoring and coding  
2.7.1 PANAS data  
PANAS positive and negative scales were scored for participants’ baseline 
and post-VR responses. Change scores were calculated for both scales by 
subtracting post-VR scores from baseline scores. Positive change values reflected 
increased scores between baseline and VR; negative values reflected reduced 
scores. Representing PANAS scores both in pre-post format and as change scores 
made the data suitable for both repeated-measures and correlational analysis.  
2.7.2 Video data  
Measures of antagonistic/aggressive and conciliatory/prosocial responses 
were based on ratings of participants’ verbal and non-verbal interactions with the 
two avatars during the experimental scenario. An initial count of verbal and non-
verbal behaviours was conducted for each participant using a specifically designed 
coding chart (Appendix 6), broadly based on the ‘intervention criteria’ described by 
Rovira et al. (2009). These scores were then aggregated to produce overall 
frequencies for (i) aggressive/antagonistic behaviour, and (ii) conciliatory/prosocial 
behaviours. Ratings were performed by the principal researcher. Fifty percent of 
videos were randomly selected and independently rated by a blinded member of the 
research team. Inter-rater reliability was found to be good for conciliatory 
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interventions: r = 0.89, n = 17, p<.001 and antagonistic interventions: r = 0.89, n = 
17, p<.001.  
For scoring purposes, a verbal intervention was defined as any speech act 
directed towards either avatar during the confrontation. Antagonistic verbal 
interventions included swearing, using a hostile tone or volume, and provocative 
comments (e.g. insults) that were likely to exacerbate aggression in real-life 
contexts. Antagonistic non-verbal behaviours included overt acts of violence (e.g. 
pushing, punching), aggressive posturing (i.e. squaring-up to an avatar) and 
provocative gestures (e.g. waving the Arsenal scarf in the aggressor’s direction). 
Conciliatory interventions were defined as behaviours that appeared to function to 
de-escalate the situation. Verbal conciliatory interventions included pacifying 
comments (e.g. “Calm down mate”) delivered in a calm tone or volume, which were 
likely to pacify aggression in real life. Conciliatory non-verbal behaviours were those 
such as standing between the victim and aggressor and making calm gestures (e.g. 
bringing hands down to signal reductions in arousal).  
2.7.3 Interview data  
Participants’ responses to the two Likert-scale items about authenticity and 
realism were scored as continuous variables. Since the PANAS was administered 
as a pre-post measure of affect, it was decided post-hoc that only the four questions 
concerning cognitions/appraisals from the interview would be analysed and 
statistically examined. The first of these was a fixed-choice ‘victim likability’ item 
(with three response options), which was scored as a categorical variable:  
1. What did you think of the first guy (the victim) when he came in and started 
chatting to you: did you (a) like, (b) dislike, (c) feel neutral towards him?  
 
The remaining three ‘cognitions’ questions were open-ended:  
2. What was going through your mind when the second character (the aggressor) 
entered and began speaking to the first (the victim)? 
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3. What were the thoughts that were making you feel ……? (repeat the emotion 
that the participant identified as their dominant emotion in the previous question) 
 
4. What was your main motivation for wanting to intervene during the confrontation 
(e.g. to intimidate aggressor/pacify/protect victim etc.)? 
 
 Participants’ responses to these three questions were content analysed. 
This approach assumes that the many words in text can be reduced into much fewer 
content categories, whilst maintaining their original themes, issues and ideas 
(Weber, 1990). Emergent categories can then be analysed using standard statistical 
methods. Accordingly, participants’ verbatim responses were coded into an 
overarching emergent theme of ‘cognitive salience’, constituting three broad 
categories: (a) victim-salient, (b) aggressor-salient and (c) self-salient. Victim-salient 
responses reflected thoughts of concern for the victim’s wellbeing/safety, wanting to 
help/rescue him, expressing empathy (e.g. fearful on his behalf) or guilt for not 
helping. The latter two categories reflected anger-oriented cognitive appraisals and 
interpretations. Specifically, aggressor-salient responses denoted hostile cognitions 
towards the aggressor, including derogatory descriptions of him, expressing a desire 
to physically or verbally attack him, or wanting to teach him a lesson. Self-salient 
cognitions were those that concerned the participant such as thoughts of being 
personally affronted, humiliated, disrespected and/or undermined by the 
confrontation, or frustrated at being unable to effect change in the outcome of the 
scenario.  
For each participant, a total score was computed for each type of cognition 
(victim-salient, aggressor-salient and self-salient). This was calculated by 
aggregating participants’ responses to each of the three interview questions. 
Participants could therefore achieve a score for each type of cognition in the range 
of 0-3. This nominal data was entered into SPSS for non-parametric analysis. 
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2.8 Statistical analysis 
To address the study’s hypotheses, the data was analysed in the following 
steps:  
1. Affect: Mixed-model ANOVAs were computed to assess whether changes in 
participants’ positive and negative affective states from baseline to post-VR differed 
according to diagnostic status. 
2. Cognitions: Mann-Witney U tests were computed to assess whether the 
frequency of each type of cognition (pooled across the three interview questions) 
differed between the two groups. These were conducted separately for each type of 
cognition (victim-salient, aggressor-salient and self-salient). For the ‘victim likeability’ 
item, a chi-square test was computed with diagnostic status. 
3. Behaviour: T-tests were computed to assess whether the frequency of 
participants’ behavioural responses (antagonistic and conciliatory) differed 
according to diagnostic status.  
 4. Relationship between dependent outcomes: Two sets of correlational analyses 
were conducted in order to examine the relationship between behaviour and 
emotional reactivity. First, Pearson’s correlations were computed between PANAS 
(positive and negative) change scores and the frequency of behavioural 
interventions (antagonistic and conciliatory). Second, Spearman’s Rho correlations 
were computed between the frequencies of behavioural interventions and the three 
types of nominal ‘cognitions’.  
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3. RESULTS 
3.1 Data preparation 
Prior to analysis, the distributions of all variables were evaluated against 
parametric test assumptions. Variables were examined separately for the 15 ASPD 
participants and 20 healthy volunteers. Bar charts of the three categorical 
‘cognitions’ variables confirmed that frequency splits fell within acceptable limits for 
both ASPD and healthy volunteer groups. Frequency splits were evaluated against 
Rummel’s (1970) criteria that only 90-10 splits (or above) are problematic because 
the correlation coefficients between these and other variables are truncated.  
Visual depictions of all continuous outcome variables revealed one high-
scoring ASPD outlier on the PANAS negative scale at baseline, two low-scoring 
ASPD outliers for the PANAS positive scale at baseline and one high-scoring ASPD 
outlier for antagonistic behaviours. One healthy volunteer high-scoring outlier was 
observed for the PANAS positive scale post-VR, and two others for antagonistic 
behavioural interventions. Outliers across variables appeared to reflect the general 
direction of scores obtained by other cases in their respective groups. All cases 
were therefore considered legitimate for retention in the analyses but steps were 
taken to reduce their impact. In accordance with Tabachnick & Fidell’s (2001) 
recommendations, outliers were assigned a raw score on the offending variable(s) 
that was one unit (raw score) larger (or smaller) than the next most extreme score in 
the distribution.   
Normality of variables was assessed via visual inspection of histograms and 
by checking skewness and kurtosis values. For the healthy volunteer group, 
antagonistic interventions were initially observed to be non-normally distributed, 
owing to mild skewness (z = 3.54). However once the outlier for this variable had 
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been assigned a less extreme value, skewness fell within the margins of acceptable 
limits (z = 3.02). All other variables were normally distributed.  
 
3.2 Demographic information 
The demographic characteristics of the two study groups are presented in 
Table 1. Clinical participants had a mean age of 44 (SD = 10.10) and healthy 
volunteers of 28 (SD = 7.11). Most clinical participants left school without any 
educational qualifications (87%), whereas all healthy volunteers had obtained higher 
educational qualifications. Of the clinical participants 60% were White British, 
compared with 40% of healthy volunteers. 
Table 2 displays clinical and criminogenic characteristics of the ASPD group. 
Consistent with comorbidity rates in community samples (e.g. Robins & Price, 
1991), the majority (74%) had at least one comorbid Axis I diagnosis, most 
commonly substance misuse (60%). More than half (53%) had a comorbid Axis II 
diagnosis, the majority being borderline personality disorder. Clinical participants 
had serious and extensive offending histories, with an average of 23 previous 
convictions and the majority of index offences being violent (53%) or sexual (27%) in 
nature.  
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Table 1: Participant demographics 
 ASPD  
(n =15) 
Healthy 
volunteers  
(n = 20) 
Statistic  p value  
Age in years: M (SD) 
 
 
Education years: M (SD)   
    
 
Highest qualification: N (%) 
   None 
   GCSEs  
   A-levels  
   Higher education 
 
First language: N (%) 
   English  
   Non-English 
 
Ethnicity: N (%) 
   White British 
   Asian  
   Black 
   Mixed  
   Chinese or other 
   White other  
 
Football team: N (%) 
   Arsenal  
   Other 
   None   
 
 
43.7 (10.10) 
range: 24-62 
 
9.3 (1.60) 
range: 6-13 
 
 
13 (86.7%) 
1(6.7%) 
1 (6.7%) 
- 
 
 
15 (100%) 
-  
 
 
9 (60.0%) 
- 
1 (6.7%) 
3 (20.0%) 
- 
2 (13.3%) 
 
 
1 (6.7%) 
5 (33.3%) 
9 (60.0%) 
 
27.8 (7.11) 
range: 20-47 
 
19.1 (2.97) 
range: 14-24 
 
 
- 
- 
- 
20 (100.0%) 
 
 
16 (80%) 
4 (20%) 
 
 
8 (40.0%) 
5 (25.0%) 
2 (10.0%) 
1 (5.0%) 
1 (5.0%) 
3 (15.0%) 
 
 
6 (30.0%) 
6 (30.0%) 
8 (40.0%) 
 
 
Z = -3.86 
 
 
Z = -5.05 
 
 
 
 
 
 
 
 
χ² =3.29 
 
 
 
 
 
 
 
 
 
 
 
χ² = 3.07 
>.001* 
 
 
>.001* 
 
 
 
 
 
 
 
 
0.09 
 
 
 
 
 
 
 
 
 
 
 
0.21 
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Table 2: Clinical and criminogenic characteristics of the ASPD group  
Characteristic  Descriptive data  
Number of Axis I disorders: M (SD) 
 
Type of Axis I disorder: N (%) 
     Schizophrenia  
     Major Depression 
     Anxiety disorder 
     Substance misuse  
 
Number of Axis II disorders: M (SD) 
 
Type of Axis II disorder: N (%) 
     Borderline 
     Schizotypal  
     Paranoid   
 
Index offence: N (%)  
     Violent  
     Sexual  
     Acquisitive 
 
Number previous convictions: M (SD) 
 
 
Treatment in mental health services/prison (years): M (SD) 
1.10 (0.88) 
range: 0-3 
 
2 (13.3%) 
2 (13.3%) 
3 (20.0%) 
9 (60.0%) 
 
0.6 (0.63) 
 
range: 0-2 
7 (46.7%) 
1 (6.7%) 
1 (6.7%) 
 
 
8 (53.3%) 
4 (26.7%) 
3 (20.0%) 
 
20.3 (24.0) 
range: 1-95 
 
11.7 (7.72) 
range: 3-29 
 
3.3. Baseline equivalence of groups  
Between-group equivalence tests (see Table 1) revealed that the ASPD 
group was older and less educated than healthy volunteers. This most likely 
reflected the fact that ASPD participants had invariably spent a number of years in 
secure facilities (and were therefore older), and lower educational level is an 
inherent characteristic of ASPD (Robins, Tipp & Pzybeck, 1991). Further analysis 
indicated that age and education correlated with several dependent outcomes for 
the two groups combined (see Table 3). Although it was considered unlikely that 
these demographic characteristics were responsible for between-group differences 
in outcomes (especially given that research suggests that emotion regulation 
increases with age; Urry & Gross, 2010), further education- and age-effects 
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analyses were computed for healthy volunteers as a precautionary safeguard (see 
Table 3). This confirmed that neither variable was associated with any of the 
dependent outcomes. Therefore further analysis did not adjust for baseline 
differences. 
Table 3: Correlations between age, education and outcome variables  
 
Note *p< .05 level 
Note **p< .01  
Note - correlation not applicable: frequency of responses = zero 
 
3.3 VR scenario ecological validity    
Interview question: How realistic were the unfolding events in the experience 
that you have just had (10-point Likert scale)? Descriptive data from the two groups 
combined indicated that the scenario was perceived to be sufficiently realistic (M = 
7.50, SD = 1.74). ASPD participants found the scenario more realistic (M = 8.33, SD 
= 1.45) than healthy volunteers (M = 6.90, SD = 1.71): t(33) = 2.61; p = 0.013.  
 
Interview question: To what extent was your reaction authentic/the same as you 
would do in real life (10-point Likert scale)? Overall, participants reported that their 
          Age           Education                               
Combined groups    
 
PANAS negative scale change scores 
 
Pearson 
 
 0.43* 
 
-0.52** 
PANAS positive scale change scores Pearson  0.14  0.01 
Total antagonistic behaviours  Pearson  0.46** -0.36* 
Total conciliatory behaviours  Pearson -0.29 -0.29 
Total victim-salient cognitions Spearman -0.32 -0.50** 
Total aggressor-salient cognitions  Spearman  0.19 -0.31 
Total self-salient cognitions  Spearman  0.39* -0.44** 
Healthy volunteers only    
 
PANAS negative scale change scores 
 
Pearson 
 
0.22 
 
-0.19 
PANAS positive scale change scores Pearson 0.42 -0.42 
Total antagonistic behaviours Pearson 0.05 -0.04 
Total conciliatory behaviours Pearson 0.22 -0.18 
Total victim-salient cognitions  Spearman -0.03  0.03 
Total aggressor-salient cognitions  Spearman 0.03 -0.03 
Total self-salient cognitions  Spearman  - - 
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reactions to the VR scenario were quite authentic (M = 7.49, SD = 1.82). There was 
no difference between the two groups, with ASPD participants reporting similar 
levels of authenticity (M = 7.73 SD = 1.49) to healthy volunteers (M = 7.30, SD = 
2.10): t(33) = 0.69; p = .49. 
3.4 Group comparisons 
3.4.1 The affect hypothesis was that between baseline and post-VR, ASPD 
participants would show a greater increase on the negative scale and a greater 
decrease on the positive scale of the PANAS than healthy volunteers.  
PANAS negative scale: PANAS negative scores violated Mauchly’s Test of 
Sphericity (χ² = 0.00; p<.01); therefore ANOVA results were interpreted via the 
Greenhouse-Geisser test. Descriptive PANAS data is presented in Table 4. There 
was a main effect of ‘point of measurement’ (baseline – post-VR), indicating that for 
the two groups combined, scores increased from baseline (M = 15.00) to post-VR 
(M = 19.34): F(1, 33) = 25.50; p > 0.001 (d = 1.75). There was no main effect of 
diagnostic group; ASPD participants did not differ in their PANAS negative scores 
averaged across the two time points (M = 17.93) compared with healthy volunteers 
(M = 16.60): F(1,32) = 0.75; p = .39. In line with the hypothesis, there was a 
significant interaction (see Figure 3) between ‘point of measurement’ and ‘diagnostic 
status’, confirming that ASPD participants showed a greater increase on the PANAS 
negative scale between baseline and post-VR (mean increase = 8.40) than healthy 
volunteers (mean increase = 1.30): F(1,33) = 13.66; p < 0.001 (d = 1.28) 
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Table 4: PANAS scores at baseline and post-VR 
 
      
 
 
 Point of measurement 
 
 
Baseline          Post-VR                
M (SD)              M (SD)              
Diagnostic status  
 
ASPD  (n = 15) 
 
 
Healthy volunteers  
(n = 20) 
 
                            
 PANAS negative  
 PANAS positive 
 
 PANAS negative  
 PANAS positive  
 
 
13.73 (3.37) 
35.93 (3.97) 
 
15.95 (5.76) 
29.40 (6.68) 
 
22.13 (6.25) 
33.20 (8.04) 
 
17.25 (5.27) 
29.20 (7.42) 
 
 
 
 
 
 
 
 
Figure 3: Diagnostic status by point of measurement for PANAS negative scale  
 
PANAS positive scale: PANAS positive scale scores (see Table 4) violated 
Mauchly’s Test of Sphericity (χ² = 0.00; p<.01): therefore ANOVA results were 
interpreted via the Greenhouse-Geisser test. There was no main effect of ‘point of 
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measurement’ (baseline – post-VR), indicating that for the two groups combined, 
there was no difference between PANAS positive scores at baseline (M = 32.20) 
compared with post-VR (M = 30.91): F(1, 33) = 1.91; p = .18. There was a main 
effect of ‘diagnostic status’ (ASPD – healthy volunteers), indicating that ASPD 
participants yielded higher scores averaged across the two time points (M = 34.57) 
compared with healthy volunteers (M = 29.30): F(1,33) = 6.58; p = .02 (d = 0.81). 
Contrary to the hypothesis, there was no interaction between ‘diagnostic status’ and 
‘point of measurement’, indicating that the groups did not differ from one another in 
their PANAS positive scale change scores: F(1, 33) = 1.43; p = .24.  
3.4.2 The cognitions hypothesis was that participants with ASPD would report more 
anger-oriented and less victim-empathic cognitions about the VR scenario than 
healthy volunteers.  
Across the three combined ‘cognitions’ interview questions, ASPD 
participants reported more anger-oriented cognitions than healthy volunteers. 
Specifically, Table 5 shows that the ASPD group reported more ‘aggressor-salient’ 
cognitions (Mdn = 1) than healthy volunteers (Mdn = 0): U = 97.0, z = -1.97, p = .02 
(r = 0.33). The ASPD group also reported more ‘self-salient’ cognitions (Mdn = 1) 
than healthy volunteers (Mdn = 0): U = 70.0, z = -3.64, p < .001 (r = 0.62). 
Conversely, ASPD participants endorsed fewer ‘victim-salient’ cognitions (Mdn = 1) 
than healthy volunteers (Mdn = 3): U = 52.5, z = -3.48, p < .001 (r = 0.59). These 
findings were consistent with the study’s hypothesis.  
 
 
 
 
 121 
 
Table 5: Descriptive and significance data for cognitions and behaviour outcomes  
 
 
Dependent 
outcome  
        
     ASPD 
    N = 15 
 
Healthy volunteers 
       N =20 
 
Statistic   Sig      E.S1              
 
Cognitions  
 
Mdn (Range) 
 
Mdn (range) 
 
U 
 
p 
 
r 
 
   Victim-salient  
 
1.0 (1-3) 
 
3 (1-3) 
 
52.5 
 
.001** 
 
0.59 
   Aggressor-salient  1.0 (1-3) 0 (0-1) 97.0 .02* 0.33 
   Self-salient  
 
Behaviour 
 
   Conciliatory 
   Antagonistic 
1.0 (1-3) 
 
M (SD) 
 
2.80 (2.24) 
2.40 (3.46) 
0 (0) 
 
M (SD) 
 
7.05 (4.52) 
0.70 (1.22) 
70.0 
 
t 
 
-3.34 
1.82 
<.001* 
 
p 
 
.001** 
.08 
0.62 
 
d 
 
1.26 
0.73 
 
Note * p< .05 level (one-tailed) 
Note ** p< .01 level (one-tailed) 
 
There was a moderately strong association between ‘victim likeability’ and 
diagnostic status: χ² (2, n = 35) = 10.21; p = .006, Cramer’s V = 0.54. Table 6 shows 
that ASPD participants were more prone to disliking the victim than were healthy 
volunteers (40% and 0%, respectively). Conversely healthy volunteers were more 
likely to report liking the victim than were ASPD participants (65% and 13%, 
respectively). These findings were in line with the study’s hypotheses and consistent 
with the aforementioned finding that ASPD participants reported fewer victim-salient 
(empathic) cognitions than healthy volunteers. 
Table 6: Descriptive data for ‘victim likeability’  
 
  ASPD (n = 15)  Healthy volunteers (n = 20)  Total (N = 35) 
Cognition type          n (%)               n (%)         N (%) 
 
Liked victim  
 
2 (13%) 
 
         13 (65%) 
 
15 (43%) 
 
Disliked victim  
 
6 (40%) 
 
          0 (0%) 
 
6 (17%) 
 
Neutral to victim  
 
7 (46%) 
 
          7 (35%) 
 
14 (40%) 
 
                                                          
1
 For cognitions effect size calculations r =  Z / √N. Values were evaluated against Cohen’s (1988) 
criteria where r: small ≥ .10, medium ≥ .30, large ≥ .50. 
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3.4.3 The behaviour hypothesis was that participants with ASPD will display more 
aggressive/antagonistic behavioural interventions and fewer conciliatory/prosocial 
interventions during VR than healthy volunteers. 
Significant heterogeneity of variance was observed for both antagonistic 
(Levene F(1, 33) = 15.85; p < .001) and conciliatory interventions (Levene F(1, 33) = 
7.75; p = .009). Therefore t-tests were interpreted via ‘equal variances not assumed’ 
and non-parametric tests (Mann-Whitney U) were computed as an adjunct. Table 5 
shows that there was a trend towards ASPD participants conducting more 
antagonistic/aggressive interventions (M = 2.40) than healthy volunteers (M = 0.70); 
however this did not reach significance on parametric: t(33) = 1.82; p = .08, and 
non-parametric tests: U = 118.5; p =.11 (one-tailed). Participants with ASPD 
conducted fewer conciliatory/pro-social behavioural interventions (M = 2.80) than 
healthy volunteers (M = 7.05): t(33) = -3.34; p = .001 (d = 1.26), U = 67.5; p = .006 
(one-tailed).  
3.2.4 The hypothesised relationship between outcomes was that antagonistic 
behaviour would positively correlate with negative affect and anger-oriented 
cognitions. Conversely, conciliatory behaviour was expected to positively correlate 
with positive affect and victim-empathic cognitions.  
Behaviour and affect: In accordance with the hypotheses, increased negative 
affect positively correlated with more antagonistic behaviour: r = 0.348, N = 35; p = 
.02, and increased positive affect positively correlated with conciliatory behaviour: r 
= .466, N = 35; p = .002 (see Table 7).  
Behaviour and cognitions: In accordance with the hypotheses, there was a 
positive correlation between empathy-oriented (victim-salient) cognitions and 
conciliatory behaviour: r = 0.284, N = 35; p = 0.029. Table 7 shows that whilst trends 
concerning the relationship between anger-oriented cognitions (aggressor-salient 
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and self-salient) and behaviour were in the direction of the hypothesis, they did not 
reach statistical significance. 
Table 7: Correlations between behaviour and other outcomes  
Note * p<.05 (one-tailed) 
Note **p<.01 (one-tailed) 
Note - correlation not computed  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  Conciliatory  
  behaviour         
 
Antagonistic  
behaviour 
Dependent outcome  Correlation    
 
PANAS negative scale change score  
PANAS positive scale change score 
 
Pearson’s 
Pearson’s  
 
     
   -  
0.466** 
 
0.348*  
  - 
Empathy-oriented cognitions 
Victim-salient  
 
Spearman’s Rho 
 
           
0.284* 
 
 
  - 
 
Anger-oriented cognitions   
Aggressor-salient  
Self-salient  
 
Spearman’s Rho 
Spearman’s Rho 
       
       - 
       - 
 
0.268 
0.274 
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4. DISCUSSION 
4.1. Main findings 
The current study investigated the influence of VR provocation on the 
emotional and behavioural reactivity of participants diagnosed with ASPD compared 
with healthy volunteers. The results suggested that the VR experimental scenario 
was an ecologically valid and effective means of inducing negative emotionality: 
participants reported finding the scenario – and their responses to it – quite 
authentic, and showed an increase in negative affect from baseline to post-VR.  
There are three main findings with regard to the overarching hypothesis that 
provocation would result in greater negative emotional and behavioural reactivity in 
ASPD participants than in healthy volunteers. The ASPD group showed (1) greater 
increases in negative affect, (2) more anger-oriented and fewer empathy-oriented 
cognitions, and (3) less conciliatory/prosocial behaviour than the healthy volunteers. 
ASPD participants also displayed a trend towards increased aggressive behaviour. 
Modest support was provided for the subsidiary hypothesis: prosocial behaviour was 
correlated with positive affect and victim-empathic cognitions but the relationship 
between aggression and negative emotional reactivity was less compelling, with 
several non-significant trends. Contrary to predictions, there was no evidence that 
the VR scenario impacted on participants’ positive affective states, either within or 
between groups.  
4.1.1 Negative emotional reactivity  
Between-group differences in negative affective and cognitive reactivity 
provide tentative support for the notion that ASPD may entail difficulties regulating 
emotions under conditions of perceived threat. This is in line with previous research 
indicating that impulsive traits of ASPD are associated with negative emotional 
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reactivity (Hicks & Patrick, 2006) and with deficits in brain regions that govern 
inhibition (Morgan & Lilienfeld, 2000).  
Comparative increases in anger-oriented cognitions mirror Lobbestael et al’s 
(2009) observation of cognitive hyper-responsivity in ASPD compared with control 
participants. However, the present finding that ASPD participants displayed greater 
increases in negative affect was not observed by Lobbestael et al. (2009). This 
discrepancy could be accounted for by incomparable affective outcome measures; 
the present study indexed a broad dimension of negative affect (using the PANAS) 
whilst Lobbestael et al. (2009) measured only anger. It is possible that individuals 
with ASPD experience a range of negative affective changes (e.g. shame, 
humiliation) in response to provocation, which narrower measures of anger fail to 
capture.  
  A further explanation for the above inconsistency lies in the notion that the 
strength and imminence of an anger stimulus determines whether an antisocial 
individual displays an ‘orienting’ or ‘fight’ response in their defensive shifting 
(Fanselow & Lester, 1988). It is speculated that because the present research 
utilised a more imminent (and ecologically valid) anger-induction method than 
Lobbestael et al. (2009), ASPD participants experienced affective shifts in 
accordance with a defensive response. Taken together these studies raise the 
possibility that individuals with ASPD display more predatory-like orienting strategies 
under conditions of remote threat, but atypical increases in negative emotional 
reactivity when imminent threat is perceived. Future studies should aim to test this 
hypothesis via remote and imminent VR provocation, incorporating physiological 
measurement as an objective dimension of defensive reactivity.  
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4.1.2 Emotional reactivity and conciliatory/prosocial behaviour 
Between-group differences in conciliatory behaviour – and the observed 
relationship between these behaviours and indices of positive emotionality (cognitive 
and affective) – tentatively suggest that patterns of emotional reactivity influenced 
expressions of prosocial behaviour. These findings are in line with developments in 
moral psychology implicating emotions and empathy as essential ingredients of 
prosocial behaviour (Gilligan, 1993). However, following provocation no differences 
were observed between the groups in positive affect, suggesting that reductions in 
positive emotionality alone are unlikely to account for less conciliatory behaviour in 
the ASPD group.  
It is tentatively suggested that the paucity of prosocial interventions reflected 
a combination of reduced positive emotionality (i.e. less victim-empathic cognitions) 
and increased negative emotionality (i.e. more self-salient and aggressor-salient 
cognitions) arising from pre-existing deficits in the ASPD group. This is consistent 
with research showing that ASPD entails subtle impairments in empathy and 
perspective-taking (Dolan & Fullam, 2004) and that reduced prosocial behaviour is 
associated with a lack of appreciation for the emotional states of others (Blackhart, 
Nelson, Knowles, & Baumeister, 2009), poor emotion regulation (Twenge, 
Baumeister, DeWall, Ciarocco, & Bartels, 2007) and increased focus on the self 
(DeWall & Baumeister, 2006).  
Conceptualised within a mentalization model of ASPD (Bateman & Fonagy, 
2008) mentalization deficits are exacerbated when the attachment or affiliative 
system is activated, meaning that individuals with ASPD experience their own 
actions as being without consequence and become unable to extricate another’s 
mental state. Thus comparatively less conciliatory behaviour from ASPD participants 
could be formulated as a temporary inability to experience the victim’s perspective 
and a reduced sense of their own ability to effect change during a period of 
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interpersonally provoked emotional hyper-arousal. However, these inferences are 
speculative and further research is required to directly examine the relationship 
between emotional reactivity, mentalizing and the commission of prosocial 
behaviour in ASPD.  
Alternatively, it is possible that individuals with APSD would fail to display 
prosocial behaviour even during periods of emotional stability, when no direct threat 
to self is experienced. Research shows that adolescents with externalising problems 
express less affiliative (relationship-building) social goals than healthy volunteers 
(Lochman, Wayland & White, 1993) and young offenders display less mature moral 
judgments than their peers (Larden, Melin, Holst & Langstrom, 2006). It is plausible 
that these types of baseline deficits would result in less prosocial behaviour in 
ASPD, regardless of levels of emotional arousal. Future research could include a 
baseline activation task (e.g. a non-anger-inducing VR scenario designed to elicit 
prosocial behaviour and moral decision-making) to investigate the extent to which 
prosocial behaviour deficits in ASPD originate from pre-primed social processing 
deficits versus emotional activation.  
An important factor to consider when interpreting prosocial behavioural 
outcomes is that the clinical participants had been in receipt of mental health and/or 
prison treatment for an average of 12 years. Treatment for violent offenders typically 
comprises cognitive-behaviourally informed anger management (e.g. Violent 
Offender Treatment Protocol; Braham, Jones & Hollin, 2008), which seeks to 
promote contingency management and behavioural inhibition skills. Thus a failure to 
intervene could be seen as an adaptive learnt strategy for ‘staying out of trouble’ 
(i.e. removing oneself from involvement in conflict). This – and other methodological 
factors (see below) – complicates interpretation.  
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4.1.3 Emotional reactivity and antagonistic/aggressive behaviour  
Trends regarding antagonistic/aggressive behaviour provide tentative 
support for the notion that as with other cluster B disorders, persons with ASPD may 
have particular problems inhibiting aggressive impulses during emotionally laden 
situations (Verona, Sprague & Sadeh 2012). Findings are consistent with research 
demonstrating that emotional contexts can impede the ability to inhibit aggression 
(Verona & Sedeh & Curtin, 2009), sustained negative affect biases high stress-
reactive individuals towards more intense and sustained acts of aggression (Verona 
et al., 2002) and individuals with ASPD show high levels of reactivity and prefrontal 
cortex deficits when exposed to negative emotional contexts (Sprague & Verona, 
2010).  
In a similar vein to prosocial outcomes, these findings could be formulated 
within a mentalization model of ASPD (Bateman & Fonagy, 2008), which suggests 
that the common pathway to violence is a momentary inhibition in the capacity for 
mentalization, triggered by a sense of threat to self. Crucially, this model takes 
account of a diminished sense of self-worth, which previous explanatory models of 
ASPD argue underpins violence, by way of shame that can be dealt with only 
through the violent humiliation of others (e.g. Gilligan, 1996). Qualitatively, this fits 
with the greater frequency of self-salient and aggressor-salient cognitions and a 
trend towards increased aggression observed in the current ASPD sample. 
However, in light of the exploratory nature of the study and the fact that 
mentalization was not directly indexed these inferences are speculative. 
Furthermore, the absence of statistical significance means that particular caution 
should be applied not to over-interpret aggressive behavioural outcomes.  
There are a number of potential explanations for between-group differences 
in aggressive behaviour failing to reach significance. First, as discussed in relation 
to conciliatory behaviour, clinical participants may have honed skills in treatment, 
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enabling them to inhibit aggressive impulses in spite of increased negative 
emotionality. Second, although participants reported that the scenario and their 
responses to it were quite authentic, it is possible that ‘in vitro’ provocation lacked 
the necessary properties to provoke a full-blown fight response. It is unfortunate that 
the physiological data collected proved uninterpretable as this would have facilitated 
a more proficient evaluation of the scenario’s anger-arousal potential. Finally, it is of 
course possible that individuals with ASPD are no more likely to respond impulsively 
to provocation than non-aggression-prone persons, and aggression in ASPD may 
be more akin to the instrumental type observed in psychopathy. These competing 
explanations, coupled with methodological and design limitations detailed below, 
complicate interpretation of the findings.  
4.2 Limitations  
Several limitations warrant discussion. First with regard to generalisability, 
the degree to which the clinical group was representative of the ASPD population is 
questionable owing to the aforementioned length of time spent in treatment services, 
the fact that only patients with community leave (indicative of risk reduction) were 
eligible to take part, and the relatively high refusal rate. Consequently it is possible 
that the achieved sample posed less risk of aggression than individuals with ASPD 
in the general population. Alternatively, because recruitment primarily took place in 
specialist forensic personality disorder services, individuals with particularly 
profound personality disorders and forensic needs may have been recruited. The 
fact that participants had an average of 20 previous convictions and index offences 
of a primarily violent or sexual nature supports this possibility. Future studies are 
required with untreated ASPD individuals (i.e. upon entry to services) in order to 
better understand patterns of emotional reactivity inherent in this population, and 
establish whether these are ameliorated with treatment. External validity may have 
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also been compromised by the fact that the healthy volunteers largely comprised 
students with higher educational qualifications.  
A second limitation in relation to sampling is that the majority of clinical 
participants had comorbid Axis I and Axis II diagnoses, most commonly substance 
misuse and borderline personality disorder. Given that both of these diagnoses are 
associated with difficulties in emotion regulation, it is not possible to disentangle how 
much of the variability in emotional and behavioural reactivity was attributable to 
ASPD symptomatology. Future research should endeavour to address this by 
screening out comorbid psychiatric conditions and/or including control groups. Also 
problematic is that rates of psychopathy were not assessed and it is likely that some 
clinical participants – particularly those recruited from specialist forensic personality 
disorder services – met criteria for psychopathy. Given that psychopathic offenders 
show chronic under-arousal during provocation (e.g. Lobbestael et al., 2011), the 
responses of more callous/unemotional participants could have reduced between-
group differences in emotional and behavioural reactivity. Controlling for 
psychopathy represents an important priority in the event of replication.  
A noteworthy potential confounding factor is that the ASPD group found the 
experimental scenario more realistic than the healthy volunteers. Qualitative reports 
during interview suggested that this was because many clinical participants had 
previously been involved in similar conflicts in pubs. It is possible that these prior 
experiences influenced emotional responsivity (i.e. akin to a trauma response) and 
future studies should endeavour to design VR scenarios that are equitable in 
salience for clinical and healthy volunteer groups. Furthermore, as aforementioned 
this study did not include a baseline activation task, meaning it was not possible to 
differentiate how much of the variance in emotional arousal resulted from 
differences in emotional processing versus emotional reactivity. Additionally, the 
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experimenter was not blinded to group membership and may have therefore 
unwittingly influenced participants’ behaviour during VR and interview responses.  
Several limitations should also be acknowledged in relation to measurement. 
First, behavioural reactivity was assessed during VR provocation, whereas self-
reported affect and cognitions were indexed immediately afterwards. This was done 
in order to capture behaviour ‘live’ but means that a time effect could have 
confounded the comparison between behaviour and indices of emotional reactivity. 
This is one potential explanation for the correlations between anger-oriented 
cognitions and aggressive behaviour falling short of significance. Second, as 
aforementioned the PANAS was administered in order to assess broad dimensions 
of positive and negative affect, but this meant it was unclear which feelings changed 
following provocation.  Third, reliance on self-report tools is problematic in antisocial 
populations (Lobbestael et al., 2009) and future research should endeavour to 
obtain physiological markers of emotional reactivity as originally intended. Fourth, a 
semi-structured interview was developed with the aim of eliciting participants’ 
experiential perspectives but the post-hoc decision to only analyse cognitions 
ultimately resulted in a somewhat reductionist approach. Finally, multiple statistical 
tests were conducted thereby increasing the Type I error rate. A Bonferoni 
corrective procedure was not applied as this was an exploratory study and it was 
considered important to identify any potential relationships in the data for future 
researchers to investigate. It is somewhat reassuring that the majority of effect sizes 
were medium or large, suggesting that significant findings are likely to be replicable.  
4.3 Implications for research and practice  
This study highlights the need for continued large-scale and 
methodologically robust research into the emotional reactivity of individuals with 
ASPD. Future studies should endeavour to address the current limitations by 
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controlling for comorbidity, administering a baseline VR activation task, developing a 
scenario that is equally salient for clinical and control groups, ensuring blinding of 
outcome assessors and indexing physiological markers of arousal. In particular 
research is required to better understand the effects of remote versus imminent 
threat, patterns of reactivity in untreated ASPD samples, and the relationship 
between mentalization, emotional reactivity, prosocial behaviour and aggression. VR 
represents a promising method for pursuing these objectives but the anger-arousal 
potential of ‘in vitro’ provocation requires more precise evaluation.  
The results of this study hold several implications for the treatment of 
persons with ASPD. If, as the findings suggest, interpersonal aggression primarily 
reflects emotional hyper-responsivity, then treatments that target emotional and 
behavioural regulation may be indicated, such as dialectical behaviour therapy 
(Linehan, 1987) and mentalization-based treatment for ASPD (Bateman & Fonagy, 
2008). Controlled research into the efficacy of these approaches is an important 
priority, particularly given that a recent systemic review highlighted “insufficient trial 
evidence to justify using any form of psychological intervention with adults with 
ASPD” (Gibbon, Duggan, Stoffers, et al., 2010).  
The current findings suggest that in addition to facilitating a better 
understanding of the processes involved in ASPD, VR may prove useful in the 
treatment of aggression and violence. At present, cognitive-behavioural therapy is 
the most common approach to anger-management (Beck & Fernandez, 1998) and 
there is some – albeit limited – evidence of efficacy for improving outcomes in ASPD 
(Gibbon et al., 2010). This approach emphasises the development and rehearsal of 
adaptive skills, traditionally honed through imaginal or role-play exposure. Recent 
research suggests that VR may be a potent alternative for anger exposure in non-
clinical groups (e.g. Miyahira et al., 2010) and the current findings suggest that 
individuals with ASPD may also benefit from ‘in vitro’ methods. Involving persons 
diagnosed with ASPD in the design of VR treatment scenarios may help maximise 
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ecological validity and promote service-user involvement, which is currently lacking 
in forensic services (National Service User Involvement Network, 2011).  
A further potential use for VR concerns risk assessment in forensic 
personality disorder services. An ecologically valid scenario, sufficiently potent to 
provoke authentic responses, may enable a ‘risk algorithm’ to be generated based 
on the four markers of affect, cognitions, physiological arousal and behaviour. For 
example the current finding that 40 percent of ASPD participants disliked the victim 
avatar and none of the healthy volunteers expressed similar thoughts, suggests that 
negative attitudes towards a VR victim (coupled with other indicators of reactivity) 
could indicate a propensity towards antisocial behaviour. However, the small sample 
size and other methodological drawbacks in the present study, renders these 
inferences premature. Modified large-scale replications are required to ascertain the 
utility, feasibility and predictive validity of virtual risk assessments. The latter could 
be evaluated by comparing the longitudinal accuracy of VR probability risk estimates 
to those obtained with established paper-based tools (e.g. the HCR-20; Webster et 
al., 1997). 
A final implication for practice concerns attitudes toward ASPD. Individuals 
with this diagnosis are stigmatised and have historically been excluded from 
services (NICE CG 77, 2010). Negative attitudes are likely to be exacerbated by the 
terms ASPD and psychopathy being used interchangeably, despite the diagnoses 
being clinically distinct. Conceptualising ASPD as a disorder that entails difficulties 
in regulating emotions may engender more optimistic and less pejorative attitudes in 
staff working with this population, and provide an alternative discourse to the ‘cold-
blooded’ offender frequently portrayed in the media. Reducing stigma and 
discrimination in ASPD is an important policy objective (Personality Disorder: no 
longer a diagnosis of exclusion; DoH, 2003) and reflected in treatment guidelines 
(NICE CG 77, 2010).   
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4.4 Summary  
In summary this is the first study known to have assessed the impact of 
provocation on individuals with a well-established diagnosis of ASPD, using a 
seemingly ecologically valid stimulus. Overall, clinical participants showed greater 
negative emotional reactivity, less victim empathy and conciliatory behaviour, and a 
trend toward more aggression. Findings support the notion that ASPD entails 
difficulties with emotion regulation and behavioural inhibition under conditions of 
perceived imminent threat. Potential implications include ascertaining the efficacy of 
emotion-regulation-driven treatment approaches for ASPD, reinforcing the 
distinction between ASPD and psychopathy, and using VR as a tool to assess and 
treat risk of aggression/violence in this population. However, these findings are 
exploratory and large-scale modified replications are required before firm 
conclusions can be reached about patterns of emotional and behavioural reactivity 
in ASPD.  
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Part 3: Critical Appraisal  
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1. Overview  
This appraisal briefly outlines my interest in the research area. It then 
considers the strengths and limitations of using a multi-method approach to 
measurement and being reliant on technology in psychological research. Next as 
highlighted in the empirical paper, it gives more detailed consideration to VR as a 
potential tool to assess and treat risk of aggression and violence in ASPD. Finally, I 
reflect on some risk management and ethical considerations associated with 
conducting research with this population.  
2. Background interest  
My interest in the research area was in part influenced by my experience 
working clinically in forensic mental health settings, but also informed by my own 
developmental context. Discussions of ‘the mad, bad and dangerous’ were 
commonplace during my childhood, with a number of family members working in the 
legal system. I was curious about why some people ended up in the criminal justice 
system and, being raised in inner city London, I could not fail to notice how crime 
and mental health seemed to systematically vary with social disadvantage and 
inequality. These early experiences formed the basis for my developing interest in 
ASPD.  
Before training I worked in a number of secure hospitals with diverse clinical 
presentations and varying levels of criminogenic risk. I was particularly struck by 
how individuals diagnosed with ASPD presented apparent paradoxes, on the one 
hand displaying prosocial behaviour and a capacity for self-reflection, and on the 
other engaging in challenging behaviour against an extensive backdrop of 
criminality. Rarely did I encounter the ‘cold-blooded and calculated’ criminal 
stereotype. My observations were instead of individuals who had profound difficulty 
inhibiting their responses to painful emotions, in particular shame, humiliation and 
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rejection. These observations were captured in explanatory models of ASPD in 
which violence and humiliation are conceptualised as strategies for coping with the 
impact of shame on an inflated but fragile sense of self (Gilligan, 1996).  
When Peter Fonagy presented the opportunity to conduct research with this 
clinical group, using an exciting new approach to prime emotional arousal, it was the 
exact opportunity I was seeking. Intuitively it made sense that like other Cluster B 
disorders, ASPD could be partly understood as a disorder of emotion regulation 
leading to maladaptive behaviour in the context of interpersonal distress. When I 
began researching this topic I was therefore surprised to find a lack of empirical 
research involving individuals with a well-defined diagnosis of ASPD, and only one 
study that had directly sought to measure emotional reactivity (Lobbestael, Arntz, 
Cima & Chakhssi, 2009).  
3. Measurement issues   
3.1 Multi-method measurement  
 From the outset there were several key objectives to take into consideration 
when designing an approach to measurement. An initial priority was to capture the 
full associative network comprising emotions (Berkowitz, 1990) without burdening 
participants with an exhaustive list of tasks. Second, given the exploratory nature of 
the study both in terms of working with an under-researched population and using 
VR provocation, it was important to elicit participants’ idiosyncratic experiential 
perspectives. This needed to be balanced alongside valid indices of emotionality 
that could reliably detect change, and with establishing a meaningful strategy for 
coding and interpreting observational data. Consequently a multi-method 
measurement approach was adopted. This entailed several strengths and 
drawbacks on a theoretical, practical and interpretive level.  
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A conceptual strength of the measurement approach is that multi-method 
research can be less vulnerable to inaccurate inferences arising from error because 
it enables cross-validation and cross-fertilization of research procedures and 
findings (Brewer & Hunter 1989). When triangulated outcomes have good 
convergent validity (providing they are not vulnerable to the same sources of 
measurement error as one-another), conclusions can be made with greater 
conviction (Bryman, 2001). When disparity is observed between outcomes, 
consideration of possible explanations for the clash is necessitated (e.g. Deacon, 
Bryman & Fenton, 1998).  
In terms of the current study, convergent validity was mixed, with indices of 
positive emotionality correlating with conciliatory behaviour but the relationship 
between negative cognitions and aggression falling short of significance. This 
encouraged me to think critically about sources of measurement error (e.g. a time-
lag measurement effect confounder) and hypothesise about factors that may have 
influenced the relationship between outcomes. For example, I tentatively suggested 
that through treatment, participants with ASPD had learnt to inhibit behavioural 
manifestations of aggression but remained prone to anger-oriented thinking. This 
highlighted fresh avenues for research, which would have been missed if a mono-
method measurement approach had been employed.  
A further strength of the measurement approach was that it avoided heavy 
reliance on self-report questionnaires. I considered this particularly important in 
research with participants diagnosed with ASPD for several reasons. First, at the 
study’s outset I was aware of research suggesting that because lying is a central 
characteristic of ASPD, ratings on self-report tools may reflect text-appropriate 
ratings, rendering them unreliable indicators of internal states (Herpentz et al., 
2001). Second, educational disadvantage (and related literacy problems) is a 
reliable concomitant of ASPD (Swanson, Bland & Newman, 1994), reflected in the 
low levels of academic qualifications observed in the present study. I hoped that by 
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restricting the number of tasks that required reading and writing, and offering a high 
level of support with questionnaires when required, the research burden on clinical 
participants would be reduced. This seemed to be effective as many participants 
reported enjoying the experience of taking part, offering their time in the event of 
future studies.  
Third, my personal observation of working clinically with this client group is 
that structured learning environments can provoke unhappy memories of school, 
arousing anxiety about failure and negative evaluation. I was keen to avoid this, 
primarily for ethical reasons but also as a potential confounder in emotional 
reactivity outcomes. I was also aware that forensic service-users are often required 
to complete extensive self-report batteries about their thoughts and feelings, and I 
was concerned that this would engender more frustration amongst clinical 
participants, thereby introducing an additional confounder in reactivity outcomes. 
Therefore balancing structured measures, interviews and experiential tasks seemed 
most appropriate. Nevertheless, it remained possible that the research process had 
a differential impact on groups, by virtue of clinical participants being understandably 
concerned about how they would be perceived in light of the stigma associated with 
having a criminal history and a diagnosed personality disorder.  
The main drawback associated with a multi-method approach was that with 
so many sources of data to analyse, it was not possible to do each component 
justice within the confines of the project. For example it would have been interesting 
to analyse change scores on individual PANAS (Watson, Clark & Tellegen, 1988) 
items but the time constraints coupled with the risk of increasing the Type I error 
rate with additional statistical tests, meant that this was not possible. Similarly, an 
interview protocol was developed with the intention of gaining a more in depth 
picture of participants’ experiences than would be possible with a standardised tool. 
However, the decision to only analyse questions pertaining to cognitions (in light of 
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time constraints), resulted in a somewhat reductionist approach and meant that 
some of the richness of the data was lost.  
For example, many clinical participants described how the scenario elicited 
similar emotions to those they had experienced in fights many years prior, making 
them aware of their continued vulnerability to respond with aggression and 
reinforcing the importance of avoiding places where they could encounter conflict 
(e.g. pubs) in the future. A number of clinical participants with comorbid substance 
misuse diagnoses further commented on how seeing virtual pint glasses triggered 
dormant cravings. These qualitative reports made me think about the potential for 
VR-based treatments for offenders with ASPD (see below). It was disappointing not 
to be able to capture these reflections in the results of the empirical paper, and in 
retrospect it would have been useful to fully exploit experiential interview reports and 
administer a standardised measure of cognitions as an adjunct. Nevertheless, the 
three ‘cognitive salience’ constructs that emerged from the data could contribute to 
future research by forming the basis of a structured tool in the event of replication.   
3.2 Technological considerations  
Several lessons were learnt from conducting a project in which the success 
of data collection hinged on technological equipment. This was most notable with 
regard to physiological data, which regrettably proved unusable. From the point at 
which the project was first conceptualised, heart-rate was considered a key indicator 
of arousal, and muscle tension (triceps) an objective gauge of participants’ desire to 
respond impulsively with physical aggression. Accordingly, much of the preparation 
time prior to data collection involved familiarising myself with the physiological 
equipment (NEXUS 4) and learning how to interpret outcomes.  
It quickly became apparent that there was an absence of departmental 
expertise available to inform this process and therefore much of my learning 
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occurred during testing with participants. Unfortunately my limited experience meant 
that I did not detect subtle anomalies in the data arising from an equipment fault, 
which were probably exacerbated by interference from the virtual reality equipment. 
It was only after completion of testing that I managed to consult with suitably 
qualified researchers and I was informed that the data was not salvageable. This 
was disappointing as physiological data would have not only been useful for 
hypothesis testing but also for validating the anger-arousal potential of the VR 
scenario.  
On reflection it was over-ambitious to expect to master physiological 
measurement techniques alongside the significant challenges associated with 
recruiting a hard-to-reach sample and becoming accustomed to the nuances of 
virtual reality. In the event of replication, it will be important to ascertain if experts 
are available to assist from the outset and thereafter allocate sufficient time to 
conduct a pilot in which equipment faults can be detected and trouble-shooted.  
Using state-of-the-art VR technology also incurred certain advantages and 
disadvantages. On the one hand it enabled me to capture and analyse ‘live’ 
behaviour during ecologically valid conditions of provocation. This represented an 
important step in better understanding emotional and behavioural reactivity in an 
under-researched clinical population. However, during both the pilot phase and 
testing with healthy volunteers, there were several occasions when I had to cancel 
participants at the last minute due to equipment failures.  
A further limitation was that the VR equipment was not sophisticated enough 
for avatars to respond to participants once the altercation had begun. A number of 
participants commented that the realism and believability of VR was compromised 
by the fact that they could not effect change in the outcome of the scenario. In 
addition to impacting on ‘presence’, this raised the possibility that when participants 
attempted to intervene, an absence of reinforcing social cues led them to ‘give up’ 
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more easily, thereby reducing the authenticity of their behaviour. Additionally, 
although in many ways the VR scenario was highly realistic, it occasionally 
appeared clunky. For example in the initial conversation with the victim avatar, 
participants sometimes misheard his responses and requested clarification. The 
system was not sophisticated enough to repeat small extracts from the pre-recorded 
array of utterances, and my observations were that this temporarily suspended 
participants’ sense of immersion.  
The scenario content also introduced unanticipated difficulties. During 
recruitment several clinical participants refused to take part as they had a strong 
existing affiliation with a football team and were understandably unwilling to take on 
the role of an Arsenal supporter. This made recruitment of an already hard to access 
sample more difficult. Furthermore a number of participants from both clinical and 
healthy volunteer groups commented in interview that they felt uncomfortable during 
their initial conversation with the victim avatar as they did not know the answers to 
his questions about football. Future studies may benefit from using an alternative 
scenario that elicits less apprehension in participants during both the recruitment 
and participation phases.  
4. Virtual risk assessment and treatment  
4.1. Virtual risk assessment 
The findings from the empirical study raise the possibility that VR could be 
used to assist the risk assessment process in forensic personality disorder services. 
At a population level there is a strong statistical association between the diagnosis 
of ASPD and violent offending behaviour (Singleton, Melzer & Gatwood, 1998). 
However, ASPD is a very broad diagnostic category (DSM-IV; APA, 2000), 
encompassing people who never commit offences as well as those who commit the 
most serious crimes. Consequently, the diagnosis alone is of little value as an 
indicator of risk (NICE CG 77, 2009). The assessment of risk of violence in ASPD is 
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further complicated by the fact that some patients may be persuasive and deceptive, 
rendering the clinical interview an inaccurate guide to the severity of the disorder 
and associated risks.  
It is generally accepted that the best way to assess violence risk is through 
structured clinical judgement (Monahan, Steadman & Silver et al., 2001), namely 
based on standardised information alongside prior knowledge about an individual 
case. Several measures have been developed to facilitate this process (e.g. the 
HCR-20; Webster, Douglas, Eaves & Hart, 1997), with the key aim of balancing 
specificity and sensitivity in evaluations of probability. Although these instruments 
are moderately predictive of recidivism (e.g. Dahle, 2006), they have limited 
accuracy predicting behaviour at an individual level in clinical practice (NICE GC 77, 
2009). As a result, the development of any measure that discriminates between the 
degree and severity of ASPD is likely to assist the process of risk assessment (NICE 
CG 77, 2009).  
It is possible that VR provocation could inform this process by balancing 
judgement based on general patterns of behaviour, whilst providing idiosyncratic 
information about individual clients’ personal risk factors. Specifically, in the event of 
large-scale data collection, it may be possible to develop an algorithm based on the 
four markers of affect, cognitions, physiological arousal and behaviour during VR. 
This would enable an individual’s pattern of reactivity to be compared to normative 
samples, such that their probability of reoffending could be calculated with sufficient 
specificity and sensitivity. At the same time, there may be scope for clinicians to use 
their existing knowledge of individual clients to build VR scenarios that reflect 
idiosyncratic high risk situations, allowing more precise evaluation of that particular 
individual’s risk of recidivism. Predictive validity could then be evaluated by 
obtaining longitudinal follow-up data of actual rates of reoffending.   
Evidently, developments in VR risk assessment would necessitate large 
scale normative data from which reactivity cut-off values could be derived. 
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Furthermore the scope for clinicians to develop individual scenarios will depend on 
the cost and flexibility of VR equipment in the future. Consequently the potential for 
VR-based risk assessment requires ongoing research, using the most sophisticated 
technology available.  
4.2. Virtual anger treatment  
If, as the results of the empirical paper suggest, aggression in ASPD 
primarily reflects poor behavioural inhibition during anger-arousing circumstances, 
then aggression in this population may be amenable to exposure therapy. Exposure 
is a central ingredient of CBT and is thought to be effective by way of de-
conditioning the anger learning cycle (Foa & Rothbaum, 1998), and facilitating the 
integration of corrective information (Foa & Hearst-Ikeda, 1996). However traditional 
methods of anger exposure are subject to several limitations. Imaginal techniques 
are dependent on an individual’s capacity to visualise stimuli, role-play may lack 
sufficient realism to provoke an emotional response, and in vivo exposure raises 
serious ethical and safety implications.  
For these reasons, several VR-based anger exposure protocols have been 
developed and there is preliminary evidence to support their anger-arousal potential 
(e.g. Miyahira et al., 2010), echoed by the results of the current empirical study. 
When viewed alongside the fact that CBT offence-focused treatment is 
commonplace in the UK (e.g. Ireland, 2004) and shows preliminary efficacy with 
ASPD populations (Gibbon et al., 2010), it is plausible that VR exposure could offer 
an effective new treatment component for violent offenders with ASPD. 
In addition to the foregoing, VR exposure may lend itself ideally to progress 
monitoring in anger treatment, overcoming the limitations associated with traditional 
evaluative methods. Historically, assessment of skills acquisition has been largely 
limited to self-ratings and/or external ratings (e.g. staff observations), which are 
vulnerable to social desirability and stereotyping biases (Frankfort-Nachmias & 
Nachmias, 2000). Although role-play exercises may be used to gauge the 
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development of anger-management skills, they may lack generalisability and be 
difficult to implement with large numbers of service-users. By contrast, VR exposure 
can be administered relatively easily and may provide a more objective, 
ecologically-valid gauge of treatment progress.  
Evidently, a key factor in developing ‘virtuous reality’ treatment protocols for 
ASPD will be to design scenarios that can sufficiently prime anger and evoke 
realistic responses. This will necessitate a cooperative interplay between software 
engineers, health care providers and service-users, representing an exciting 
opportunity for collaborative research initiatives in the future.   
 
5. Final reflections 
The research process raised several ethical and risk management 
considerations that warrant discussion. First, owing to the anger-arousal potential of 
the scenario, participants’ violent offending histories, and the absence of prior 
research to draw upon, I experienced some anxiety and apprehension about the 
potential for violence arising from participation in the study. These concerns were 
echoed by the ethics committee and by clinicians assisting in the recruitment 
process. However, I also felt that precisely because research with this population 
was lacking, it was important to go ahead with the study in order to facilitate a better 
understanding of the processes implicated in ASPD aggression. For me this was 
particularly important in light of the general paucity of evidence to support 
efficacious interventions for ASPD (Gibbon, Duggan, Stoffers, et al., 2010). 
I was also mindful of the ethical obligation to avoid pejorative stereotypes, 
whilst adopting a sensible approach to risk management. I found it useful to 
remember that clinical participants had been judged by the Ministry of Justice and 
their respective clinical teams to be sufficiently safe to be living in – or spending 
extended periods of time in – the community.  At the same time it was essential to 
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implement a rigorous risk management protocol, including a no-lone-working policy, 
carrying a personal alarm and including strategies for reducing participants’ residual 
arousal following VR (e.g. a relaxation exercise). 
As noted, at the outset of the project I was aware of research suggesting that 
self-report tools with ASPD samples may be an inaccurate gauge of internal states. 
However, as the project unfolded I saw this is less problematic because participants 
demonstrated a willingness to discuss their propensity towards aggression. For me 
this illustrates the importance of holding clinical characteristics in mind when 
designing and conducting research, whilst remaining flexible to individual variation 
and being careful not to apply negative stereotypes. This may be particularly 
important when collaborating with participants diagnosed with ASPD, given that they 
are likely to have experienced a high level of stigma and discrimination in the past 
(NICE CG 77, 2009). 
Having worked clinically with service-users diagnosed with ASPD, I am 
personally invested in developing the rehabilitative pathway, which necessitates 
evidence of improved psychological wellbeing and reduction in risk. However, like 
any psychological condition, successful treatment hinges on developing a coherent 
understanding of the mechanisms that give rise to and maintain problems. It is 
unfortunate that historically this group of offenders has shared the ‘untreatability’ 
stigma associated with psychopathy, without the elusive glamour.  I hope that my 
reflections on the research process will encourage future researchers to recognise 
that with sufficient planning and determination, the barriers to conducting research 
with this population can, and should, be overcome. 
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APPENDIX 2: RECRUITMENT AIDES  
Advertisement for healthy volunteers  
 
Research Poster for Healthy Volunteers  
Version 1: 16.07.2011                                      
 This project has been approved by UCL ethics committee  
 
VIRTUAL REALITY STUDY 
 
 
We are looking for men to take part in a doctoral research project 
looking at how people respond to virtual reality scenarios. The 
study will take up to 90 minutes; you will be paid for your time. 
For more information please email ophelia.phillips.09@ucl.ac.uk  
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Clinician Letter Requesting Recruitment Support  
Version 1: 16.07.2011 
Project approved by Camberwell & St Giles Research Ethics Committee                                
 
 
(To appear on Trust headed paper) 
 
 
Ophelia Phillips  
Research Department of Clinical,  
Educational and Health Psychology  
University College London 
1-19 Torrington Place 
London WC1E 6BT 
Email: ophelia.phillips.09@ucl.ac.uk 
 
 
  
Date 
                    Clinician name & address 
 
 
Dear Dr. 
 
 
We are writing to request your support in helping to identify and recommend 
potential participants for a research project. This study is investigating the way in 
which people respond when they witness aggressive interactions in a virtual reality 
environment. The research does not involve any medical procedures.  It is intended 
to contribute to an understanding of psychophysiological markers of antisocial 
personality disorder.  
 
We are looking to recruit 20 participants with a diagnosis of antisocial personality 
disorder who are currently in receipt of care from inpatient and outpatient NHS 
services. Potential participants are required to be English-speaking and possess 
basic literacy skills. Due to the use of virtual reality, patients with an epileptic 
condition will not be able to take part. Additionally, patients with an active major 
mental illness will not be eligible to participate.  
 
The study will take place in the Department of Computer Science, University College 
London (UCL). Therefore, potential participants who currently reside in inpatient 
services are required to have been granted unescorted community leave of a 
sufficient time period to travel to and from UCL and take part in the research. It is 
estimated that participation will take 1 hour 30 minutes (excluding travel time). 
Participants will be paid for their involvement in the study.  
 
We include our information sheet for further details about the study, which you may 
wish to discuss with potential participants. If your patient expresses interest in 
participating, Ophelia Phillips (researcher) will come to meet with them at a 
convenient time to explain the research in more detail and obtain informed consent. 
In this instance, Ophelia Phillips will liaise with the patient and yourself to arrange an 
appointment at UCL.  
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We do not anticipate any adverse effects from taking part in this study. However, if 
for any reason concerns are raised regarding your patient’s safety or wellbeing 
during their participation, a member of the research team will contact you (or a pre-
agreed designated member of their clinical team) directly to inform you of this.  
 
Please let us know if you have any questions. 
 
 
 
Yours sincerely, 
 
 
Ophelia Phillips     
Trainee Clinical Psychologist 
University College London / Camden & Islington NHS Foundation Trust 
 
Professor Peter Fonagy 
Head of the Department of Clinical, Educational & Health Psychology  
University College London 
 
Dr. Chris Barker  
Reader in Clinical Psychology  
University College London, Department of Clinical, Educational & Health Psychology                                                                                                                           
 
Dr. Stephen Butler 
Senior Lecturer, Department of Clinical, Educational & Health Psychology 
University College London 
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Responsible Clinician letter about participation:  
Version 1: 16.07.2011 
Project approved by Camberwell & St Giles Research Ethics Committee                                                                        
 
 (To appear on Trust headed paper) 
 
Ophelia Phillips  
Research Department of Clinical,  
Educational and Health Psychology  
University College London 
1-19 Torrington Place 
London WC1E 6BT 
Email: ophelia.phillips.09@ucl.ac.uk 
Date 
Clinician name & address 
 
 
 
Dear Dr. 
 
re. patient name 
d.o.b. 
 
 
 
We are writing to inform you that your patient has agreed to take part in a research 
project, investigating the way in which people respond when they witness 
aggressive interactions in a virtual reality environment.   
 
The research does not involve any medical procedures.  It is intended to contribute 
to an understanding of psychophysiological markers of antisocial personality 
disorder. We do not expect there to be any adverse effects, but we include our 
information sheet in case your patient wishes discuss any aspects of the study with 
you.  
 
In addition, if any concerns about your patient’s safety or wellbeing are raised during 
their participation, a member of the research team will contact you (or a pre-agreed 
designated member of their clinical team) to inform you of this.  
 
Please let us know if you have any questions. 
 
 
 
Yours sincerely, 
 
 
Ophelia Phillips     
Trainee Clinical Psychologist 
University College London / Camden & Islington NHS Foundation Trust 
 
Professor Peter Fonagy 
Head of the Department of Clinical, Educational & Health Psychology  
University College London 
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Dr. Chris Barker  
Reader in Clinical Psychology  
University College London, Department of Clinical, Educational & Health Psychology 
 
Dr. Stephen Butler 
Senior Lecturer, Department of Clinical, Educational & Health Psychology 
University College London 
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APPENDIX 3: ETHICAL APPROVAL LETTERS  
 
UCL ETHICAL APPROVAL  
UCL GRADUATE SCHOOL  
UCL RESEARCH ETHICS COMMITTEE  
      
 
   
 
 
 
Professor Mel Slater 
Department of Computer Science 
UCL 
 
  
 
9 June 2011 
 
 
Dear Professor Slater 
 
Re: Ethics Application: 0206/002: Bystander responses to violent emergencies – a 
virtual reality experiment  
 
I am pleased to confirm that I have approved your request to extend the above 
project for a further 18 months; until June 2013 and to include Ophelia Phillips and 
her supervisor, Dr Chris Barker, as additional researchers. 
 
I also approve your proposal to widen the recruitment criteria to men over 18, to use 
additional, non-intrusive standardised questionnaire depending on the results of the 
pilot work and to use heart rate and EMG recordings via a non-invasive 
physiological measurement device. 
 
As always, please notify the Administrator of the Ethics Committee, Helen Dougal, if 
you propose to make any further amendments.  It is also your responsibility to report 
to the Committee any unanticipated problems or adverse events involving risks to 
participants or others.   
 
On completion of the research you must submit a brief report (a maximum of two 
sides of A4) of your findings/concluding comments to the Committee, which includes 
in particular issues relating to the ethical implications of the research.   
 
 
With best wishes 
 
 
Yours sincerely  
 
 
 
 
Sir John Birch 
Chair, UCL Research Ethics Committee  
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APPENDIX 4: INFORMATION FOR PARTICIPANTS  
Information sheet for clinical participants                                                              
 
Version 5: 14.09.2011 
 
PROJECT APPROVED BY NRES COMMITTEE LONDON – CAMBERWELL ST 
GILES  
(To appear on Trust headed paper) 
Information Sheet: Clinical Participants     
                                                            
You will be given a copy of this information sheet. 
PROJECT TITLE: A VIRTUAL REALITY STUDY OF HOW PEOPLE RESPOND 
WHEN WITNESSING AGGRESSIVE INTERACTIONS 
Researcher 
Name 
Ophelia Phillips  
Work Address Department of Clinical, Educational and Health Psychology, 
University College London, 1-19 Torrington Place, 4th Floor, 
London WC1E 7HB 
Contact Details  email: ophelia.phillips.09@ucl.ac.uk 
INVITATION TO TAKE PART  
We would like to invite you to take part in our research study. Before you decide we 
would like you to understand why the research is being done and what it would 
involve for you. One of our team will go through the information sheet with you 
and answer any questions you have. We‘d suggest this should take about 10 
minutes. (Part 1 tells you the purpose of this study and what will happen to you if 
you take part. Part 2 gives you more detailed information about the conduct of the 
study). Ask us if there is anything that is not clear. Talk to others about the study if 
you wish. 
PART 1: DETAILS OF STUDY  
Purpose: This research project is looking at people’s reactions to virtual 
environments. This takes the form of cutting edge technology, where a room is filled 
with 3-Dimensional projections that simulate a real life scenario with moving 
interactive characters. The aim of the study is to develop our understanding of how 
people respond when they witness aggressive interactions between other people. 
We are interested in how people respond physiologically, emotionally and 
behaviourally. This project is part of a student research project. Please take time to 
read the following information carefully and ask us if there is anything unclear or if 
you would like more information. If you are happy to take part in the study you will 
be asked to sign an informed consent form.  
Why have I been invited to take part in this study? You have been invited to take 
 178 
 
part in this study because we are looking for males aged between 18 and 60 years 
who have contact with forensic mental health services and have been given a 
diagnosis of Antisocial Personality Disorder. We are hoping to recruit twenty 
participants. The study will take place in the Department of Computer Science, 
University College London. It is therefore only possible for you to take part if you 
have been granted unescorted community leave of sufficient time period (1 hour 30 
minutes plus travel to and from University College London) by the Ministry of 
Justice, and that this is supported by your clinical team.  
Do I have to take part? No, it is up to you to decide whether or not to take part. If 
you do decide to take part you will be given this information sheet to keep, and be 
asked to sign a consent form. You are still free to withdraw at any time, and you do 
not need to give a reason for this. This would not affect the standard of care you 
receive.   
 
 
What will happen if I decide to take part? In addition to your direct involvement in 
the study, if you agree to take part one of the researchers Ophelia Phillips, Trainee 
Clinical Psychologist will have access to your medical records. This is in order to 
find out some basic information about you (e.g. your age and diagnosis), how long 
you have been in contact with forensic mental health services, and what your 
criminal history is. All of this information will be stored in a way to ensure that you 
are not identifiable. Your direct participation in the project involves five phases and 
is likely to take between an hour and an hour-and-a-half in total.   
 
Phase 1 - Questionnaires: Before entering the virtual environment, we invite 
people to complete three questionnaires which ask about your thoughts, feelings 
and behaviour in general, as well as how you feel at the time of the study. There are 
no right or wrong answers. One of these questionnaires will be given both before 
and immediately after the virtual environment experience. Completion of 
questionnaires will take approximately 45 minutes and you will be able to ask for 
assistance from a member of the research team if you require.  
 
Phase 2 - Physiological measures: We invite people to have their physiological 
responses measured in two ways; muscle tension and heart rate. To do this we will 
request to attach two electrodes to you; one to your upper arm and one to your 
chest. This will be carried out by a male member of the research team who has 
experience of doing so, in line with standard health and safety conventions. Another 
member of the research team will also be present during electrode placement for 
further assistance.  
 
Once this equipment has been attached, we ask participants to enter the virtual 
reality room and explore the environment that depicts a pub for two minutes. You 
will be given instructions in the use of virtual reality before entering. Once you are 
familiar with the use of virtual reality, you will be asked to put on glasses that 
produce three-dimensional images. During this initial two minute phase, a member 
of the research team seated outside the virtual reality room will take some 
measurements of your resting heart-rate and muscle tension using specialist 
computer software.  
 
Phase 3 - Virtual Reality: After Part 2 has been completed, you will be invited to 
remain in the virtual pub and continue observing the environment. The scenario will 
last for two minutes and twenty seconds during which you will encounter and be 
invited to interact with two virtual characters. You will witness an interaction 
between these two characters; the language used will be realistic to the scenario. 
You will also be asked to respond to the situations and characters to you encounter 
as you would in everyday life. You will also be asked to wear an Arsenal football 
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team scarf, and to imagine that you are an avid Arsenal supporter. 
 
During your time in the environment a member of the research team will take further 
muscle tension and heart rate measurements from outside the virtual reality room. 
Your behaviour and verbal responses in the virtual environment will be video-
recorded for the purpose of analysing data from the study. Once this has been 
coded by the researcher, the video tapes will be wiped clean. 
 
There will be another researcher directly outside the virtual room at all times to 
ensure you feel comfortable during the exercise.  
 
Phase 4 – Post-questionnaire and Interview: Once you have completed the 
exercise you will be asked to complete one of the written questionnaires from Stage 
1 a second time. You will then be interviewed briefly about the thoughts and feelings 
you experienced during virtual reality. Phase 4 is estimated to take 10 minutes. Any 
data obtained from the interview will be coded. Direct quotes from your interview will 
NOT be used in the write-up of this study.  
 
 
Phase 5 – Relaxation and scenario ending: You will be asked to take part in a 
five minute relaxation exercise, which will be read out by one of the researchers. 
You will then be read a vignette by one of the researchers, explaining how the 
scenario ended between the two characters in the bar.  
 
Expenses and payment: To thank you for your time, you will be paid £6.00 per 30 
minutes of your time spent, which is likely to be 1 hour 30 minutes (totalling £18.00). 
You will also be reimbursed for travel expenses to and from University College 
London.  
 
What are the possible disadvantages and risks of taking part?  
Information about the virtual reality equipment: When people use virtual reality 
systems they occasionally experience a degree of nausea. If at any time you wish to 
stop taking part in the study for this or any other reason, please say so and we will 
stop.  
 
There is some research to suggest that people using virtual reality might experience 
some disturbance in vision afterwards. No long term studies are known to us, but 
some studies which have conducted testing after about 30 minutes, have found that 
the effect is sometimes still there. It is therefore advised that you do not drive a car, 
motorcycle or operate complicated machinery in the four hours flowing virtual reality. 
With all kinds of video equipment there is a possibility that an epileptic episode may 
be generated. If you have epilepsy please tell us. We would not want you to 
take part in the study in this case.  
 
Information about the virtual scenario: It is possible that you may experience a 
degree of stress or apprehension when witnessing aggression escalating between 
virtual characters. If at any time you wish to stop taking part for this or any other 
reason, please tell us and we will stop.  
 
Some researchers have expressed concern that witnessing violence and 
aggression in virtual reality may increase the likelihood of people becoming 
aggressive after being exposed to these virtual scenarios. To our knowledge no 
research has directly investigated this. However, recent research into violent video-
games and increased aggression in players has found no evidence to support this 
concern. If however you do notice an increase in aggressive thoughts or urges 
following your time in the virtual environment and after the relaxation exercise, 
please tell us. In this case we will talk to you about your concerns in order to offer 
you further support.  
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What are the benefits of taking part? We cannot promise the study will help you 
but the information we get from this study will help improve the understanding of 
Antisocial Personality Disorder. Additionally, some people report that they enjoy 
taking part in virtual reality, finding it interesting and novel.  
 
What if there is a problem? Any complaint about the way you have been dealt with 
during the clinical trial or any possible harm you might suffer will be addressed. 
Detailed information concerning this is given in Part 2 of this information sheet.  
 
Will my taking part in the study be kept confidential? All information from the 
study will be kept confidential and you will not be identified. As participation is 
anonymous, it will not be possible for us to withdraw your data once you have 
returned your questionnaires. 
 
PART 2: ADDITIONAL INFORMATION 
 
What will happen if I don’t want to carry on with the study? If you withdraw from 
the study, we will destroy all your identifiable information, but we may use non-
identifiable data that we have collected up until your withdrawal.  
 
What if there is problem? Every care will be taken in the course of this study.  
However, in the unlikely event that you are injured by taking part, compensation 
may be available.  
 
If you suspect that the injury is the result of the Sponsor’s (University College 
London) or the hospital's negligence then University College London is insured for 
this study.  After discussing with Ophelia Phillips, please contact Dr Stephen Butler 
(telephone number: 0207 679 5985), who is the Chief Investigator for the research 
and is based at the Department of Clinical, Educational & Health Psychology, 
University College London.  
 
If you have a concern about any aspect of this study, you should ask to speak to the 
researcher (Ophelia Phillips) who will do her best to answer your questions 
(telephone number 0207 916 9189). If you remain unhappy and wish to complain 
formally about any aspect of the way you have been approached or treated by 
members of staff or about any adverse events you may have experienced due to 
your participation in the research, the normal National Health Service complaints 
mechanisms are available to you. Please ask the researcher, Ophelia Phillips if you 
would like more information on this. Details can also be obtained from the 
Department of Health website: http://www.dh.gov.uk  
 
Will my taking part in this study be kept confidential? All information which is 
collected about you during the course of the research will be kept strictly 
confidential, and any information about you which leaves the hospital/surgery will 
have your name and address removed so that you cannot be recognised. All data 
concerning you will be stored in a locked facility.  
 
Your Responsible Clinician will be informed of your involvement in this research, but 
will not be provided with information about the data we obtain from you such as your 
responses to questionnaires. All data gathered will be kept strictly within the 
research team. If the researcher has any concerns about your health and safety 
during your participation in the study, they will notify your Responsible Clinician of 
this.  
 
What will happen to the results of the research study? The results of the 
research will be analysed as part of a doctorate in clinical psychology and the 
findings are likely to be published in a scientific journal. Participants will not be 
identified in any report or publication. Please inform Ophelia Phillips if you would 
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like to be sent a copy of the study’s findings. 
 
Who is organising and funding this research? University College London are 
sponsoring and funding this research.  
 
Who has reviewed this study? All research in the NHS is looked at by 
independent group of people, called a Research Ethics Committee, to protect your 
interests. This study has been reviewed and given favourable opinion by 
Camberwell & St Giles Research Ethics Committee. 
 
 
All data will be collected and stored in accordance with the Data Protection 
Act 1998. 
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Information Sheet for Healthy Volunteers                                                              
 
Version 5: 14.09.2011 
 
PROJECT APPROVED BY UCL AND NRES COMMITTEE LONDON – 
CAMBERWELL ST GILES     
                                                      
 
Information Sheet: Healthy Volunteer Participants 
You will be given a copy of this information sheet. 
PROJECT TITLE: A VIRTUAL REALITY STUDY OF HOW PEOPLE RESPOND 
WHEN WITNESSING AGGRESSIVE INTERACTIONS 
Researcher Name Ophelia Phillips  
Work Address Department of Clinical, Educational and Health Psychology, 
University College London, 1-19 Torrington Place, 4th Floor, 
London WC1E 7HB 
Contact Details  email: ophelia.phillips.09@ucl.ac.uk 
INVITATION TO TAKE PART  
We would like to invite you to take part in our research study. Before you decide we 
would like you to understand why the research is being done and what it would 
involve for you. One of our team will go through the information sheet with you 
and answer any questions you have. We‘d suggest this should take about 10 
minutes. (Part 1 tells you the purpose of this study and what will happen to you if you 
take part. Part 2 gives you more detailed information about the conduct of the study). 
Ask us if there is anything that is not clear.  
PART 1: DETAILS OF STUDY  
Purpose: This research project is looking at people’s reactions to virtual 
environments. This takes the form of cutting edge technology, where a room is filled 
with 3-Dimensional projections that simulate a real life scenario with moving 
interactive characters. The aim of the study is to develop our understanding of how 
people respond when they witness aggressive interactions between other people. We 
are interested in how people respond physiologically, emotionally and behaviourally. 
This project is part of a student research project. Please take time to read the 
following information carefully and ask us if there is anything unclear or if you would 
like more information. If you are happy to take part in the study you will be asked to 
sign an informed consent form.  
Why have I been invited to take part in this study? You have been invited to take 
part in this study because we are looking healthy males aged between 18 and 60. We 
are hoping to recruit twenty participants. The study will take place in the Department 
of Computer Science, University College London.  
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Do I have to take part? No, it is up to you to decide whether or not to take part. If 
you do decide to take part you will be given this information sheet to keep. You are 
still free to withdraw at any time, and you do not need to give a reason for this.  
What will happen if I decide to take part? Your participation in this project involves 
five phases and is likely to take between an hour and an hour-and-a-half in total.   
 
Phase 1 - Questionnaires: Before entering the virtual environment, we invite people 
to complete three questionnaires which ask about your thoughts, feelings and 
behaviour. There are no right or wrong answers. One of these questionnaires will be 
given both before and immediately after the virtual environment experience. 
Completion of questionnaires will take approximately 45 minutes and you will be able 
to ask for assistance from a member of the research team if you require.  
 
Phase 2 - Physiological measures: We invite people to have their physiological 
responses measured in two ways; muscle tension and heart rate. To do this we will 
request to attach two electrodes to you; one to your upper arm and one to your chest. 
This will be carried out by a male member of the research team who has experience 
of doing so, in line with standard health and safety conventions. Another member of 
the research team will also be present during electrode placement for further 
assistance.  
 
Once this equipment has been attached, we ask participants to enter the virtual 
reality room and explore the environment that depicts a pub for two minutes. You will 
be given instructions in the use of virtual reality before entering. Once you are familiar 
with the use of virtual reality, you will be asked to put on glasses that produce three-
dimensional images. During this initial two minute phase, a member of the research 
team seated outside the virtual reality room will take some measurements of your 
resting heart-rate and muscle tension using specialist computer software.  
 
Phase 3 - Virtual Reality: After Part 2 has been completed, you will be invited to 
remain in the virtual pub and continue observing the environment. The scenario will 
last for two minutes and twenty seconds during which you will be invited to interact 
with two virtual characters. You will witness an interaction between these two 
characters; the language used will be realistic to the situation. You will also be asked 
to respond to the situations and characters to you encounter as you would in 
everyday life. You will also be asked to wear an Arsenal football team scarf, and to 
imagine that you are an avid Arsenal supporter. 
 
During your time in the environment a member of the research team will take further 
muscle tension and heart rate measurements from outside the virtual reality room. 
Your behaviour and verbal responses in the virtual environment will be video-
recorded for the purpose of analysing data from the study. Once this has been 
coded by the researcher, the video tapes will be wiped clean. There will be another 
researcher directly outside the virtual room at all times to ensure you feel comfortable 
during the exercise.  
 
Phase 4 – Post-questionnaire and Interview: Once you have completed the 
exercise you will be asked to complete one of the written questionnaires from Stage 1 
a second time. You will then be interviewed briefly about the thoughts and feelings 
you experienced during virtual reality. Phase 4 is estimated to take 10 minutes. Any 
data obtained from the interview will be coded. Direct quotes from your interview will 
NOT be used in the write-up of this study.  
 
Phase 5 – Relaxation and scenario ending: You will be asked to take part in a five 
minute relaxation exercise, which will be read out to you by one of the researchers. 
You will then be read a vignette by one of the researchers, explaining how the 
scenario ended between the two characters in the bar.  
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Expenses and payment: To thank you for your time, you will be paid £6.00 per 30 
minutes of your time spent, which is likely to be 1 hour 30 minutes (totalling £18.00).  
 
What are the possible disadvantages and risks of taking part?  
Information about the virtual reality equipment: When people use virtual reality 
systems they occasionally experience a degree of nausea. If at any time you wish to 
stop taking part in the study for this or any other reason, please say so and we will 
stop.  
 
There is some research to suggest that people using virtual reality might experience 
some disturbance in vision afterwards. No long term studies are known to us, but 
some studies which have conducted testing after about 30 minutes, have found that 
the effect is sometimes still there. It is therefore advised that you do not drive a car, 
motorcycle or operate complicated machinery in the four hours flowing virtual reality. 
With all kinds of video equipment there is a possibility that an epileptic episode may 
be generated. If you have epilepsy please tell us. We would not want you to take 
part in the study in this case.  
 
Information about the virtual scenario: It is possible that you may experience a 
degree of stress or apprehension when witnessing aggression escalating between 
virtual characters. If at any time you wish to stop taking part for this or any other 
reason, please tell us and we will stop.  
 
Some researchers have expressed concern that witnessing violence and aggression 
in virtual reality may increase the likelihood of people becoming aggressive 
afterwards. To our knowledge no research has directly investigated this. However, 
recent research into violent video-games and increased aggression in players has 
found no evidence to support this concern. If however you do notice an increase in 
aggressive thoughts or urges following your time in the virtual environment and the 
relaxation exercise, please tell us. In this case we will talk to you about your concerns 
in order to offer you support.  
 
What are the benefits of taking part? We cannot promise the study will help you 
but the information we get from this study will help improve the understanding of how 
people respond to aggressive stimuli. Additionally, some people report that they enjoy 
taking part in virtual reality, finding it interesting and novel.  
 
What if there is a problem? Any complaint about the way you have been dealt with 
during the clinical trial or any possible harm you might suffer will be addressed. 
Detailed information concerning this is given in Part 2 of this information sheet.  
 
Will my taking part in the study be kept confidential? All information from the 
study will be kept confidential and you will not be identified. As participation is 
anonymous, it will not be possible for us to withdraw your data once you have 
returned your questionnaires and taken part in the virtual reality task. 
 
PART 2: ADDITIONAL INFORMATION 
What will happen if I don’t want to carry on with the study? If you withdraw from 
the study, we will destroy all your identifiable information, but we may use non-
identifiable data that we have collected up until your withdrawal. 
 
What if there is problem? Every care will be taken in the course of this study.  
However, in the unlikely event that you are injured by taking part, compensation may 
be available. If you suspect that the injury is the result of the Sponsor’s (University 
College London) negligence then the study is insured by University College London.  
After discussing with the researcher, please contact Dr Stephen Butler (telephone 
number: 0207 679 5985), who is the Chief Investigator for the research and is based 
at the Department of Clinical, Educational & Health Psychology, University College 
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London.  
 
Will my taking part in this study be kept confidential? All information which is 
collected about you during the course of the research will be kept strictly confidential 
and stored in a locked facility.  
 
What will happen to the results of the research study? The results of the 
research will be analysed as part of a doctorate in clinical psychology and the 
findings are likely to be published in a scientific journal. Participants will not be 
identified in any report or publication. Please inform Ophelia Phillips if you would like 
to be sent a copy of the study’s findings. 
 
Who is organising and funding this research? University College London are 
sponsoring this research.  
 
Who has reviewed this study? All research in the NHS is looked at by independent 
group of people, called a Research Ethics Committee, to protect your interests. This 
study has been reviewed and given favourable opinion by UCL Research Ethics 
Committee.  
 
All data will be collected and stored in accordance with the Data Protection Act 
1998. 
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Consent Form for Clinical Participants:                                                                 
 
Version 4: 20.07.2011 
 
PROJECT APPROVED BY NRES COMMITTEE LONDON – CAMBERWELL ST 
GILES  
(To appear on Trust headed paper) 
 
 
 
Centre Number:  
Study Number:  
Patient Identification Number for this trial:  
Date: 
 
CONSENT FORM FOR CLINICAL PARTICIPANTS 
 
PROJECT TITLE: A VIRTUAL REALITY STUDY OF HOW PEOPLE RESPOND 
WHEN WITNESSING AGGRESSIVE INTERACTIONS 
 
Name of Researcher: Ophelia Phillips 
 
 
Please initial box  
I confirm that I have read and understand the information sheet  
dated 14.09.2011 (Version 5) for the above study. I have  
had the opportunity to consider the information, ask questions  
and have had these answered satisfactorily.  
 
I understand that my participation is voluntary and that I am free  
to withdraw at any time without giving any reason, without my  
medical care or legal rights being affected.  
 
If I decide to withdraw from the study, any identifiable data collected up 
to this point will be destroyed but non-identifiable data may be used for 
the research.  
  
I understand that relevant sections of my medical notes and data  
collected during the study may be looked at this research team at  
University College London, where it is relevant to my taking part in this research.  
I give permission for these individuals to have access to my records.  
 
I understand that I will be interviewed briefly about the thoughts and  
feelings I experienced during virtual reality. Any data obtained from  
this interview will be coded and direct quotes from my interview  
will NOT be used in the write-up of this study.  
 
I agree to my Responsible Clinician being informed of my participation  
in the study.  
 
I understand that my Responsible Clinician will be contacted if  
concerns arise about my safety during my participation in the study.  
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I understand that my verbal responses and behaviour will be  
video-recorded during my time in virtual reality. These responses will  
be coded anonymously and will not be identifiable or linked to me in  
the final report.  
 
I understand that I must not take part if I have epilepsy.  
 
I understand that the information I have submitted will be published  
as a report and I will be sent a copy if I request this.  Confidentiality and  
anonymity will be maintained and it will not be possible to identify me  
from any publications. 
 
I understand that I am being paid for my assistance in this research  
and that some of my personal details will be passed to UCL Finance  
for administration purposes.  
 
I consent to the processing of my personal information for the  
purposes of this research study. 
 
I understand that such information will be treated as strictly  
confidential and handled in accordance with the provisions  
of the Data Protection Act 1998. 
 
I agree to take part in the above study.  
 
 
 
 
Name of patient                              Date                                Signature  
 
 
 
 
 
Name of person                              Date                                Signature  
taking consent  
 
 
 
 
 
 
 
 
When completed: 1 for participant; 1 for researcher site file; 1 (original) to be kept in 
medical notes. 
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Consent Form for Healthy Volunteer Participants                                                 
 
Version 4: 20.07.2011 
PROJECT APPROVED BY NRES COMMITTEE LONDON – CAMBERWELL ST 
GILES AND UCL RESEARCH ETHICS COMMITTEE 
 
 
Centre Number:  
Study Number:  
Participant Identification Number for this trial:  
Date: 
 
CONSENT FORM FOR HEALTHY VOLUNTEER PARTICIPANTS 
 
PROJECT TITLE: A VIRTUAL REALITY STUDY OF HOW PEOPLE RESPOND 
WHEN WITNESSING AGGRESSIVE INTERACTIONS 
 
Name of Researcher: Ophelia Phillips 
 
 
Please initial box  
I confirm that I have read and understand the information sheet  
dated 14.09.11 (version 5) for the above study. I have  
had the opportunity to consider the information, ask questions  
and have had these answered satisfactorily.  
 
I understand that my participation is voluntary and that I am free  
to withdraw at any time without giving any reason. 
 
If I decide to withdraw from the study, any identifiable data collected up 
to this point will be destroyed but non-identifiable data may be used for 
the research.  
 
I understand that my verbal responses and behaviour will be  
video-recorded during my time in virtual reality. These responses will  
be coded anonymously and will not be identifiable or linked to me in  
the final report.  
 
I understand that I will be interviewed briefly about the thoughts and  
feelings I experienced during virtual reality. Any data obtained from  
this interview will be coded and direct quotes from my interview  
will NOT be used in the write-up of this study.  
 
I understand that I must not take part if I have epilepsy.  
 
I understand that the information I have submitted will be published as a report  
and I will be sent a copy if I request this.  Confidentiality and  
anonymity will be maintained and it will not be possible to identify me  
from any publications. 
 
I understand that I am being paid for my assistance in this research  
and that some of my personal details will be passed to UCL Finance  
for administration purposes.  
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I consent to the processing of my personal information for the  
purposes of this research study. 
 
I understand that such information will be treated as strictly  
confidential and handled in accordance with the provisions  
of the Data Protection Act 1998. 
 
I agree to take part in the above study.  
 
 
 
 
Name of participant                         Date                               Signature  
 
 
 
 
 
Name of person                              Date                                Signature  
taking consent  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
When completed: 1 for participant and 1 for researcher site file  
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APPENDIX 5: POST VR TOOLS  
 
Post VR semi-structured interview schedule                                                           
 
Version 1: 16.07.2011 
(To appear on Trust headed paper) 
PROJECT APPROVED BY NRES COMMITTEE LONDON – CAMBERWELL ST 
GILES AND UCL RESEARCH ETHICS COMMITTEE 
 
 
Post Virtual Reality Semi-Structured Interview  
 
1. Can you briefly describe what you think was happening while you were in the 
room? 
 
 
2. How realistic were the unfolding events in the experience that you have just 
had? Can you rate this on a scale from 1-10, with one being quite unrealistic and 
easily seen as fantasy, and 10 being quite like real life  
 
3. (a) How did you feel when the first character (the victim) began talking to you?  
(b) What did you think of him: did you (a) like, (b) dislike or (c) feel neutral towards 
him?  
 
4. (a) What did you feel when the second character (aggressor) entered and began 
speaking to the first? (prompt: e.g. angry/fearful/embarrassed/excited/disgusted 
etc.)  
(b) What was going through your mind?  
      (c) What did you feel about the two characters at this point (e.g. did you 
sympathise/feel  
       more affiliated with either?) 
 
5. (a) At which point in the scenario did you experience your strongest emotions  
(b) Which emotion? 
 
6. (a) What was your most prominent/overriding emotion during the scenario? 
      (b) What were the thoughts that were making you feel ……. (repeat the emotion 
they  specified in 6a. 
  
7. Did you feel at any time you wanted to do something about what was 
happening/intervene?  
 
8. (If they wanted to) What was your main motivation for wanting to intervene 
during the confrontation (e.g. to intimidate/pacify/protect victim etc.)?  
 
9. (If they did not want to intervene) What would have made it more likely that you 
would have personally intervened (even though you knew it was virtual reality)? 
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10. To what extent was your reaction authentic/the same as real life (scale 1-10)?  
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Progressive Muscular Relaxation Script                                                                        
 
Version 1: 16.07.2011 
(To appear on Trust headed paper) 
PROJECT APPROVED BY NRES COMMITTEE LONDON – CAMBERWELL ST 
GILES AND UCL RESEARCH ETHICS COMMITTEE 
 
Progressive muscular relaxation script for participants post-virtual reality 
Begin by finding a comfortable position sitting down. You can change positions any 
time during this exercise to make yourself more comfortable as needed. 
Please turn your attention to your breathing. Breathe in forcefully and deeply, and 
hold this breath. Hold it...hold it... and now release. Let all the air go out slowly, and 
release all the tension.  
Take another deep breath in. Hold it.... and then exhale slowly, allowing the tension 
to leave your body with the air.  
Now breathe even more slowly and gently... breathe in....hold....out.... 
..breathe in...hold...out... 
Continue to breathe slowly and gently. Allow your breathing to relax you.  
The next exercise focuses on relaxing the muscles of your body. 
Start with the large muscles of your legs. Tighten all the muscles of your legs. Tense 
the muscles further. Hold onto this tension. Feel how tight and tensed the muscles in 
your legs are right now. Squeeze the muscles harder, tighter... Continue to hold this 
tension. Feel the muscles wanting to give up this tension. Hold it for a few moments 
more.... and now relax. Let all the tension go. Feel the muscles in your legs going 
limp, loose, and relaxed. Notice how relaxed the muscles feel now. Feel the 
difference between tension and relaxation. Enjoy the pleasant feeling of relaxation in 
your legs. 
Now focus on the muscles in your arms. Tighten your shoulders, upper arms, lower 
arms, and hands. Squeeze your hands into tight fists. Tense the muscles in your 
arms and hands as tightly as you can. Squeeze harder.... harder..... hold the tension 
in your arms, shoulders, and hands. Feel the tension in these muscles. Hold it for a 
few moments more.... and now release. Let the muscles of your shoulders, arms, 
and hands relax and go limp. Feel the relaxation as your shoulders lower into a 
comfortable position and your hands relax at your sides. Allow the muscles in your 
arms to relax completely. 
Focus again on your breathing. Slow, even, regular breaths. Breathe in relaxation.... 
and breathe out tension..... in relaxation....and out tension.... Continue to breathe 
slowly and rhythmically. 
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Now focus on the muscles of your buttocks. Tighten these muscles as much as you 
can. Hold this tension..... and then release. Relax your muscles. 
Tighten the muscles of your back now. Feel your back tightening, pulling your 
shoulders back and tensing the muscles along your spine. Arch your back slightly as 
you tighten these muscles. Hold.... and relax. Let all the tension go. Feel your back 
comfortably relaxing into a good and healthy posture. 
Turn your attention now to the muscles of your chest and stomach. Tighten and 
tense these muscles. Tighten them further...hold this tension.... and release. Relax 
the muscles of your trunk.  
Finally, tighten the muscles of your face. Scrunch your eyes shut tightly, wrinkle your 
nose, and tighten your cheeks and chin. Hold this tension in your face.... and relax. 
Release all the tension. Feel how relaxed your face is. 
Notice all of the muscles in your body.... notice how relaxed your muscles fee l. 
Allow any last bits of tension to drain away. Enjoy the relaxation you are 
experiencing. Notice your calm breathing.... your relaxed muscles.... Enjoy the 
relaxation for a few moments.... 
When you are ready to return to your usual level of alertness and awareness, slowly 
begin to re-awaken your body. Wiggle your toes and fingers. Swing your arms 
gently. Shrug your shoulders. Stretch if you like. 
You may now end this progressive muscle relaxation exercise feeling calm and 
refreshed.  
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Vignette – shaking hands and making up  
Version 1: 14.09.2011 
 
PROJECT APPROVED BY NRES COMMITTEE LONDON – CAMBERWELL ST 
GILES  
(To appear on Trust headed paper) 
 
After you left the two characters in the pub, a third, neutral character entered who 
was not affiliated with any particular football team. This character intervened 
between the two men and asked them what had been happening. The three of them 
sat at a table and talked calmly about what had happened. The person who initially 
started the confrontation apologised to the other character for being rude. The 
apology was accepted and both men shook hands, leaving the bar with no hard 
feelings. Do you have any questions about this?  
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APPENDIX 6: BEHAVIOUR CODING CHART TEMPLATE  
Participant ID Number of conciliatory/ 
prosocial interventions  
                                               
Non-verbal       Verbal 
Number of antagonistic/ 
aggressive interventions  
 
Non-verbal         Verbal                                
     
     
     
     
     
     
 
 
    
     
     
     
     
     
     
 
 
 
 
 
 
 
 
 
 
